Processing 00000000.tx.1: Heterogeneity within Animal Thioredoxin Reductases EVIDENCE FOR ALTERNATIVE FIRST EXON SPLICING* Qi-An Sun, Francesca Zappacosta, Valentina M. 

Phrase: "Heterogeneity within Animal Thioredoxin Reductases EVIDENCE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "FOR ALTERNATIVE FIRST EXON SPLICING"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "* Qi-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376586:Qi [Idea or Concept]

Phrase: "An Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Francesca Zappacosta,"

Phrase: "Valentina M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Factor, Peter J. 

Phrase: "Factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "Peter J."
Processing 00000000.tx.3: Wirth, Dolph L. 

Phrase: "Wirth,"

Phrase: "Dolph L."
Processing 00000000.tx.4: Hatfield, and Vadim N. 

Phrase: "Hatfield,"

Phrase: "and"

Phrase: "Vadim N."
Processing 00000000.tx.5: Gladyshev** From the Department of Biochemistry, University of Nebraska, Lincoln, Nebraska 68588,the SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406,the Laboratory of Experimental Carcinogenesis, NCI, National Institutes of Health, Bethesda, Maryland 20892,and the Basic Research Laboratory, NCI, National Institutes of Health, Bethesda, Maryland 20892 Received for publication, June 1,2000, and in revised form, September 25,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Animal thioredoxin reductases (TRs) are selenocysteine-containing flavoenzymes that utilize NADPH for reduction of thioredoxins and other protein and nonprotein substrates. 

Phrase: "Gladyshev"

Phrase: "*"

Phrase: "*"

Phrase: "From the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "University of Nebraska,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027523:Nebraska [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lincoln,"

Phrase: "Nebraska 68588,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: "the SmithKline Beecham Pharmaceuticals,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   827   C1254351:Pharmaceuticals [Pharmacologic Substance]
   793 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   734   C0331901:Smith Kline Beecham [Health Care Related Organization]
   734   C1552903:SmithKline Beecham [Health Care Related Organization]

Phrase: "King of Prussia,"

Phrase: "Pennsylvania 19406,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "the Laboratory of Experimental Carcinogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "NCI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513882:NCI [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]

Phrase: "and"

Phrase: "the Basic Research Laboratory,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0022886:research laboratory [Research Activity]
   901   C0681833:Basic Research [Research Activity]
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1527178:Basic [Functional Concept]
   827   C3244292:laboratory [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: "NCI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513882:NCI [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "June 1,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 25,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animal thioredoxin reductases (TRs)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "are"

Phrase: "selenocysteine-containing flavoenzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0544533:Flavoenzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "utilize"

Phrase: "NADPH for reduction of thioredoxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "other protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "nonprotein substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.6: Three types of mammalian TRs are known, with TR1 being a cytosolic enzyme, and TR3, a mitochondrial enzyme. 

Phrase: "Three types of mammalian TRs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0332307:Types [Qualitative Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "with TR1"

Phrase: "being"

Phrase: "a cytosolic enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "TR3,"

Phrase: "a mitochondrial enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.7: Previously characterized TR1 and TR3 occurred as homodimers of 55-57-kDa subunits. 

Phrase: "Previously characterized TR1"

Phrase: "and"

Phrase: "TR3"

Phrase: "occurred as homodimers of 55-57-kDa subunits."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0450382:55 [Intellectual Product]
   744   C1532717:kDa [Quantitative Concept]
   744   C1709305:Occurred [Activity]
   711   C1711351:Subunit [Quantitative Concept]
   711 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.8: We report here that TR1 isolated from mouse liver, mouse liver tumor, and a human T-cell line exhibited extensive heterogeneity as detected by electrophoretic, immunoblot, and mass spectrometry analyses. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that TR1"

Phrase: "isolated from mouse liver,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C1517914:Mouse Liver [Tissue]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2346688:LIVER [Food]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "mouse liver tumor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0023903:LIVER TUMOR [Neoplastic Process]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   734   C1517914:Mouse Liver [Tissue]

Phrase: "and"

Phrase: "a human T-cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0039194:T-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "extensive heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "as"

Phrase: "detected by electrophoretic, immunoblot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020985:Immunoblot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mass spectrometry analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]
Processing 00000000.tx.9: In particular, a 67-kDa band of TR1 was detected. 

Phrase: "In particular,"

Phrase: "a 67-kDa band of TR1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: Furthermore, a novel form of mouse TR1 cDNA encoding a 67-kDa selenoprotein subunit with an additional N-terminal sequence was identified. 

Phrase: "Furthermore,"

Phrase: "a novel form of mouse TR1 cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a 67-kDa selenoprotein subunit with an additional N-terminal sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.11: Subsequent homology analyses revealed three distinct isoforms of mouse and rat TR1 mRNA. 

Phrase: "Subsequent homology analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "three distinct isoforms of mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "rat TR1 mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.12: These forms differed in 5' sequences that resulted from the alternative use of the first three exons but had common downstream sequences. 

Phrase: "These forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "differed in 5'"

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "resulted from the alternative use of the first three exons"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C1524063:Use of [Functional Concept]
   739   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0042153:use [Functional Concept]
   739   C0205435:First [Quantitative Concept]
   739   C0205449:Three [Quantitative Concept]
   739   C0457083:Use [Functional Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1523987:Alternative [Conceptual Entity]
   739   C1947944:Use [Intellectual Product]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "but"

Phrase: "had"

Phrase: "common downstream sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.13: Similarly, expression of multiple mRNA forms was observed for human TR3 and Drosophila TR. 

Phrase: "Similarly,"

Phrase: "expression of multiple mRNA forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1515670:mRNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1554102:Formal Expression [Idea or Concept]

Phrase: "was"

Phrase: "observed for human TR3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "Drosophila TR."
Processing 00000000.tx.14: In these genes, alternative first exon splicing resulted in the formation of predicted mitochondrial and cytosolic proteins. 

Phrase: "In these genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "alternative first exon splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "resulted in the formation of predicted mitochondrial"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0026237:Mitochondrial [Cell Component]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C0681842:Predicted [Idea or Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1882327:%{Predicted} [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "cytosolic proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.15: In addition, a human TR3 gene overlapped with the gene for catechol-O-methyltransferase (COMT) on a complementary DNA strand, such that mitochondrial TR3 and membrane-bound COMT mRNAs had common first exon sequences; 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a human TR3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "overlapped with the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "for catechol-O-methyltransferase (COMT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on a complementary DNA strand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704972:Strand [Spatial Concept]
   827   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "such"

Phrase: "that mitochondrial TR3"

Phrase: "and"

Phrase: "membrane-bound COMT mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "common first exon sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.16: however, transcription start sites for predicted cytosolic TR3 and soluble COMT forms were separated by ~30 kilobases. 

Phrase: "however,"

Phrase: "transcription start sites for predicted cytosolic TR3"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   814   C0949639:Transcription Start Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040649:Transcription [Genetic Function]
   748   C0205145:Sites [Spatial Concept]
   748   C0439659:Start [Temporal Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "soluble COMT forms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0348078:forms [Qualitative Concept]
   804   C0376315:Forms [Manufactured Object]
   771 E C1522492:Form [Functional Concept]
   717   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]

Phrase: "were"

Phrase: "separated by ~30 kilobases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   737   C0582519:kilobase [Quantitative Concept]
Processing 00000000.tx.17: Thus, this study demonstrates a remarkable heterogeneity within TRs, which, at least in part, results from evolutionary conserved genetic mechanisms employing alternative first exon splicing. 

Phrase: "Thus,"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "a remarkable heterogeneity within TRs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "which,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "results from evolutionary conserved genetic mechanisms"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C0441712:Mechanisms [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   748   C0282688:Genetic Evolution [Biologic Function]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "alternative first exon splicing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]
Processing 00000000.tx.18: Multiple transcription start sites within TR genes may be relevant to complex regulation of expression and/or organelle- and cell type-specific location of animal thioredoxin reductases.  

Phrase: "Multiple transcription start sites within TR genes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   814   C0949639:Transcription Start Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0040649:genes transcription [Genetic Function]
           Transcription
   748   C0205145:Sites [Spatial Concept]
   748   C0439659:Start [Temporal Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "relevant to complex regulation of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "and/or"

Phrase: "organelle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelle [Cell Component]

Phrase: "and"

Phrase: "cell type-specific location of animal thioredoxin reductases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450429:Location [Spatial Concept]
   744   C1515974:Location [Body Location or Region]
Processing 00000000.tx.19: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The thioredoxin redox system is one of two major redox systems in animal cells, which, together with the glutathione system, participates in the redox control of a great variety of biological processes involved in cell life and death (1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The thioredoxin redox system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "one of two major redox systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in animal cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which,"

Phrase: "together with the glutathione system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "participates in the redox control of a great variety of biological processes"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   753   C0031845:Biological Processes [Physiologic Function]
   751   C0678661:Biological control [Biologic Function]
   736   C0005532:Biological [Biomedical Occupation or Discipline]
   736   C0030012:Redox [Molecular Function]
   736   C0205460:biological [Qualitative Concept]
   736   C0243148:control [Qualitative Concept]
   736   C0549177:Great [Quantitative Concept]
   736   C1550141:Control [Substance]
   736   C1704243:Great [Quantitative Concept]
   736   C1882979:Control [Conceptual Entity]
   736   C1883525:Variety [Conceptual Entity]
   736   C2346866:Variety [Conceptual Entity]
   736   C2587213:Control [Functional Concept]
   736   C3274648:Control [Qualitative Concept]
   703   C1184743:Process [Body Part, Organ, or Organ Component]
   703   C1522240:Process [Phenomenon or Process]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell life and death"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0007587:Cell Death [Cell Function]
   804   C0011065:Death [Organism Function]
   804   C0376558:Life [Idea or Concept]
   804   C1306577:Death, NOS [Finding]
   721 E C0595998:lives [Finding]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Disruption of the gene for thioredoxin 1,a 12-kDa thiol disulfide oxidoreductase, results in embryonic lethality in mice (4) demonstrating an essential role of the thioredoxin system in the development of mammals. 

Phrase: "Disruption of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "for thioredoxin 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1956394:Thioredoxin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a 12-kDa thiol disulfide oxidoreductase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0087081:Thiol-Disulfide Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1537381:oxidoreductase [Gene or Genome]

Phrase: "results in embryonic lethality"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0013935:Embryonic [Embryonic Structure]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(4"

Phrase: ")"

Phrase: "demonstrating"

Phrase: "an essential role of the thioredoxin system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of mammals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]
Processing 00000000.tx.21: Three distinct thioredoxin reductases (TRs)1 (5-10) are responsible for maintaining thioredoxins in a reduced state and are also capable of reducing a great variety of other protein and nonprotein redox substrates. 

Phrase: "Three distinct thioredoxin reductases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(TRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "responsible for maintaining thioredoxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in a reduced state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "are"

Phrase: "also capable of reducing"

Phrase: "a great variety of other protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "nonprotein redox substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.22: The cytosolic thioredoxin reductase (TR1), the most characterized of the three enzymes, was known for decades, but only recently it was found to be a selenium-containing protein (11). 

Phrase: "The cytosolic thioredoxin reductase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(TR1"

Phrase: ")"

Phrase: ","

Phrase: "the most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "characterized of the three enzymes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1880022:Characterized [Activity]

Phrase: "was"

Phrase: "known for decades,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   756   C2981279:Decade [Quantitative Concept]

Phrase: "but"

Phrase: "only recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a selenium-containing protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: TR1 contains a C-terminal penultimate selenocysteine residue encoded by TGA (12), and this residue is essential for catalytic activity of the enzyme (13-15). 

Phrase: "TR1"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a C-terminal penultimate selenocysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C1709915:Residue [Conceptual Entity]
   799   C1882936:RESIDUE [Phenomenon or Process]
   727 E C1609982:Residual [Qualitative Concept]

Phrase: "encoded by TGA (12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0679058:encoded [Mental Process]
   770   C2699751:TGA [Gene or Genome]
   770   C2700640:Encoded [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "is"

Phrase: "essential for catalytic activity of the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]

Phrase: "(13-15"

Phrase: ")."
Processing 00000000.tx.24: One of the first indications that multiple TR forms occur in mammalian cells was immunoblot analyses of various human TR preparations. 

Phrase: "One of the first indications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "that multiple TR forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "occur in mammalian cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "immunoblot analyses of various human TR preparations."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020985:Immunoblot [Laboratory Procedure]
           Immunoblot Analysis
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]
Processing 00000000.tx.25: An enzyme possessing TR activity that was isolated from a human lung adenocarcinoma cell line NCI-H441 failed to react with antibodies specific for rat liver TR1 (11), whereas TR isolated from a human T-cell line JPX9 reacted with these antibodies (12). 

Phrase: "An enzyme possessing TR activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "was"

Phrase: "isolated from a human lung adenocarcinoma cell line NCI-H441"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   777   C0682523:Human Cell Line [Cell]
   760   C0007600:Cell Line [Cell]
   760   C0152013:Lung adenocarcinoma [Neoplastic Process]
   760   C1510779:Adenocarcinoma Cell [Cell]
   757   C0427861:cell human [Laboratory or Test Result]
   739   C0001418:Adenocarcinoma [Neoplastic Process]
   739   C0007634:Cell [Cell]
   739   C0024109:Lung [Body Part, Organ, or Organ Component]
   739   C0086418:Human [Human]
   739   C0205132:Line [Spatial Concept]
   739   C0205409:Isolated [Functional Concept]
   739   C0819757:LUNG [Tissue]
   739   C1269647:Cell [Cell]
   739   C1278908:Lung [Body Part, Organ, or Organ Component]
   739   C1513882:NCI [Health Care Related Organization]
   739   C1548221:Isolated [Idea or Concept]
   739   C1550648:Line [Substance]
   739   C1552960:Line [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "react with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for rat liver TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "TR"

Phrase: "isolated from a human T-cell line JPX9"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   793   C0682523:Human Cell Line [Cell]
   770   C0007600:Cell Line [Cell]
   770   C0039194:T-cell [Cell]
   767   C0427861:cell human [Laboratory or Test Result]
   744   C0007634:Cell [Cell]
   744   C0086418:Human [Human]
   744   C0205132:Line [Spatial Concept]
   744   C0205409:Isolated [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "reacted with these antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.26: Determination of internal peptide sequences of the T-cell TR demonstrated that this protein was TR1 (12). 

Phrase: "Determination of internal peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "sequences of the T-cell TR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0039194:T-cell [Cell]
   783   C1267822:Tr cell [Cell]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0007634:Cell [Cell]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1269647:Cell [Cell]
   753   C1519249:Sequence [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "TR1"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.27: Unfortunately, the NCI-H441 enzyme was not sequenced, and in retrospect it seems possible, that this TR could have been encoded by a different gene. 

Phrase: "Unfortunately,"

Phrase: "the NCI-H441 enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: ","

Phrase: "and in retrospect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this TR"

Phrase: "could"

Phrase: "have"

Phrase: "been"

Phrase: "encoded by a different gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C0679058:encoded [Mental Process]
   760   C1705242:Different [Qualitative Concept]
   760   C2700640:Encoded [Activity]
Processing 00000000.tx.28: In addition to a TR form not reacting with anti-TR1 antibodies, subsequent studies identified two forms of TR1 isolated from either NCI-H441 or HeLa cells that showed a positive immunoblot signal with these antibodies (16-18). 

Phrase: "In addition to a TR"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reacting with anti-TR1 antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two forms of TR1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "isolated from either NCI-H441"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205409:Isolated [Functional Concept]
   760   C1513882:NCI [Health Care Related Organization]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a positive immunoblot signal with these antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.29: Yet, these forms differed in catalytic activity, selenium content, and affinity for column matrices. 

Phrase: "Yet,"

Phrase: "these forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "differed in catalytic activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0007382:Catalytic [Natural Phenomenon or Process]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "selenium content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "affinity for column matrices."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.30: In particular, forms that differed in the ability to bind to a heparin column were extensively characterized (16-18). 

Phrase: "In particular,"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "differed in the ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "bind to a heparin column"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.31: However, differences in either protein or gene sequences, or in post-translational modifications that were responsible for the observed changes in catalytic and chromatographic properties, were not reported. 

Phrase: "However,"

Phrase: "differences in either protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "gene sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0017337:Gene [Gene or Genome]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "or in post-translational modifications"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0033666:Post-Translational Modifications [Molecular Function]
   760   C0687676:Post [Temporal Concept]
   760   C1519614:Translational [Genetic Function]
   760   C1704687:Post [Manufactured Object]
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "responsible for the observed changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in catalytic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:Catalytic [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "chromatographic properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.32: Recently, two additional thioredoxin reductases, TR2 and TR3, were identified that contained the conserved selenocysteine residue (5-10). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "two additional thioredoxin reductases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "TR2"

Phrase: "and"

Phrase: "TR3,"

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the conserved selenocysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.33: These enzymes had also other sequences essential for catalytic activity, including an N-terminal disulfide active center, NADPH- and FAD-binding domains and dimer interface sequences (5-10). 

Phrase: "These enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "had"

Phrase: "also"

Phrase: "other sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "essential for catalytic activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an N-terminal disulfide active center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205099:Center [Spatial Concept]

Phrase: "NADPH-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "FAD-binding domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
   734   C3156162:FAD binding [Molecular Function]

Phrase: "and"

Phrase: "dimer interface sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.34: The three TR enzymes showed >50% sequence identity, although TR1 and TR2 were closely related enzymes, while TR3 was a more evolutionary distant enzyme (10). 

Phrase: "The three TR enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ">50% sequence identity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]

Phrase: "although"

Phrase: "TR1"

Phrase: "and"

Phrase: "TR2"

Phrase: "were"

Phrase: "closely related enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "while"

Phrase: "TR3"

Phrase: "was"

Phrase: "a more evolutionary distant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.35: TR3 (also called TR (5) and TrxR2 (6)), like TR1, appeared to be ubiquitously expressed (5-10). 

Phrase: "TR3"

Phrase: "(also called TR (5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0679006:Call [Mental Process]
   779   C1947967:Call [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "TrxR2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425351:TRXR2 [Gene or Genome]

Phrase: "(6"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "like TR1,"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.36: This enzyme was described as a mitochondrial thioredoxin reductase because it was shown to contain a mitochondrial signal peptide. 

Phrase: "This enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "described as a mitochondrial thioredoxin reductase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1425351:THIOREDOXIN REDUCTASE, MITOCHONDRIAL [Gene or Genome]
   790   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1456398:THIOREDOXIN, MITOCHONDRIAL [Gene or Genome]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1552738:described [Idea or Concept]
   753   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "because"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a mitochondrial signal peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.37: In addition, this protein was localized in mitochondria by detecting various transiently expressed, tagged forms of TR3 and by immunoblot assays with antibodies specific for TR3 (5-10). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "localized in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C0392752:Localized [Spatial Concept]

Phrase: "by detecting various transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0442726:detect [Finding]

Phrase: "expressed"

Phrase: ","

Phrase: "tagged forms of TR3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and by immunoblot assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0020985:assays immunoblot [Laboratory Procedure]
           Immunoblot
   770   C1515981:And [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for TR3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: TR2 had not been extensively characterized nor its full amino acid sequence reported (10). 

Phrase: "TR2"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "extensively"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "nor"

Phrase: "its full amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   923   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.39: In the present report, we describe the occurrence of multiple forms of TR1 and TR3 and utilize genetic and biochemical techniques to characterize the basis for heterogeneity within animal TR preparations. 

Phrase: "In the present report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "describe"

Phrase: "the occurrence of multiple forms of TR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243132:occurrence [Functional Concept]
   748   C1554210:occurrence [Idea or Concept]
   748   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "TR3"

Phrase: "and"

Phrase: "utilize"

Phrase: "genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "biochemical techniques to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "characterize"

Phrase: "the basis for heterogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1527178:Basis [Functional Concept]
   770   C1874451:Basis [Pharmacologic Substance]

Phrase: "within animal TR preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.40: We find differences in 5'-end cDNA sequences for mammalian TR1, mammalian TR3, and Drosophila TR that resulted from the alternative use of first exons.  

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "differences in 5'-end cDNA sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "for mammalian TR1,"

Phrase: "mammalian TR3,"

Phrase: "and"

Phrase: "Drosophila TR"

Phrase: "that"

Phrase: "resulted from the alternative use of first exons."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1524063:Use of [Functional Concept]
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0042153:use [Functional Concept]
   744   C0205435:First [Quantitative Concept]
   744   C0457083:Use [Functional Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1523987:Alternative [Conceptual Entity]
   744   C1947944:Use [Intellectual Product]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.41: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Partial Isolation of Mouse TRs from Normal Livers and Liver Tumors on an ADP-Sepharose Column-- Male wild type and transforming growth factor (TGF)/c-myc double transgenic mice (6-15 months old) were maintained and labeled with 75Se, and their livers and liver tumors were dissected as described previously (19). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Partial Isolation of Mouse TRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "from Normal Livers"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   966   C0577059:normal liver [Finding]
   861   C0023884:Livers [Body Part, Organ, or Organ Component]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   827 E C1278929:Liver [Body Part, Organ, or Organ Component]
   827 E C2346688:LIVER [Food]
   789 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "Liver Tumors on an ADP-Sepharose Column"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   778   C0023903:liver tumors [Neoplastic Process]
   748   C0027651:Tumors [Neoplastic Process]
   714 E C1578706:Tumor [Intellectual Product]
   714 E C3273930:Tumor [Finding]

Phrase: "--"

Phrase: "Male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "wild type and transforming growth factor (TGF)/c-myc"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   878   C0445393:Wild C [Intellectual Product]
   812   C1883559:Wild Type [Organism Attribute]
   793   C0332307:Type [Qualitative Concept]
   793   C0445392:Wild [Intellectual Product]
   793   C1547052:*Type [Quantitative Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(6-15 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "labeled with 75Se,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "their livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "liver tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0023903:liver tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: The coexpression of TGF and c-Myc results in multiple liver tumor formation by 6months of age. 

Phrase: "The coexpression of TGF"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C1510411:Transforming [Pathologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "c-Myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "results in multiple liver tumor formation"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0023903:LIVER TUMOR [Neoplastic Process]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0220781:formation [Biologic Function]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1274040:Result [Functional Concept]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C1522492:Formation [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C2346688:LIVER [Food]
   753   C2825142:Result [Finding]
   753   C3273930:Tumor [Finding]

Phrase: "by 6months"

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.43: Three unlabeled wild type mouse livers (4g) and a single 75Se-labeled wild type liver (0.5g) were mixed and homogenized in 10ml of 40mM Tris-HCl, pH 7.5,100mM NaCl, 1mM EDTA, 0.6mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 5g/ml aprotinin, and 5g/ml leupeptin (buffer A). 

Phrase: "Three unlabeled wild type mouse livers"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   810   C1517914:Mouse Liver [Tissue]
   799   C0023884:Livers [Body Part, Organ, or Organ Component]
   766 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   766 E C1278929:Liver [Body Part, Organ, or Organ Component]
   766 E C2346688:LIVER [Food]
   727 E C0205054:Hepatic [Body Location or Region]

Phrase: "(4g"

Phrase: ")"

Phrase: "and"

Phrase: "a single 75Se-labeled wild type liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0023884:Liver [Body Part, Organ, or Organ Component]
   799   C0736268:LIVER [Body Part, Organ, or Organ Component]
   799   C1278929:Liver [Body Part, Organ, or Organ Component]
   799   C2346688:LIVER [Food]
   743 E C0205054:Hepatic [Body Location or Region]

Phrase: "(0.5g"

Phrase: ")"

Phrase: "were"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "homogenized in 10ml of 40mM Tris-HCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0450402:40mm [Quantitative Concept]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.6mM 4-"

Phrase: "(2-aminoethyl"

Phrase: ")"

Phrase: "benzenesulfonyl fluoride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "5g/ml leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(buffer A"

Phrase: ")."
Processing 00000000.tx.44: The homogenate was centrifuged at 18,000rpm for 20min, and the supernatant was loaded directly onto a 3-ml ADP-Sepharose (Amersham Pharmacia Biotech) column. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000rpm for 20min,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "directly onto a 3-ml ADP-Sepharose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0036681:Sepharose [Carbohydrate]
   748   C0439526:/mL [Quantitative Concept]
   748   C0523452:ADP [Laboratory Procedure]
   748   C1947931:Directly [Qualitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]
Processing 00000000.tx.45: The column was washed extensively with 150mM NaCl and 40mM Tris-HCl, pH 7.5,and proteins were eluted with 1M NaCl in 40mM Tris-HCl, pH 7.5.

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively with 150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "40mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with 1M NaCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0470296:1M [Quantitative Concept]
   770   C1959973:% NaCl [Quantitative Concept]

Phrase: "in 40mM Tris-HCl,"

Phrase: "pH 7.5."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.46: Protein fractions were tested by SDS-PAGE and immunoblot analyses with antibodies specific for TR1 and TR3 (10), pooled, and further analyzed by a two-dimensional gel electrophoresis. 

Phrase: "Protein fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "tested by SDS-PAGE"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0392366:tested [Intellectual Product]
   770   C1704732:Page [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "immunoblot analyses with antibodies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "specific for TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "TR3"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by a two-dimensional gel electrophoresis."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   804   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   778   C1705052:2-Dimensional [Spatial Concept]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0205448:Two [Quantitative Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1382104:Gel [Substance]
Processing 00000000.tx.47: TR1 was also isolated from TGF/c-myc tumors using the same procedure except that 5unlabeled liver tumors (11.5g) and one 75Se-labeled liver tumor (3.5g) were homogenized in 15ml of buffer A. 

Phrase: "TR1"

Phrase: "was"

Phrase: "also"

Phrase: "isolated from TGF/c-myc tumors"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   782   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1295487:factor c [Amino Acid, Peptide, or Protein,Enzyme]
   741   C0598934:growth tumor [Neoplastic Process]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0027651:Tumors [Neoplastic Process]
   739   C0205409:Isolated [Functional Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0332307:Type [Qualitative Concept]
   739   C1510411:Transforming [Pathologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1547052:*Type [Quantitative Concept]
   739   C1548221:Isolated [Idea or Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   706 E C0370215:Isolate [Substance]
   706 E C1578706:Tumor [Intellectual Product]
   706 E C1875400:ISOLATE [Pharmacologic Substance]
   706 E C3273930:Tumor [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that 5unlabeled liver tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0023903:liver tumors [Neoplastic Process]
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "(11.5g"

Phrase: ")"

Phrase: "and"

Phrase: "one 75Se-labeled liver tumor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0023903:LIVER TUMOR [Neoplastic Process]
   804   C0027651:Tumor [Neoplastic Process]
   804   C1578706:Tumor [Intellectual Product]
   804   C3273930:Tumor [Finding]

Phrase: "(3.5g"

Phrase: ")"

Phrase: "were"

Phrase: "homogenized in 15ml of buffer A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.48: TR1 Purification-- TR1 was isolated from mouse liver, rat prostate, and a human T-cell line JPX9 according to a three-step procedure that involved DEAE-Sepharose (Amersham Pharmacia Biotech), ADP-Sepharose, and phenyl-HPLC columns (TosoHaas) as described previously (12). 

Phrase: "TR1 Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "TR1"

Phrase: "was"

Phrase: "isolated from mouse liver,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C1517914:Mouse Liver [Tissue]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2346688:LIVER [Food]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "rat prostate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882832:Rat Prostate [Body Part, Organ, or Organ Component]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a human T-cell line JPX9 according to a three-step procedure"

Phrase: "that involved DEAE-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Sepharose [Carbohydrate]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "ADP-Sepharose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "and"

Phrase: "phenyl-HPLC columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]

Phrase: "(TosoHaas"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.49: To obtain 75Se-labeled TR1, unlabeled mouse livers were mixed with a single 75Se-labeled wild type liver. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "75Se-labeled TR1,"

Phrase: "unlabeled mouse livers"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   884   C1517914:Mouse Liver [Tissue]
   827   C0023884:Livers [Body Part, Organ, or Organ Component]
   793 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   793 E C1278929:Liver [Body Part, Organ, or Organ Component]
   793 E C2346688:LIVER [Food]
   755 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "mixed with a single 75Se-labeled wild type liver."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0023884:Liver [Body Part, Organ, or Organ Component]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   742   C0205430:Mixed [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C0736268:LIVER [Body Part, Organ, or Organ Component]
   742   C1278929:Liver [Body Part, Organ, or Organ Component]
   742   C1547052:*Type [Quantitative Concept]
   742   C1708632:Labeled [Qualitative Concept]
   742   C2346688:LIVER [Food]
   742   C3160715:Mixed [Finding]
   708 E C0181496:Label [Manufactured Object]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]
   708 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.50: Isolated proteins were analyzed by immunoblot assays with antibodies specific for TR1, TR2, and TR3 (10), protein staining with Coomassie Blue and by detecting 75Se with a PhosphorImager (Molecular Dynamics). 

Phrase: "Isolated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "analyzed by immunoblot assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0020985:assays immunoblot [Laboratory Procedure]
           Immunoblot
   770   C0936012:Analyzed [Research Activity]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for TR1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "TR2,"

Phrase: "and"

Phrase: "TR3"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "protein staining with Coomassie Blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and by detecting 75Se"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C0442726:detect [Finding]

Phrase: "with a PhosphorImager"

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")."
Processing 00000000.tx.51: To further fractionate the enzyme, TR1 preparation was dialyzed against 20mM Tris-HCl, pH 7.0,and applied onto a heparin-HPLC column (TosoHaas). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "fractionate"

Phrase: "the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "TR1 preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "dialyzed against 20mM Tris-HCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "applied onto a heparin-HPLC column"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0185125:Applied [Health Care Activity]
   753   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "(TosoHaas"

Phrase: ")."
Processing 00000000.tx.52: The proteins were eluted with a gradient of 20-500 mM Tris-HCl, pH 7.0.75Se was detected in fractions with a -counter. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with a gradient of 20-500 mM Tris-HCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   739   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   739   C0439182:% gradient [Quantitative Concept]
   739   C0812409:Gradient [Quantitative Concept]
   739   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.0.75Se"

Phrase: "was"

Phrase: "detected in fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1264633:Fractions [Quantitative Concept]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C1554103:Fraction [Idea or Concept]

Phrase: "with a -counter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0677601:Counter [Manufactured Object]
   861   C1705206:Counter [Medical Device]
Processing 00000000.tx.53: JPX9 cells were grown on an RPMI 1640medium in the presence of 10% fetal bovine serum and metabolically labeled with 75Se as described previously (12). 

Phrase: "JPX9 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on an RPMI 1640medium"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "metabolically"

Phrase: "labeled with 75Se"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.54: Human A431 cell line was grown as described (10) and TRs were purified from sonicated crude extracts on an ADP-Sepharose column as described for mouse enzymes. 

Phrase: "Human A431 cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "grown as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "TRs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "were"

Phrase: "purified from sonicated crude extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1258023:Crude Extracts [Chemical]
   760   C1998793:Purified [Functional Concept]
   726   C2828366:Extract [Substance]

Phrase: "on an ADP-Sepharose column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "as"

Phrase: "described for mouse enzymes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.55: Two-dimensional Gel Electrophoresis-- Two-dimensional gel electrophoresis of 75Se-contining polypeptides was performed as described previously (20). 

Phrase: "Two-dimensional Gel Electrophoresis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   923   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C1705052:2-Dimensional [Spatial Concept]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0205448:Two [Quantitative Concept]
   812   C1382104:Gel [Substance]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "--"

Phrase: "Two-dimensional gel electrophoresis of 75Se-contining polypeptides"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   793   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   770   C1705052:2-Dimensional [Spatial Concept]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0205448:Two [Quantitative Concept]
   744   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.56: Briefly, 25l of each TR preparation (500g of total protein), which was partially purified on an ADP-Sepharose column, were resolved in the first dimension on an isoelectric focusing (IEF) gel, followed by separation in the second dimension on a 10% polyacrylamide gel under reducing conditions. 

Phrase: "Briefly,"

Phrase: "25l of each TR preparation"

Phrase: "(500g of total protein"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "partially"

Phrase: "purified on an ADP-Sepharose column,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036681:Sepharose [Carbohydrate]
   753   C0523452:ADP [Laboratory Procedure]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1998793:Purified [Functional Concept]

Phrase: "were"

Phrase: "resolved in the first dimension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205435:First [Quantitative Concept]
   760   C0439534:Dimension [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "on an isoelectric focusing (IEF) gel,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0022169:Isoelectric Focusing [Laboratory Procedure]
   827   C0000936:focusing [Clinical Attribute]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
   827   C2981153:Focusing [Finding]
   793 E C0205234:Focus [Spatial Concept]
   793 E C1285542:focus [Functional Concept]

Phrase: "followed by separation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in the second dimension"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439534:Dimension [Quantitative Concept]
   761 E C1707753:Dimensionality [Spatial Concept]

Phrase: "on a 10% polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "under reducing conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.57: The separated polypeptides were electroblotted on polyvinylidene difluoride membranes, the blots stained with Ponceau S, and the 75Se-containing proteins detected on the dried membranes by the PhosphorImager analysis. 

Phrase: "The separated polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "electroblotted on polyvinylidene difluoride membranes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "the blots"

Phrase: "stained with Ponceau S,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   865   C0071720:Ponceau S stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ponceau S
   802   C0491958:STAIN, PONCEAU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the 75Se-containing proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected on the dried membranes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membranes [Tissue]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1512080:Dried [Qualitative Concept]
   760   C2827485:Dried [Body Substance]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "by the PhosphorImager analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.58: Peptide Mapping-- TR samples purified by one-dimensional or two-dimensional gel electrophoresis were transferred onto polyvinylidene difluoride membranes and stained with either Ponceau S or Sulforodamine B.Bands were excised and digested with trypsin as described (21). 

Phrase: "Peptide Mapping"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0030944:Peptide Mapping [Laboratory Procedure]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1283195:Mapping [Activity]
   827 E C0024779:Map [Manufactured Object]
   827 E C1706473:Map [Conceptual Entity]

Phrase: "--"

Phrase: "TR samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "purified by one-dimensional"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205447:One [Quantitative Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "two-dimensional gel electrophoresis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   923   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C1705052:2-Dimensional [Spatial Concept]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0205448:Two [Quantitative Concept]
   812   C1382104:Gel [Substance]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "were"

Phrase: "transferred onto polyvinylidene difluoride membranes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "stained with either Ponceau S"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0071720:Ponceau S stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ponceau S
   781   C0491958:STAIN, PONCEAU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "Sulforodamine B.Bands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]
   734   C0065078:sulforodamine B [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "excised"

Phrase: "and"

Phrase: "digested with trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.59: After digestion, peptides were extracted from the membrane with the addition of 10l of formic acid:ethanol (1:1) for 1h at room temperature. 

Phrase: "After digestion,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "extracted from the membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 10l"

Phrase: "of formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:Ethanol [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: 0.5l were sampled directly from the supernatant to the matrix-assisted laser desorption ionization (MALDI) plate, mixed with 0.5l of -cyano-4-hydroxy cinnamic acid matrix (10mg/ml in acetonitrile/trifluoroacetic acid, 0.1%) and allowed to air-dry before data collection. 

Phrase: "0.5l"

Phrase: "were"

Phrase: "sampled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0441621:sampled [Diagnostic Procedure]
  1000   C0870078:sampled [Idea or Concept]
   966 E C0370003:Sample [Substance]
   966 E C2347026:Sample [Conceptual Entity]

Phrase: "directly from the supernatant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1550101:Supernatant [Body Substance]
   770   C1947931:Directly [Qualitative Concept]

Phrase: "to the matrix-assisted laser desorption ionization (MALDI) plate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0005971:Plate [Medical Device]
   799   C1139930:plate [Medical Device]
   799   C3537155:Plate [Manufactured Object]
   780   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "with 0.5l of -cyano-4-hydroxy cinnamic acid matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1704640:Matrix [Spatial Concept]
   791   C1706515:Matrix [Body Substance]

Phrase: "(10mg/ml in acetonitrile/trifluoroacetic acid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "0.1%"

Phrase: ")"

Phrase: "and"

Phrase: "allowed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0683607:allowed [Social Behavior]

Phrase: "air-dry before data collection."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010995:Data Collection [Research Activity]
   760   C0001861:Air [Substance]
   760   C0011682:Dry [Natural Phenomenon or Process]
   760   C0205222:Dry [Qualitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1512080:Dry [Qualitative Concept]
   760   C1516698:Collection [Functional Concept]
   760   C1704814:Collection [Idea or Concept]
   760   C3245479:data [Medical Device]
   760   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: Spectra were acquired on a Voyager RP mass spectrometer using oxidized bovine insulin chain as internal standard for calibration (21, 22). 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "acquired on a Voyager RP mass spectrometer"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0183396:Mass Spectrometer [Medical Device]
   748   C0183395:Spectrometer [Medical Device]
   748   C0439661:Acquired [Temporal Concept]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1538326:RP [Gene or Genome]
   748   C1710143:Spectrometer [Manufactured Object]
   748   C3152252:Mass [Quantitative Concept]
   748   C3245488:acquired [Intellectual Product]
   748   C3541325:RP [Idea or Concept]
   714 E C1706701:Acquire [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oxidized bovine insulin chain as internal standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]

Phrase: "for calibration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006751:Calibration [Quantitative Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.62: Mass Spectrometric Analysis of Intact Human TR Molecules-- Mass spectrometric analysis of native or alkylated human TR proteins was performed on a API300 triple quadrupole mass spectrometer equipped with a Micro-IonSpray source. 

Phrase: "Mass Spectrometric Analysis of Intact Human TR Molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   725   C1513380:Molecular Analysis [Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Mass spectrometric analysis of native"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "or"

Phrase: "alkylated human TR proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "performed on a API300 triple quadrupole mass spectrometer"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0183396:Mass Spectrometer [Medical Device]
   744   C0183395:Spectrometer [Medical Device]
   744   C0205174:Triple [Quantitative Concept]
   744   C0577559:Mass [Finding]
   744   C0884358:Performed [Functional Concept]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1710143:Spectrometer [Manufactured Object]
   744   C2347727:Quadrupole [Research Device]
   744   C3152252:Mass [Quantitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "equipped with a Micro-IonSpray source."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0085672:MICRO [Laboratory Procedure]
   753   C0449416:Source [Finding]
   753   C1553035:Micro [Quantitative Concept]
   753   C1705919:Source [Idea or Concept]
Processing 00000000.tx.63: Prior to MS analysis proteins were purified by RP-HPLC on a narrow-bore Vydac C4 column (1502.1mm, 5m) using a linear gradient of 0-70% acetonitrile containing 0.1% trifluoroacetic acid and a flow rate of 250l/min. 

Phrase: "Prior to MS analysis proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purified by RP-HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008562:HPLC [Laboratory Procedure]
   770   C1538326:RP [Gene or Genome]
   770   C1998793:Purified [Functional Concept]
   770   C3541325:RP [Idea or Concept]

Phrase: "on a narrow-bore Vydac C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "(1502.1mm,"

Phrase: "5m"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "of 0-70% acetonitrile containing 0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040982:Trifluoroacetic Acid [Organic Chemical]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "a flow rate of 250l/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2826285:Flow Rate [Quantitative Concept]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.64: Samples were manually collected and directly injected into the mass spectrometer ion source by infusion at 1l/min. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "manually"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "injected into the mass spectrometer ion source"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0183396:Mass Spectrometer [Medical Device]
   778   C1708574:Ion Source [Research Device]
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C0183395:Spectrometer [Medical Device]
   748   C0449416:Source [Finding]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1700702:ION [Functional Concept]
   748   C1705919:Source [Idea or Concept]
   748   C1710143:Spectrometer [Manufactured Object]
   748   C3152252:Mass [Quantitative Concept]
   714   C1720154:Inject [Functional Concept]

Phrase: "by infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "at 1l/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.65: Reduction and alkylation of TRs was conducted in denaturing conditions (6M guanidine HCl, pH 8.0) using iodoacetamide as an alkylating agent. 

Phrase: "Reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "alkylation of TRs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002074:Alkylation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "conducted in denaturing conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0004927:Conduct [Individual Behavior]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "(6M guanidine HCl,"

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "iodoacetamide as an alkylating agent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.66: Other Procedures-- Mouse cDNA clones (clone ID 607552,accession number AI662374, Stratagene mouse skin cDNA library; and clone ID 2064717,accession number AI789478, Sugano mouse kidney-mkia cDNA library) were purchased from Research Genetics and their insert sequences experimentally determined. 

Phrase: "Other Procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "--"

Phrase: "Mouse cDNA clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(clone ID 607552,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0009013:Clone [Cell]
   827   C0600091:ID [Intellectual Product]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "accession number AI662374,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "Stratagene mouse skin cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"

Phrase: "and"

Phrase: "clone ID 2064717,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0009013:Clone [Cell]
   827   C0600091:ID [Intellectual Product]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "accession number AI789478,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "Sugano mouse kidney-mkia cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   799   C0023621:Library [Manufactured Object,Organization]
   799   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Research Genetics"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0243064:genetics research [Research Activity]
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "their insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "experimentally"

Phrase: "determined."
Processing 00000000.tx.67: The two clones overlapped for 510nucleotides and the combined cDNA sequence was 3626nucleotides long. 

Phrase: "The two clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "overlapped for 510nucleotides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0185027:overlapped [Therapeutic or Preventive Procedure]
   756 E C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "the combined cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "3626nucleotides"

Phrase: "long."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.68: SDS-PAGE, immunoblot, and isoelectrofocusing analyses were performed with electrophoretic supplies and gels from Novex. 

Phrase: "SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "immunoblot,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "and"

Phrase: "isoelectrofocusing analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed with electrophoretic supplies"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   770   C0038848:Supplies [Manufactured Object]
   770   C0884358:Performed [Functional Concept]
   770   C1875802:Supplies [Medical Device]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1999230:Supply [Activity]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "gels from Novex."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0017243:Gels [Biomedical or Dental Material]
   756 E C1382104:Gel [Substance]
Processing 00000000.tx.69: Immunoblot membranes were developed with a SuperSignal detection kit (Pierce) or an ECL detection kit (Amersham Pharmacia Biotech) using previously developed antibodies specific for TR1, TR2, and TR3 (10). 

Phrase: "Immunoblot membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "developed with a SuperSignal detection kit (Pierce"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "an ECL detection kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously developed antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for TR1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "TR2,"

Phrase: "and"

Phrase: "TR3"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.70: We have previously demonstrated strict isozyme specificity of these antibodies (10). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "strict isozyme specificity of these antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0003264:antibodies specificity [Molecular Function]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
   731 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.71: Nucleotide sequences were analyzed with BLAST programs (23). 

Phrase: "Nucleotide sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0004793:Sequences, Nucleotide [Nucleotide Sequence]
       E   Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed with BLAST programs"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0337026:Blast [Natural Phenomenon or Process]
   770   C0368761:blast [Cell]
   770   C0376691:Programs [Intellectual Product]
   770   C0936012:Analyzed [Research Activity]
   770   C3484370:Programs [Functional Concept]
   737 E C1709697:Program [Conceptual Entity]
   737 E C2728259:Program [Pharmacologic Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.72: Exons were predicted with a NetGene2 program. 

Phrase: "Exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "predicted with a NetGene2 program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681842:Predicted [Idea or Concept]
   760   C1709697:Program [Conceptual Entity]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
Processing 00000000.tx.73: Mitochondrial signal peptides were predicted with the PSORT II or SignalP programs.  

Phrase: "Mitochondrial signal peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptides [Amino Acid Sequence]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "predicted with the PSORT II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681842:Predicted [Idea or Concept]
   760   C1428115:PSORT [Gene or Genome]
   760   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "or"

Phrase: "SignalP programs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0376691:Programs [Intellectual Product]
   861   C3484370:Programs [Functional Concept]
   827 E C1709697:Program [Conceptual Entity]
   827 E C2728259:Program [Pharmacologic Substance]
Processing 00000000.tx.74: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Heterogeneity within Mouse Thioredoxin Reductase Preparations-- To determine whether mouse TR1 occurs in multiple forms and if the distribution of these forms differs between normal and malignant cells, we partially isolated TRs from a pool of 75Se-labeled wild type mouse livers and from a pool of 75Se-labeled liver tumors developed in TGF/c-myc double transgenic mice. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Heterogeneity within Mouse Thioredoxin Reductase Preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "mouse TR1"

Phrase: "occurs in multiple forms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "if"

Phrase: "the distribution of these forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "differs between normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "malignant cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0334227:Malignant cells [Cell]
  1000   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we partially isolated TRs from a pool"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   737   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of 75Se-labeled wild type mouse livers"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   810   C1517914:Mouse Liver [Tissue]
   799   C0023884:Livers [Body Part, Organ, or Organ Component]
   766 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   766 E C1278929:Liver [Body Part, Organ, or Organ Component]
   766 E C2346688:LIVER [Food]
   727 E C0205054:Hepatic [Body Location or Region]

Phrase: "and from a pool of 75Se-labeled liver tumors"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   770   C0023903:Tumor of liver [Neoplastic Process]
           liver tumors
   742   C0023884:Liver [Body Part, Organ, or Organ Component]
   742   C0027651:Tumors [Neoplastic Process]
   742   C0337051:Pool [Geographic Area]
   742   C0736268:LIVER [Body Part, Organ, or Organ Component]
   742   C1278929:Liver [Body Part, Organ, or Organ Component]
   742   C1509144:pool [Clinical Attribute]
   742   C1515981:And [Idea or Concept]
   742   C1708632:Labeled [Qualitative Concept]
   742   C2346688:LIVER [Food]
   742   C2349200:Pool [Functional Concept]
   708 E C0181496:Label [Manufactured Object]
   708 E C1578706:Tumor [Intellectual Product]
   708 E C2827499:Label [Governmental or Regulatory Activity]
   708 E C3273930:Tumor [Finding]

Phrase: "developed in TGF/c-myc"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1295487:factor c [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C0332307:Type [Qualitative Concept]
   742   C1510411:Transforming [Pathologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.75: To minimize potential losses of certain TR forms due to different elution profiles of these forms on columns commonly used in TR isolation procedures, we utilized only a single step, an affinity ADP-Sepharose chromatography, to purify TRs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "potential losses of certain TR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1517945:Loss [Quantitative Concept]

Phrase: "forms due to different elution profiles of these forms"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C1441565:Elution [Laboratory Procedure]
   742   C1705242:Different [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]
   708 E C1522492:Form [Functional Concept]
   708   C1979963:Profile [Laboratory Procedure]
   708   C2003903:Profile [Functional Concept]

Phrase: "on columns commonly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "used in TR isolation procedures,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   806   C0204727:isolation procedures [Therapeutic or Preventive Procedure]
           Isolation
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]
   760   C1273517:used [Finding]
   760   C2700391:procedures [Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "we"

Phrase: "utilized"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a single step,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0037179:Single [Population Group]
   861   C0087136:single [Finding]
   861   C0205171:Single [Quantitative Concept]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "an affinity ADP-Sepharose chromatography,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   902   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   812   C0008550:Chromatography [Laboratory Procedure]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "TRs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.76: When 75Se-labeled protein extracts obtained from either normal livers or liver tumors were fractionated on an ADP-Sepharose column, TR1, seen as a 75Se-labeled band (Fig. 1A, lanes 3and 6), and TR3, which is masked by TR1 due to its lower abundance (6, 10), were separated from the remainder of 75Se-labeled proteins (Fig. 1A). 

Phrase: "When"

Phrase: "75Se-labeled protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2828366:Extract [Substance]

Phrase: "obtained from either normal livers"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C0577059:Liver normal [Finding]
   760   C0023884:Livers [Body Part, Organ, or Organ Component]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   726 E C1278929:Liver [Body Part, Organ, or Organ Component]
   726 E C1706701:Obtain [Activity]
   726 E C2346688:LIVER [Food]

Phrase: "or"

Phrase: "liver tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0023903:liver tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "fractionated on an ADP-Sepharose column,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036681:Sepharose [Carbohydrate]
   753   C0523452:ADP [Laboratory Procedure]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1979893:Fractionated [Qualitative Concept]

Phrase: "TR1,"

Phrase: "seen as a 75Se-labeled band"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0175723:Band [Medical Device]
   753   C0205397:Seen [Qualitative Concept]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C0181496:Label [Manufactured Object]
   719 E C1947903:See [Activity]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lanes 3and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "TR3,"

Phrase: "which"

Phrase: "is"

Phrase: "masked by TR1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0150108:masked [Research Activity]
   790   C0150112:MASKED [Functional Concept]
   790   C1555580:masked [Idea or Concept]
   756 E C0024861:Mask [Medical Device]
   756 E C1538279:MASK [Gene or Genome]
   756 E C1845191:MASK [Gene or Genome]

Phrase: "due to its lower abundance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "(6,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "separated from the remainder of 75Se-labeled proteins"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.77: Two other major 75Se-labeled proteins that did not bind to the column were glutathione peroxidase 1(GPx1) and glutathione peroxidase 4(GPx4) (19). 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other major 75Se-labeled proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to the column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "glutathione peroxidase 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0763282:glutathione peroxidase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:glutathione peroxidase 1 [Gene or Genome]
           GLUTATHIONE PEROXIDASE
   901   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(GPx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415275:GPX1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "glutathione peroxidase 4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084035:glutathione peroxidase 4 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415278:GLUTATHIONE PEROXIDASE 4 [Gene or Genome]
   901   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(GPx4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415278:GPX4 [Gene or Genome]

Phrase: ")"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.78: Since we used identical procedures for fractionation of normal and tumor samples, comparison of GPx1 and other selenoprotein bands in normal (Fig. 1A, lane 1) and tumor (Fig. 1A, lane 4) samples suggested that the levels of GPx1 were decreased in tumors. 

Phrase: "Since"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "identical procedures for fractionation of normal"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0025664:procedures [Intellectual Product]
   753   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C2700391:procedures [Activity]
   719 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   719 E C3274430:PROCEDURE [Health Care Activity]
   719 E C3538935:Procedure [Idea or Concept]
   719 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "tumor samples,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "comparison of GPx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "other selenoprotein bands in normal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027651:Tumor [Neoplastic Process]
  1000   C1578706:Tumor [Intellectual Product]
  1000   C3273930:Tumor [Finding]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the levels of GPx1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "decreased in tumors."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0027651:Tumors [Neoplastic Process]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]
Processing 00000000.tx.79: A similar decrease was previously observed when normal livers from TGF/c-myc mice were compared with liver tumors from the same mice (19). 

Phrase: "A similar decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "normal livers from TGF/c-myc mice"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   755   C0126032:liver growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0018270:normal growth [Organism Function]
   754   C0578019:Normal growth [Finding]
   738   C0023884:Livers [Body Part, Organ, or Organ Component]
   738   C0205307:Normal [Qualitative Concept]
   738   C0439166:% normal [Quantitative Concept]
   738   C2347086:% Normal [Quantitative Concept]
   737   C0577059:Liver normal [Finding]
   721   C1517914:Mouse Liver [Tissue]
   704 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   704 E C1278929:Liver [Body Part, Organ, or Organ Component]
   704 E C2346688:LIVER [Food]

Phrase: "were"

Phrase: "compared with liver tumors"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0023903:liver tumors [Neoplastic Process]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1707455:Compared [Activity]
   770   C2346688:LIVER [Food]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "from the same mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.80: On the other hand, the latter studies found that expression of TR1 was slightly increased in liver tumors relative to surrounding normal livers in TGF/c-myc mice (19). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the latter studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that expression of TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased in liver tumors"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0023903:liver tumors [Neoplastic Process]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "relative to surrounding normal livers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "in TGF/c-myc mice"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   827   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1295487:factor c [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0150312:In [Quantitative Concept]
   791   C0220844:growth [Physiologic Function]
   791   C0332285:In [Spatial Concept]
   791   C0332307:Type [Qualitative Concept]
   791   C1510411:Transforming [Pathologic Function]
   791   C1521761:Factor [Functional Concept]
   791   C1547052:*Type [Quantitative Concept]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.81: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 1B shows immunoblot analyses of mouse TR1 and TR3 enriched from normal wild type and transgenic malignant livers on an ADP-Sepharose column. 

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "immunoblot analyses of mouse TR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "TR3"

Phrase: "enriched from normal wild type"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205307:Normal [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0359583:enriched [Food]
   760   C0439166:% normal [Quantitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "transgenic malignant livers on an ADP-Sepharose column."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0023884:Livers [Body Part, Organ, or Organ Component]
   711 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   711 E C1278929:Liver [Body Part, Organ, or Organ Component]
   711 E C2346688:LIVER [Food]
Processing 00000000.tx.83: Proteins isolated from these two sources migrated similarly on SDS-PAGE. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated from these two sources"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205409:Isolated [Functional Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0449416:sources [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1705919:Source [Idea or Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "similarly on SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.84: TR1 had a molecular mass of ~57 kDa, whereas TR3 migrated as an ~55-kDa protein. 

Phrase: "TR1"

Phrase: "had"

Phrase: "a molecular mass of ~57 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: "whereas"

Phrase: "TR3"

Phrase: "migrated as an ~55-kDa protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0007507:Protein 55 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0232902:Migrated [Functional Concept]
   753   C0450382:55 [Intellectual Product]
   753   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.85: Although TR1 is more abundant than TR3 in liver (16), the ratio of these enzymes was approximately the same in wild type and tumor samples (Fig. 2B), suggesting that expression of TR3, like that of TR1 (but in contrast to GPx1), was unchanged or perhaps somewhat elevated during malignant transformation in TGF/c-myc mice. 

Phrase: "Although"

Phrase: "TR1"

Phrase: "is"

Phrase: "more abundant than TR3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "the ratio of these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "the same in wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445247:Same [Qualitative Concept]

Phrase: "and"

Phrase: "tumor samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that expression of TR3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "like that"

Phrase: "of TR1"

Phrase: "("

Phrase: "but in contrast to GPx1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C1415275:GPX1 [Gene or Genome]
   760   C1979874:Contrast [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "or"

Phrase: "perhaps somewhat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2984079:Somewhat [Intellectual Product]

Phrase: "elevated during malignant transformation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0040682:Transformation [Cell Function]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0205282:Malignant [Qualitative Concept]
   770   C0334590:MALIGNANT [Neoplastic Process]
   770   C1510411:Transformation [Pathologic Function]
   770   C1533592:MALIGNANT [Neoplastic Process]
   770   C1705163:Transformation [Research Activity]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "in TGF/c-myc mice."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   827   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1295487:factor c [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0150312:In [Quantitative Concept]
   791   C0220844:growth [Physiologic Function]
   791   C0332285:In [Spatial Concept]
   791   C0332307:Type [Qualitative Concept]
   791   C1510411:Transforming [Pathologic Function]
   791   C1521761:Factor [Functional Concept]
   791   C1547052:*Type [Quantitative Concept]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]
Processing 00000000.tx.86: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.87: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.88: Isolation and characterization of mouse liver thioredoxin reductases. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "characterization of mouse liver thioredoxin reductases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]
Processing 00000000.tx.89: A, detection of 75Se by PhosphorImager analysis in fractions from an ADP-Sepharose column. 

Phrase: "A,"

Phrase: "detection of 75Se"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "in fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "from an ADP-Sepharose column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
Processing 00000000.tx.90: 75Se-Labeled homogenates from wild type livers (lanes 1-3) and hepatocarcinomas of TGF/c-myc transgenic mice (lanes 4-6) were fractionated on an ADP-Sepharose column. 

Phrase: "75Se-Labeled homogenates from wild type livers"

Phrase: "(lanes 1-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "hepatocarcinomas of TGF/c-myc transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C2239176:Hepatocarcinoma [Neoplastic Process]

Phrase: "(lanes 4-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fractionated on an ADP-Sepharose column."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036681:Sepharose [Carbohydrate]
   753   C0523452:ADP [Laboratory Procedure]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.91: Flow-through (lanes 1and 4), low-salt wash (lanes 2and 5), and high-salt elution (fractions 3and 6) fractions were analyzed by SDS-PAGE analysis. 

Phrase: "Flow-through"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(lanes 1and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "low-salt wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "(lanes 2and 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "high-salt elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441565:Elution [Laboratory Procedure]

Phrase: "(fractions 3and 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1524024:analysis [Functional Concept]
   760   C1704732:Page [Intellectual Product]
Processing 00000000.tx.92: The positions of TR (mixture of TR1 and TR3), GPx1 and GPx4 are indicated on the right. 

Phrase: "The positions of TR (mixture of TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "TR3"

Phrase: ")"

Phrase: ","

Phrase: "GPx1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415275:GPX1 [Gene or Genome]

Phrase: "and"

Phrase: "GPx4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415278:GPX4 [Gene or Genome]

Phrase: "are"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.93: B, immunoblot analyses of mammalian thioredoxin reductases. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "immunoblot analyses of mammalian thioredoxin reductases."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
Processing 00000000.tx.94: Wild type liver TR fractions (A, lane 3) and liver tumor TR fractions (A, lane 6) were probed with antibodies specific for TR1 (upper panel). 

Phrase: "Wild type liver TR fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   836   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "(A,"

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "liver tumor TR fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   886   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "(A,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "specific for TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.95: The blot was then stripped and reprobed with antibodies specific for TR3 (lower panel). 

Phrase: "The blot"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for TR3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.96: Also analyzed were a homogenous preparation of a rat prostate TR1 obtained by a three-step procedure, employing DEAE-Sepharose, ADP-Sepharose, and phenyl-HPLC columns (shown as Rat prostate, lane 3) and a human TR preparation obtained by affinity chromatography of a homogenate from A431 cells on an ADP-Sepharose column (shown as Human A431 cells, lane 4). 

Phrase: "Also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "a homogenous preparation of a rat prostate TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0455052:Preparation [Health Care Activity]
   744   C1521827:Preparation [Functional Concept]

Phrase: "obtained by a three-step procedure,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0205449:Three [Quantitative Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1301820:Obtained [Functional Concept]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C2825408:Step [Manufactured Object]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]
   719 E C1706701:Obtain [Activity]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "DEAE-Sepharose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "ADP-Sepharose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "and"

Phrase: "phenyl-HPLC columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]

Phrase: "("

Phrase: "shown as Rat prostate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882832:Rat Prostate [Body Part, Organ, or Organ Component]
   770   C0033572:Prostate [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1278980:Prostate [Body Part, Organ, or Organ Component]
   737   C1547282:Show [Intellectual Product]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a human TR preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "obtained by affinity chromatography of a homogenate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0008551:Chromatography, Affinity [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C1301820:Obtained [Functional Concept]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   714 E C1706701:Obtain [Activity]

Phrase: "from A431 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "on an ADP-Sepharose column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "("

Phrase: "shown as Human A431 cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C0427861:Human cells [Laboratory or Test Result]
   760   C0007634:Cells [Cell]
   760   C0086418:Human [Human]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1547282:Show [Intellectual Product]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.97: The rat sample did not contain TR3, which had different elution profiles than TR1 from DEAE-Sepharose and phenyl-HPLC columns. 

Phrase: "The rat sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "TR3,"

Phrase: "which"

Phrase: "had"

Phrase: "different elution profiles than TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "from DEAE-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "and"

Phrase: "phenyl-HPLC columns."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]
Processing 00000000.tx.98: The positions of the 57-kDa form of TR1 and the 55-kDa form of TR3 are indicated on the right. 

Phrase: "The positions of the 57-kDa form of TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "the 55-kDa form of TR3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.99: View larger version (77K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(77K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.101: Two-dimensional gel electrophoresis of mouse TR preparations. 

Phrase: "Two-dimensional gel electrophoresis of mouse TR preparations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   793   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   770   C1705052:2-Dimensional [Spatial Concept]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   750   C0017243:Gel preparation, NOS [Biomedical or Dental Material]
           Gel
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0205448:Two [Quantitative Concept]
   744   C1382104:Gel [Substance]
Processing 00000000.tx.102: Wild type liver and TGF/c-myc liver tumor TR preparations were subjected to two-dimensional gel electrophoresis analysis, followed by detection of 75Se by PhosphorImager analysis (A-D) and staining of proteins with Ponceau S (E and F). 

Phrase: "Wild type liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "TGF/c-myc liver tumor TR preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0332307:Type [Qualitative Concept]
   788   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to two-dimensional gel electrophoresis analysis,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   853   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   804   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   778   C1705052:2-Dimensional [Spatial Concept]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0205448:Two [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1382104:Gel [Substance]
   748   C1524024:analysis [Functional Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "followed by detection of 75Se"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "by PhosphorImager analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(A-D)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "staining of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with Ponceau S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071720:Ponceau S [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.103: Panels A and B show full two-dimensional gels, whereas panels C-F show enlarged areas that correspond to 75Se signals on panels A and B.Panels A, C, and E show TR1 isolated from wild type livers, and panels B, D, and F, from liver tumors. 

Phrase: "Panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "full two-dimensional gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "whereas"

Phrase: "panels C-F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "enlarged areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "that"

Phrase: "correspond to 75Se"

Phrase: "signals on panels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441833:Panel [Idea or Concept]
   790   C1710082:Signal [Phenomenon or Process]
   790   C1999270:Panel [Intellectual Product]
   790   C3537156:Panel [Manufactured Object]

Phrase: "A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A,"

Phrase: "C,"

Phrase: "and"

Phrase: "E"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "TR1"

Phrase: "isolated from wild type livers,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0023884:Livers [Body Part, Organ, or Organ Component]
   760   C0205409:Isolated [Functional Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   726 E C1278929:Liver [Body Part, Organ, or Organ Component]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C2346688:LIVER [Food]

Phrase: "and"

Phrase: "panels B,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "from liver tumors."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0023903:liver tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.104: In addition to the mouse samples, we analyzed TR1 isolated from rat prostate by a standard three-column procedure (Fig. 1B, lane 3), and a TR preparation isolated from a human epidermoid A431 cell line using a single ADP-Sepharose column (Fig. 1B, lane 4). 

Phrase: "In addition to the mouse samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "TR1"

Phrase: "isolated from rat prostate"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1882832:Rat Prostate [Body Part, Organ, or Organ Component]
   770   C0033572:Prostate [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C1278980:Prostate [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by a standard three-column procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a TR preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "isolated from a human epidermoid A431 cell line"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   793   C0682523:Human Cell Line [Cell]
   770   C0007600:Cell Line [Cell]
   767   C0427861:cell human [Laboratory or Test Result]
   744   C0007634:Cell [Cell]
   744   C0086418:Human [Human]
   744   C0205132:Line [Spatial Concept]
   744   C0205409:Isolated [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1548221:Isolated [Idea or Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a single ADP-Sepharose column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.105: Interestingly, although the major form of human TR1 migrated as a 57-kDa band, human TR3 was present as a mixture of 55-57-kDa species. 

Phrase: "Interestingly,"

Phrase: "although"

Phrase: "the major form of human TR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "migrated as a 57-kDa band,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0175723:Band [Medical Device]
   753   C0232902:Migrated [Functional Concept]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]
   753   C1532717:kDa [Quantitative Concept]

Phrase: "human TR3"

Phrase: "was"

Phrase: "present as a mixture of 55-57-kDa species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]
Processing 00000000.tx.106: While mouse TR preparations isolated from normal and tumor samples migrated as single species and exhibited similar electrophoretic properties on SDS-PAGE gels (Fig. 1B), this electrophoretic technique is often insufficient to resolve minor differences within preparations. 

Phrase: "While"

Phrase: "mouse TR preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "isolated from normal"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0205307:Normal [Qualitative Concept]
   790   C0205409:Isolated [Functional Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C2347086:% Normal [Quantitative Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "migrated as single species"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0232902:Migrated [Functional Concept]
   770   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "exhibited similar electrophoretic properties on SDS-PAGE gels"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "this electrophoretic technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "is"

Phrase: "often insufficient to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205412:Insufficient [Qualitative Concept]
   827   C0231180:Insufficient [Qualitative Concept]
   827   C0332183:Often [Temporal Concept]
   755 E C0231179:Insufficiency [Functional Concept]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "minor differences within preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.107: Therefore, to further test protein preparations shown in Fig. 

Phrase: "Therefore,"

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.108: 1B, lanes 1and 2, we separately analyzed normal and tumor TRs by two-dimensional gel electrophoresis. 

Phrase: "1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "lanes 1and 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "we separately"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor TRs by two-dimensional gel electrophoresis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   737   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.109: Comparison of 75Se and protein profiles on two-dimensional gels for normal and tumor samples suggested that all signals shown in Fig. 

Phrase: "Comparison of 75Se"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "protein profiles on two-dimensional gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "for normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "all signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.110: 2 corresponded to TR1. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "corresponded to TR1."
Processing 00000000.tx.111: TR3 was not detected on two-dimensional gels because it was present in lower levels than TR1 and exhibited a different isoelectric point. 

Phrase: "TR3"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected on two-dimensional gels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1705052:2-Dimensional [Spatial Concept]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0205448:Two [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1382104:Gel [Substance]

Phrase: "because"

Phrase: "it"

Phrase: "was"

Phrase: "present in lower levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "than TR1"

Phrase: "and"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a different isoelectric point."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0022171:Isoelectric Point [Quantitative Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
Processing 00000000.tx.112: The two-dimensional gel electrophoresis analysis (Fig. 2) revealed dramatic heterogeneity within TR1 preparations from normal and tumor samples. 

Phrase: "The two-dimensional gel electrophoresis analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   722   C0678632:two-dimensional electrophoresis [Laboratory Procedure]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "dramatic heterogeneity within TR1 preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "from normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.113: TR1 bands were separated on two-dimensional gels according to both charge and mass. 

Phrase: "TR1 bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "separated on two-dimensional gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1705052:2-Dimensional [Spatial Concept]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0205448:Two [Quantitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "according to both charge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007961:Charge [Quantitative Concept]
  1000   C1706211:Charge [Organism Attribute]

Phrase: "and"

Phrase: "mass."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.114: Nine representative bands from two-dimensional gels for normal and tumor samples (Fig. 2, E and F) were digested with trypsin. 

Phrase: "Nine representative bands from two-dimensional gels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0175723:Bands [Medical Device]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "for normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "tumor samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E"

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "were"

Phrase: "digested with trypsin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]
Processing 00000000.tx.115: Tryptic digests were analyzed by MALDI time-of-flight mass-spectrometry (MALDI-TOF MS). 

Phrase: "Tryptic digests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0868946:Digests [Physiologic Function]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "by MALDI time-of-flight mass-spectrometry"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
  1000   C1518101:Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [Research Activity]
   921   C0282597:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [Laboratory Procedure]
           matrix assisted laser desorption ionization
   868   C0596822:laser spectrometry [Laboratory Procedure]
   821   C2348791:Time-of-Flight [Quantitative Concept]
   804   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C0023089:Laser [Manufactured Object]
   790   C0040223:Time [Temporal Concept]
   790   C0436196:Spectrometry [Laboratory Procedure]
   790   C0458142:Laser [Phenomenon or Process]
   790   C0577559:Mass [Finding]
   790   C0596801:Ionization [Phenomenon or Process]
   790   C1023865:Laser [Plant]
   790   C1269765:Assisted [Finding]
   790   C1306372:*Mass [Quantitative Concept]
   790   C1555977:Flight [Intellectual Product]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706315:Laser [Medical Device]
   790   C1706515:Matrix [Body Substance]
   790   C2610507:flight [Phenomenon or Process]
   790   C3152252:Mass [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0018896:assist [Social Behavior]
   756 E C0557034:assist [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "(MALDI-TOF MS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0039685:TOF [Congenital Abnormality]
   795   C1825291:TOF [Gene or Genome]
   795   C2348791:TOF [Quantitative Concept]
   795   C2349943:Ms. [Conceptual Entity]
   795   C3539704:MS [Gene or Genome]
   747   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.116: Experimentally determined peptide masses matched to the peptide masses predicted from the tryptic digestion of a deduced mouse TR1 sequence (see details of mouse TR1 sequences below) and covered >50% of the protein sequence (cysteine-containing and N-terminal peptides were not detected). 

Phrase: "Experimentally determined peptide masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0577559:Mass [Finding]
   779   C1306372:*Mass [Quantitative Concept]
   779   C3152252:Mass [Quantitative Concept]

Phrase: "matched to the peptide masses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0150103:matched [Research Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0577559:Mass [Finding]
   726   C1306372:*Mass [Quantitative Concept]
   726   C3152252:Mass [Quantitative Concept]

Phrase: "predicted from the tryptic digestion of a deduced mouse TR1 sequence"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C2348822:Tryptic Digestion [Research Activity]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0012238:Digestion [Organism Function]
   738   C0025914:Mouse [Mammal]
   738   C0025929:mouse [Mammal]
   738   C0026809:Mouse [Mammal]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0681842:Predicted [Idea or Concept]
   738   C1519249:Sequence [Functional Concept]
   738   C1882327:%{Predicted} [Quantitative Concept]
   738   C2349986:Digestion [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "details of mouse TR1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "sequences below"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004793:Sequence [Nucleotide Sequence]
   833   C0162326:Sequence [Nucleotide Sequence]
   833   C0162327:Sequence [Nucleotide Sequence]
   833   C1519249:Sequence [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "covered"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439844:Covered [Functional Concept]
  1000   C1999244:Covered [Functional Concept]
   966 E C0180153:cover [Medical Device]
   966 E C1707529:Cover [Medical Device]

Phrase: ">50% of the protein sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0002518:Protein Sequence [Amino Acid Sequence]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "(cysteine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "N-terminal peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.117: No post-translational modifications within TR1 that could potentially contribute to different mobilities of TR1 forms on two-dimensional gels were detected. 

Phrase: "No post-translational modifications within TR1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1704687:Post [Manufactured Object]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "potentially"

Phrase: "contribute to different mobilities of TR1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0449580:mobilities [Qualitative Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1880177:Contribute [Activity]
   719 E C0425245:Mobility [Finding]

Phrase: "forms on two-dimensional gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1705052:2-Dimensional [Spatial Concept]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0205448:Two [Quantitative Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.118: In addition, no significant differences in tryptic peptide maps were found between normal and tumor samples. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "no significant differences in tryptic peptide maps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "found between normal"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0150312:Found [Quantitative Concept]
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "tumor samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0475358:Tumor Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.119: In addition to multiple TR1 forms that were resolved by two-dimensional gel electrophoresis (Fig. 2) but migrated as a single 57-kDa band on SDS-PAGE gels (Fig. 1B), we detected TR1 forms that significantly differed from the 57-kDa isoforms. 

Phrase: "In addition to multiple TR1"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "resolved by two-dimensional gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   820   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   790   C1705052:2-Dimensional [Spatial Concept]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0205448:Two [Quantitative Concept]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "but"

Phrase: "migrated as a single 57-kDa band"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0175723:Band [Medical Device]
   748   C0205171:Single [Quantitative Concept]
   748   C0232902:Migrated [Functional Concept]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]
   748   C1532717:kDa [Quantitative Concept]

Phrase: "on SDS-PAGE gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]
   734   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "TR1"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that significantly"

Phrase: "differed from the 57-kDa isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   753   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.120: We noted that longer exposure of 75Se signals detected with a PhosphorImager and analysis of anti-TR1 immunoblot signals often produced two additional bands, ~67 and ~110 kDa. 

Phrase: "We"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that longer exposure of 75Se signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "detected with a PhosphorImager"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "analysis of anti-TR1 immunoblot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0020985:Immunoblot Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "produced"

Phrase: "two additional bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "~67"

Phrase: "and ~"

Phrase: "110 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.121: These bands partially co-purified with the 57-kDa forms and were present as minor forms in apparently homogeneous enzyme preparations. 

Phrase: "These bands partially"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "co-purified with the 57-kDa forms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   748   C1532717:kDa [Quantitative Concept]
   748   C1998793:Purified [Functional Concept]
   714 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "present as minor forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in apparently homogeneous enzyme preparations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0360722:ENZYME PREPARATIONS [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.122: The 67-and 110-kDa species did not cross-react with anti-TR2 and anti-TR3 antibodies. 

Phrase: "The 67-"

Phrase: "and"

Phrase: "110-kDa species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross-react with anti-TR2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "anti-TR3 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.123: Migration properties of the 110-kDa minor band corresponded to that of the TR1 homodimer, although the biochemical basis for the possible dimer formation under these conditions is not clear. 

Phrase: "Migration properties of the 110-kDa minor band"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "corresponded to that of the TR1 homodimer,"

Phrase: "although"

Phrase: "the biochemical basis for the possible dimer formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1527178:Basis [Functional Concept]
   744   C1874451:Basis [Pharmacologic Substance]

Phrase: "under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.124: The possible origin of the 67-kDa band is discussed below. 

Phrase: "The possible origin of the 67-kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0079946:origin [Classification]
   744   C0439659:Origin [Temporal Concept]
   744   C1550512:origin [Intellectual Product]

Phrase: "is"

Phrase: "discussed below."
Processing 00000000.tx.125: Heterogeneity within Human Thioredoxin Reductase Preparations-- We further tested if the extensive heterogeneity observed within mouse TR1 preparations, occurs in human TR1 preparations. 

Phrase: "Heterogeneity within Human Thioredoxin Reductase Preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "if"

Phrase: "the extensive heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "observed within mouse TR1 preparations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1441672:Observed [Functional Concept]
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "occurs in human TR1 preparations."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.126: For this purpose, we selected a human T-cell line, JPX9, that was previously used as a source of TR1 (12). 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "a human T-cell line,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0039194:T-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "JPX9,"

Phrase: "that"

Phrase: "was"

Phrase: "previously"

Phrase: "used as a source of TR1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0449416:Source [Finding]
   753   C1273517:used [Finding]
   753   C1705919:Source [Idea or Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.127: To purify human TR1, we initially utilized a previously developed three-step procedure (12). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "human TR1,"

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "utilized"

Phrase: "a previously developed three-step procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1948041:Procedure [Therapeutic or Preventive Procedure]
   804   C2700391:Procedure [Activity]
   804   C3274430:PROCEDURE [Health Care Activity]
   804   C3538935:Procedure [Idea or Concept]
   804   C3539779:Procedure [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.128: The purified protein was analyzed by electrospray ionization (ESI) mass spectrometry. 

Phrase: "The purified protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "analyzed by electrospray ionization (ESI) mass spectrometry."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0596495:Spectrometry, Mass, Electrospray Ionization [Laboratory Procedure]
   790   C0037813:Mass Spectrometry [Laboratory Procedure]
   790   C1516801:Electrospray Ionization [Laboratory Procedure]
   753   C0436196:Spectrometry [Laboratory Procedure]
   753   C0577559:Mass [Finding]
   753   C0596801:Ionization [Phenomenon or Process]
   753   C0936012:Analyzed [Research Activity]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.129: The recorded ESI-MS spectra showed a broad peak centered at 54,860Da, that was 230Da more than the mass predicted from the previously reported human TR1 sequence (24). 

Phrase: "The recorded ESI-MS spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1883073:Spectrum [Quantitative Concept]
   771   C2827424:Spectrum [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a broad peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "centered at 54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205099:centered [Spatial Concept]

Phrase: "860Da,"

Phrase: "that"

Phrase: "was"

Phrase: "230Da more than the mass"

Phrase: "predicted from the previously reported human TR1 sequence"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0086418:Human [Human]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0681842:Predicted [Idea or Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1519249:Sequence [Functional Concept]
   744   C1882327:%{Predicted} [Quantitative Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.130: Reduction and carboxymethylation of the enzyme increased its mass to 55,626Da, but did not significantly narrow the mass peak. 

Phrase: "Reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "carboxymethylation of the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596262:carboxymethylation [Phenomenon or Process]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "its mass to 55,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "626Da,"

Phrase: "but"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "narrow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205168:Narrow [Qualitative Concept]
  1000   C0332463:Narrow [Spatial Concept]
  1000   C0333164:Narrow [Quantitative Concept]

Phrase: "the mass peak."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]
Processing 00000000.tx.131: The difference between native and carboxymethylated forms, 762Da, corresponded to 13.4alkylated groups. 

Phrase: "The difference between native"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "carboxymethylated forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "762Da,"

Phrase: "corresponded to 13.4alkylated groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.132: The predicted human TR1 sequence contained 13cysteines and 1selenocysteine. 

Phrase: "The predicted human TR1 sequence contained 13cysteines"

Phrase: "and"

Phrase: "1selenocysteine."
Processing 00000000.tx.133: Considering that isolated TR1 is often contaminated with a truncated form lacking the last two residues, Sec498 and Gly499, the data suggested that the isolated TR1 could be fully alkylated with iodoacetic acid and that cysteines and selenocysteine were not modified in the native enzyme. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that isolated TR1"

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "contaminated with a truncated form"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205279:Contaminated [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C2349974:CONTAMINATED [Idea or Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the last two residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "Sec498"

Phrase: "and"

Phrase: "Gly499,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the isolated TR1"

Phrase: "could"

Phrase: "be"

Phrase: "fully"

Phrase: "alkylated with iodoacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0063765:Iodoacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "that cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "selenocysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074289:Selenocysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modified in the native enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0302891:Native [Functional Concept]
   760   C0392747:Modified [Functional Concept]
Processing 00000000.tx.134: We further took advantage of a recent observation that human TR1 could be additionally fractionated on a heparin column (16-18). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of a recent observation"

Phrase: "that human TR1"

Phrase: "could"

Phrase: "be"

Phrase: "additionally"

Phrase: "fractionated on a heparin column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.135: Indeed, two peaks for TR1 were eluted from the column, which were detected as 280-nm absorbing peaks (Fig. 3). 

Phrase: "Indeed,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "peaks for TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0444505:Peak [Quantitative Concept]

Phrase: "were"

Phrase: "eluted from the column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]

Phrase: "which"

Phrase: "were"

Phrase: "detected as 280-nm absorbing peaks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0312860:NM [Cell Function]
   753   C0442726:Detected [Finding]
   753   C0444505:peaks [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: The two peaks could also be detected due the absorbance of a flavin at 450nm and due to the presence of 75Se in the fractions. 

Phrase: "The two peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "due"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "the absorbance of a flavin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1268822:Absorbance [Clinical Attribute]
   760   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 450nm"

Phrase: "and due to the presence of 75Se"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1515981:And [Idea or Concept]
   748   C3146286:Due [Idea or Concept]

Phrase: "in the fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.137: Integration of two major TR1 peaks indicated that the second-eluted peak (peak II) had 3.8times higher selenium content (calculated on the basis of 75Se radioactivity) per mg of protein compared with the first-eluted peak (peak I). 

Phrase: "Integration of two major TR1 peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1158478:Integration [Genetic Function]
   753   C1705422:Integration [Machine Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the second-eluted peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: "(peak II"

Phrase: ")"

Phrase: "had"

Phrase: "3.8times higher selenium content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]

Phrase: "("

Phrase: "calculated on the basis of 75Se radioactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0034553:Radioactivity [Natural Phenomenon or Process]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: ")"

Phrase: "per mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439269:mg% [Quantitative Concept]
  1000   C1960952:mg % [Quantitative Concept]
  1000   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with the first-eluted peak"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205435:First [Quantitative Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "(peak I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.138: The possible reduced selenium content of TR1 in peak I is similar to the previous finding of a HeLa cell TR1 form that had ~0.5 selenium per protein subunit (17). 

Phrase: "The possible reduced selenium content of TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "in peak I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "similar to the previous finding of a HeLa cell TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "had ~"

Phrase: "0.5 selenium per protein subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C2348282:Selenium [Element, Ion, or Isotope]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.139: The previously isolated mixture of human T-cell TR1 forms had ~0.74 selenium per protein subunit (12), suggesting that it could be a mixture of TR1 molecules with variable selenium content. 

Phrase: "The previously isolated mixture of human T-cell TR1 forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439962:Mixture [Substance]

Phrase: "had ~"

Phrase: "0.74 selenium per protein subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C2348282:Selenium [Element, Ion, or Isotope]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "a mixture of TR1 molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "with variable selenium content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.140: Lower levels of selenium may be due to a loss of selenium from TR1 due to hydrolysis in the presence of oxygen or reactive oxygen species, or due to the presence of a truncated form of TR1 lacking C-terminal selenocysteine and glycine residues. 

Phrase: "Lower levels of selenium"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be due to a loss of selenium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C1517945:Loss [Quantitative Concept]
   748   C2348282:Selenium [Element, Ion, or Isotope]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "from TR1"

Phrase: "due to hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "reactive oxygen species,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "or due to the presence of a truncated form"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1522492:Form [Functional Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "of TR1 lacking C-terminal selenocysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0074289:Selenocysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glycine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.141: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.143: Fractionation of human TR1 preparations on a heparin column. 

Phrase: "Fractionation of human TR1 preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "on a heparin column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.144: TR1 was first isolated from 75Se-labeled human JPX9 cells using a three-step procedure (12). 

Phrase: "TR1"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "isolated from 75Se-labeled human JPX9 cells"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0086418:Human [Human]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C1708632:Labeled [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C0181496:Label [Manufactured Object]
   714 E C0370215:Isolate [Substance]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a three-step procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.145: The enzyme was then further fractionated on a heparin-HPLC column. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "then further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883708:Then [Temporal Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "fractionated on a heparin-HPLC column."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.146: Proteins eluted were detected by absorbance at 450(due to the presence of flavin and shown as the smaller signal on the upper panel) and 280nm (shown as the larger signal on the upper panel) and by detection of 75Se in fractions from the column using a -counter (lower panel). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "eluted"

Phrase: "were"

Phrase: "detected by absorbance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1268822:Absorbance [Clinical Attribute]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 450"

Phrase: "("

Phrase: "due to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of flavin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016213:flavin [Organic Chemical]
  1000   C0062166:flavin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C1572731:FLAVINE [Organic Chemical]

Phrase: "and"

Phrase: "shown as the smaller signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726   C1547282:Show [Intellectual Product]

Phrase: "on the upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "280nm"

Phrase: "("

Phrase: "shown as the larger signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0443228:larger [Quantitative Concept]
   760   C0549177:Larger [Quantitative Concept]
   760   C1704243:Larger [Quantitative Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726   C1547282:Show [Intellectual Product]

Phrase: "on the upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and by detection of 75Se"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1515981:And [Idea or Concept]

Phrase: "in fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "from the column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a -counter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0677601:Counter [Manufactured Object]
   861   C1705206:Counter [Medical Device]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.147: For subsequent analyses, fractions corresponding to peak I were pooled, as were those corresponding to peak II, and further analyzed. 

Phrase: "For subsequent analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "corresponding to peak I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:Peak [Quantitative Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "as"

Phrase: "were"

Phrase: "those corresponding to peak II,"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.148: The fractions corresponding to Peak I shown in Fig. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "corresponding to Peak I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:Peak [Quantitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.149: 3 were pooled, as were fractions corresponding to Peak II, and the two samples were further analyzed by SDS-PAGE, immunoblot assays, and isoelectric focusing (Fig. 4). 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "as"

Phrase: "were"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "corresponding to Peak II,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:Peak [Quantitative Concept]

Phrase: "and"

Phrase: "the two samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by SDS-PAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "immunoblot assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0020985:Immunoblot assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "isoelectric focusing (Fig. 4)."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0022169:Isoelectric Focusing [Laboratory Procedure]
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]
Processing 00000000.tx.150: Major protein forms in each pool migrated as a 55-and 57-kDa pair of protein bands with approximately similar staining intensity (Fig. 4A, left panel). 

Phrase: "Major protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms in each pool"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0337051:Pool [Geographic Area]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1509144:pool [Clinical Attribute]
   770   C1522492:Form [Functional Concept]
   770   C2349200:Pool [Functional Concept]

Phrase: "migrated as a 55-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0232902:Migrated [Functional Concept]
   770   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "57-kDa pair of protein bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709450:Pair [Qualitative Concept]

Phrase: "with approximately similar staining intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0522510:Intensity [Qualitative Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.151: These forms were also detected by immunoblot and PhosphorImager assays (Fig. 4A, middle and right panels). 

Phrase: "These forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "detected by immunoblot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PhosphorImager assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "and"

Phrase: "right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.152: This observation was in agreement with a previous finding of two closely migrating TR1 forms isolated from human JPX9 cells (12). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "was in agreement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0680240:Agreement [Social Behavior]
   790   C1421478:WAS [Gene or Genome]

Phrase: "with a previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "of two closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "TR1 forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "isolated from human JPX9 cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   797   C0427861:Human cells [Laboratory or Test Result]
   760   C0007634:Cells [Cell]
   760   C0086418:Human [Human]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.153: In addition, the pair of 55-and 57-kDa bands was resolved on gels either run in a nonreducing buffer, or following reduction with dithiothreitol and alkylation with iodoacetic acid, or following denaturation in 6M guanidine HCl, reduction with dithiothreitol and subsequent carboxymethylation (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the pair of 55-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709450:Pair [Qualitative Concept]

Phrase: "and"

Phrase: "57-kDa bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "was"

Phrase: "resolved on gels either run in"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C3274438:RUN-IN [Temporal Concept]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0035953:run [Daily or Recreational Activity]
   753   C0600140:run [Finding]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704688:Run [Functional Concept]
   753   C2346414:Run [Finding]
   753   C2699488:Resolved [Conceptual Entity]
   719 E C1382104:Gel [Substance]

Phrase: "a nonreducing buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "or"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "reduction with dithiothreitol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "alkylation with iodoacetic acid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002074:Alkylation [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "denaturation in 6M guanidine HCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0301642:Denaturation [Molecular Function]

Phrase: "reduction with dithiothreitol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subsequent carboxymethylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596262:carboxymethylation [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: View larger version (59K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 4.  

Phrase: "4."
Processing 00000000.tx.156: Characterization of human TR1 preparations by gel electrophoresis. 

Phrase: "Characterization of human TR1 preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "by gel electrophoresis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C0013855:Electrophoresis [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]
Processing 00000000.tx.157: A, SDS-PAGE analyses. 

Phrase: "A,"

Phrase: "SDS-PAGE analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
Processing 00000000.tx.158: Two TR1 preparations (peaks I and II; see Fig. 3) were subjected to SDS-PAGE analyses followed by detection of proteins by Coomassie Blue staining (left panel), immunoblot analyses with antibodies specific for TR1 (middle panel), and detection of 75Se by PhosphorImager analyses (right panel). 

Phrase: "Two TR1 preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "(peaks I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE analyses"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "followed by detection of proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "by Coomassie Blue staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "immunoblot analyses with antibodies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "specific for TR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "detection of 75Se"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PhosphorImager analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.159: For better visualization of protein, immunoblot and 75Se signals, three times more material was loaded on the gel from peak I than from peak II. 

Phrase: "For better visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175631:Visualization [Mental Process]
   861   C2827662:Visualization [Occupation or Discipline]

Phrase: "of protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "and"

Phrase: "75Se signals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "three times more material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Material [Substance]

Phrase: "was"

Phrase: "loaded on the gel"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "from peak I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "than"

Phrase: "from peak II."
Processing 00000000.tx.160: The positions of the 55-and 110-kDa forms are indicated on the left. 

Phrase: "The positions of the 55-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "110-kDa forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "indicated on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.161: B, isoelectric focusing. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "isoelectric focusing."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0022169:Isoelectric Focusing [Laboratory Procedure]
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]
Processing 00000000.tx.162: Two TR1 preparations (peaks I and II) were subjected to isoelectric focusing followed by detection of proteins by Coomassie Blue staining (left panel) or detection of 75Se by PhosphorImager analyses (right panel). 

Phrase: "Two TR1 preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "(peaks I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to isoelectric focusing"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0022169:Isoelectric Focusing [Laboratory Procedure]
   770   C0000936:focusing [Clinical Attribute]
   770   C2981153:Focusing [Finding]
   737 E C0205234:Focus [Spatial Concept]
   737   C0681850:Subject [Group]
   737 E C1285542:focus [Functional Concept]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "followed by detection of proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "by Coomassie Blue staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "detection of 75Se"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PhosphorImager analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.163: The positions and apparent isoelectric points of three standards are shown on the left. 

Phrase: "The positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "apparent isoelectric points of three standards"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022171:Points, Isoelectric [Quantitative Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "are"

Phrase: "shown on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.164: The 55-and 57-kDa bands were transferred onto a polyvinylidene difluoride membrane, digested with trypsin, and masses of tryptic peptides were determined with a MALDI-time of flight MS. 

Phrase: "The 55-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "57-kDa bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "transferred onto a polyvinylidene difluoride membrane,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "digested with trypsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "masses of tryptic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0577559:Mass [Finding]
   737   C1306372:*Mass [Quantitative Concept]
   737   C3152252:Mass [Quantitative Concept]

Phrase: "were"

Phrase: "determined with a MALDI-time"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   849   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
   742   C0023089:Laser [Manufactured Object]
   742   C0040223:Time [Temporal Concept]
   742   C0458142:Laser [Phenomenon or Process]
   742   C0596801:Ionization [Phenomenon or Process]
   742   C1023865:Laser [Plant]
   742   C1269765:Assisted [Finding]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706315:Laser [Medical Device]
   742   C1706515:Matrix [Body Substance]
   742   C3541383:Time [Temporal Concept]
   708 E C0018896:assist [Social Behavior]
   708 E C0557034:assist [Health Care Activity]

Phrase: "of flight MS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]
Processing 00000000.tx.165: Both bands in the doublet produced essentially identical peptide maps and matched with a set of the predicted TR1 tryptic peptides. 

Phrase: "Both bands in the doublet"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "produced"

Phrase: "essentially identical peptide maps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0024779:Map [Manufactured Object]
   812   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "matched with a set of the predicted TR1 tryptic peptides."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   739   C0036849:Set [Mental Process]
   739   C0150103:matched [Research Activity]
   739   C0681842:Predicted [Idea or Concept]
   739   C1442518:Set [Functional Concept]
   739   C1705195:Set [Conceptual Entity]
   739   C1708943:Matched [Qualitative Concept]
   739   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.166: Even in this instance, we could not detect any Cys-containing peptide, along with the N-terminal and C-terminal peptide. 

Phrase: "Even in this instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550608:Instance [Idea or Concept]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any Cys-containing peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "along with the N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "C-terminal peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C1707271:C-Terminal [Amino Acid Sequence]
Processing 00000000.tx.167: In addition to the 55/57-kDa pair of bands in peaks I and II, a protein form migrating as a 110-kDa band was observed in both TR1 samples (Fig. 4A). 

Phrase: "In addition to the 55/57-kDa pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709450:Pair [Qualitative Concept]

Phrase: "of bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "in peaks I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II,"

Phrase: "a protein form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "migrating as a 110-kDa band"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0175723:Band [Medical Device]
   753   C0232902:migrating [Functional Concept]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]
   753   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "observed in both TR1 samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441672:Observed [Functional Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.168: Like the mouse 110-kDa band, this form corresponded in size to a possible TR1 dimer. 

Phrase: "Like the mouse 110-kDa band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "this form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "corresponded in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "to a possible TR1 dimer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimer [Chemical Viewed Structurally]
Processing 00000000.tx.169: Peaks I and II differed in that a minor ~67-kDa species were present in peak I, but absent in peak II (Fig. 4A). 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: "differed in"

Phrase: "that"

Phrase: "a minor ~67-kDa species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "present in peak I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "absent in peak II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.170: This TR1 form was detected as a Coomassie Blue-stained band and as a 75Se-labeled band. 

Phrase: "This TR1 form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "detected as a Coomassie Blue-stained band"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C0442726:Detected [Finding]
   748   C1260957:Blue [Qualitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1521913:band [Cell Component]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and as a 75Se-labeled band."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1521913:band [Cell Component]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.171: It was also reactive in immunoblot assays with anti-TR1 antibodies. 

Phrase: "It"

Phrase: "was"

Phrase: "also reactive in immunoblot assays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205332:Reactive [Qualitative Concept]

Phrase: "with anti-TR1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.172: Thus, the minor 67-kDa form of TR1 was detected in both mouse and human preparations. 

Phrase: "Thus,"

Phrase: "the minor 67-kDa form of TR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "detected in both mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "human preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.173: In addition, several other minor forms of TR1 were present in peak I of human TR1. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other minor forms of TR1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "present in peak I of human TR1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
Processing 00000000.tx.174: Bands with masses higher than 110kDa could potentially be formed by a dimer formation involving the 67-kDa form. 

Phrase: "Bands with masses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0175723:Bands [Medical Device]
   756 E C0439645:Band [Spatial Concept]
   756 E C1521913:band [Cell Component]

Phrase: "higher than 110kDa"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "could"

Phrase: "potentially"

Phrase: "be"

Phrase: "formed by a dimer formation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0205431:Formed [Functional Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0596448:dimer [Chemical Viewed Structurally]
   760   C1522492:Formation [Functional Concept]
       E   Form
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the 67-kDa form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]
Processing 00000000.tx.175: The protein mixtures present in peaks I and II were further analyzed by tryptic digests followed by determination of peptide masses by MALDI MS. 

Phrase: "The protein mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "present in peaks I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0150312:Present [Quantitative Concept]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:peaks [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "II"

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by tryptic digests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0868946:Digests [Physiologic Function]
   770   C0936012:Analyzed [Research Activity]

Phrase: "followed by determination of peptide masses"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1148554:determination [Laboratory Procedure]
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]
   719   C3152252:Mass [Quantitative Concept]

Phrase: "by MALDI MS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   799   C2349943:Ms. [Conceptual Entity]
   799   C3539704:MS [Gene or Genome]
   780   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
Processing 00000000.tx.176: By matching experimentally observed peptide masses with those predicted from an in silico tryptic digest of the previously reported human TR1 sequence, we were able to cover over 70% of the human TR1 sequence. 

Phrase: "By matching experimentally observed peptide masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0577559:Mass [Finding]
   771   C1306372:*Mass [Quantitative Concept]
   771   C3152252:Mass [Quantitative Concept]

Phrase: "with those"

Phrase: "predicted from an in silico tryptic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3489666:In Silico [Machine Activity]
   753   C0681842:Predicted [Idea or Concept]
   753   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "digest of the previously reported human TR1 sequence,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0086418:Human [Human]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0868946:digest [Physiologic Function]
   744   C1519249:Sequence [Functional Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "cover over 70% of the human TR1 sequence."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0086418:Human [Human]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0180153:cover [Medical Device]
   744   C1519249:Sequence [Functional Concept]
   744   C1707529:Cover [Medical Device]
   744   C1999244:Cover [Functional Concept]
Processing 00000000.tx.177: Again, no peptide masses were detected that matched Cys-containing, N-terminal and C-terminal peptides. 

Phrase: "Again,"

Phrase: "no peptide masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "that matched Cys-containing, N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "C-terminal peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   734   C1707271:C-Terminal [Amino Acid Sequence]
Processing 00000000.tx.178: Spectra obtained from peak I and peak II were virtually identical. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "obtained from peak I"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:Peak [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "peak II"

Phrase: "were"

Phrase: "virtually identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.179: The only differences detected were an ion signal at 2110Da present only in peak I and signals at 1446and 1430Da present only in peak II. 

Phrase: "The only differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "an ion signal at 2110Da"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in peak I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0205171:Only [Quantitative Concept]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:Peak [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "signals at 1446and 1430Da"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in peak II."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0444505:Peak [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.180: These peptides could not be assigned in the human TR1 sequence. 

Phrase: "These peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "assigned in the human TR1 sequence."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0086418:Human [Human]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1516050:Assigned [Functional Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C1552601:assigned [Intellectual Product]
Processing 00000000.tx.181: Despite the close similarity observed by SDS-PAGE and mass spectrometry analyses between the various TR1 forms present in peaks I and II (Fig. 4A), these proteins had different migration properties when analyzed by isoelectric focusing (Fig. 4B). 

Phrase: "Despite the close similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similarity [Qualitative Concept]

Phrase: "observed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1441672:Observed [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "mass spectrometry analyses between the various TR1 forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "present in peaks I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021966:I- [Inorganic Chemical]
   770   C0150312:Present [Quantitative Concept]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0444505:peaks [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "II"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "different migration properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "when"

Phrase: "analyzed by isoelectric focusing"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0022169:Isoelectric Focusing [Laboratory Procedure]
   770   C0000936:focusing [Clinical Attribute]
   770   C0936012:Analyzed [Research Activity]
   770   C2981153:Focusing [Finding]
   737 E C0205234:Focus [Spatial Concept]
   737 E C1285542:focus [Functional Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.182: Each form was represented by several protein bands (Fig. 4B). 

Phrase: "Each form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "represented by several protein bands"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]
   726   C1882932:Represent [Activity]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.183: Overall, the data indicated the presence of multiple forms of human TR1 that differed in molecular masses and isoelectric points. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the presence of multiple forms of human TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "differed in molecular masses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   770   C1521991:Molecular [Qualitative Concept]
   737   C0577559:Mass [Finding]
   737   C1306372:*Mass [Quantitative Concept]

Phrase: "and"

Phrase: "isoelectric points."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022171:Points, Isoelectric [Quantitative Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
Processing 00000000.tx.184: Alternative First Exon Splicing Results in the Formation of Three Distinct mRNA Isoforms of Mouse and Rat TR1-- Having determined no post-translational modifications, we tested whether observed heterogeneity within human and mouse TR1 preparations could be explained by genetic variations within TR1 sequences. 

Phrase: "Alternative First Exon Splicing Results in the Formation of Three Distinct mRNA Isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "of Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "Rat TR1"

Phrase: "-"

Phrase: "-"

Phrase: "Having"

Phrase: "determined"

Phrase: "no post-translational modifications,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1704687:Post [Manufactured Object]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "observed heterogeneity within human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "and"

Phrase: "mouse TR1 preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "explained by genetic variations"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   833   C0042333:Variations, Genetic [Natural Phenomenon or Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205419:variations [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "within TR1 sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.185: In particular, the occurrence of the 67-kDa form of TR1, which was ~10 kDa larger than the protein deduced from known mammalian TR1 cDNAs, could not be easily explained without invoking genetic mechanisms. 

Phrase: "In particular,"

Phrase: "the occurrence of the 67-kDa form of TR1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243132:occurrence [Functional Concept]
   742   C1554210:occurrence [Idea or Concept]
   742   C2745955:Occurrence [Temporal Concept]

Phrase: "which"

Phrase: "was ~"

Phrase: "10 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "larger than the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]

Phrase: "deduced from known mammalian TR1 cDNAs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0024660:Mammalian [Mammal]
   753   C0205309:Known [Qualitative Concept]
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "explained without invoking genetic mechanisms."
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.186: During the time of our analysis, no mouse TR1 sequences were available in GenBankTM. 

Phrase: "During the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of our analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "no mouse TR1 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "available in GenBankTM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.187: Therefore, we obtained a cDNA sequence of mouse TR1 by sequencing multiple EST clones. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "a cDNA sequence of mouse TR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "by sequencing multiple EST clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.188: Surprisingly, the final 3626-nucleotide cDNA sequence encoded a protein of 613residues that had a predicted mass of 67.1kDa. 

Phrase: "Surprisingly,"

Phrase: "the final 3626-nucleotide cDNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   853   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "a protein of 613residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "had"

Phrase: "a predicted mass of 67.1kDa."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0577559:A mass [Finding]
           Mass
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.189: The deduced polypeptide contained the C-terminal penultimate selenocysteine residue encoded by a TGA codon and all sequence features found in other animal TR sequences (N-terminal disulfide active center, NADPH- and FAD-binding domains and a dimer-interface domain). 

Phrase: "The deduced polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the C-terminal penultimate selenocysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1709915:Residue [Conceptual Entity]
   804   C1882936:RESIDUE [Phenomenon or Process]
   733 E C1609982:Residual [Qualitative Concept]

Phrase: "encoded by a TGA codon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1956150:TGA Codon [Nucleotide Sequence]
   760   C0009221:Codon [Nucleotide Sequence]
   760   C0679058:encoded [Mental Process]
   760   C1095825:Codon [Plant]
   760   C2699751:TGA [Gene or Genome]
   760   C2700640:Encoded [Activity]

Phrase: "and"

Phrase: "all sequence features"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C1517495:Sequence Feature [Gene or Genome]
   983   C1704991:Sequence Feature [Qualitative Concept]
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "found in other animal TR sequences"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0003062:Animal [Animal]
   753   C0150312:Found [Quantitative Concept]
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C0243095:Find [Finding]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "(N-terminal disulfide active center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205099:Center [Spatial Concept]

Phrase: "NADPH-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "FAD-binding domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
   734   C3156162:FAD binding [Molecular Function]

Phrase: "and"

Phrase: "a dimer-interface domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.190: The predicted protein differed from the previously reported 499-amino acid sequences for mammalian TR1s (24, 25) in that the mouse protein had 114additional N-terminal residues. 

Phrase: "The predicted protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differed from the previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "499-amino acid sequences for mammalian TR1s"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   814   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")"

Phrase: "in"

Phrase: "that"

Phrase: "the mouse protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "114additional N-terminal residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.191: The new N-terminal sequence had no homology to coding regions of other proteins when analyzed using BLAST programs against nonredundant (NR) and EST data bases, except that it exhibited >70% identity with sequences deduced from a rat genomic clone that contained a partial sequence of the TR1 gene (accession number AF189711). 

Phrase: "The new N-terminal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "had"

Phrase: "no homology to coding regions of other proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0314644:Homology region [Genetic Function]
   744   C1334043:Homology [Gene or Genome]
   744   C2697616:Homology [Qualitative Concept]
   700   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]

Phrase: "when"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BLAST programs against nonredundant (NR)"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0376691:Programs [Intellectual Product]
   770   C3484370:Programs [Functional Concept]
   737 E C1709697:Program [Conceptual Entity]
   737 E C2728259:Program [Pharmacologic Substance]

Phrase: "and"

Phrase: "EST data bases,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   867   C0242356:data base [Intellectual Product]
   867   C0993637:Data Base [Intellectual Product]
   827   C0178499:bases [Chemical Viewed Functionally]
   827   C1511726:Data [Idea or Concept]
   827   C1626935:Bases [Quantitative Concept]
   827   C3245479:data [Medical Device]
   793 E C0002055:base [Inorganic Chemical]
   793 E C1527178:Basis [Functional Concept]
   793 E C1874451:Basis [Pharmacologic Substance]
   793 E C1880279:Base [Biomedical or Dental Material]
   743 E C0205112:Basal [Spatial Concept]
   734 E C0016617:Foundation [Organization]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "it"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: ">70% identity with sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0424215:Identity [Mental Process]
   770   C2003939:Identity [Finding]

Phrase: "deduced from a rat genomic clone"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009013:Clone [Cell]
   753   C0017428:Genomic [Gene or Genome]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1522642:Clone [Tissue]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a partial sequence of the TR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "(accession number AF189711"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: A second mouse TR1 sequence, which encoded a 499-amino acid protein, has recently appeared in GenBankTM (accession number AB027565). 

Phrase: "A second mouse TR1 sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "which"

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "a 499-amino acid protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "appeared in GenBankTM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0700364:APPEAR [Qualitative Concept]

Phrase: "(accession number AB027565"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.193: Comparison of two mouse TR1 cDNA sequences revealed identity in >3 kilobases that spanned most of the coding region and the entire 3'-untranslated region. 

Phrase: "Comparison of two mouse TR1 cDNA sequences revealed identity in >3 kilobases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1707455:Comparison [Activity]

Phrase: "that"

Phrase: "spanned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "most of the coding region"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0079941:Coding Region [Gene or Genome]
   760   C0009219:Coding [Occupational Activity]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0205393:Most [Quantitative Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "the entire 3'-untranslated region."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.194: These sequences, however, had no homology in 5'-end sequences (Fig. 5). 

Phrase: "These sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "however,"

Phrase: "had"

Phrase: "no homology in 5'-end sequences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0162775:Sequence Homology [Quantitative Concept]
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]
   717 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.195: Subsequent BLAST analyses of mouse dbEST revealed a mouse EST sequence (accession number AI956288) corresponding to a third TR1 form that had an additional distinct version of the 5'-end sequence, but was identical with the two full-size cDNA sequences in the downstream region (Fig. 5). 

Phrase: "Subsequent BLAST analyses of mouse dbEST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a mouse EST sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(accession number AI956288"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "corresponding to a third TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205437:Third [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "an additional distinct version of the 5'-end sequence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0333052:Version [Functional Concept]
   742   C2607870:Version [Spatial Concept]

Phrase: "but"

Phrase: "was"

Phrase: "identical with the two full-size cDNA sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "in the downstream region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1883633:Downstream Region [Nucleotide Sequence]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.196: The use of three independent 5' variants deviating from each other at the same place within the nucleotide sequence was reminiscent of the alternative use of three exons; 

Phrase: "The use of three independent 5' variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "deviating from each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0012727:deviate [Spatial Concept]

Phrase: "at the same place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442504:Place [Spatial Concept]
   861   C1704765:Place [Functional Concept]
   861   C1882509:Place [Activity]
   861   C3496241:place [Disease or Syndrome]

Phrase: "within the nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "reminiscent of the alternative use of three exons"

Phrase: ";"
Processing 00000000.tx.197: that is, different 5' sequences corresponded to alternative first exons, while common sequences corresponded to common downstream exons. 

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "different 5' sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponded to alternative first exons,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1523987:Alternative [Conceptual Entity]

Phrase: "while"

Phrase: "common sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponded to common downstream exons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205214:Common [Quantitative Concept]
   760   C0522506:Downstream [Spatial Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.198: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.199: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.200: Nucleotide sequence comparisons of TR1 forms obtained by alternative first exon splicing in mice and rats. 

Phrase: "Nucleotide sequence comparisons of TR1 forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "obtained by alternative first exon splicing"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0002345:Alternative Splicing [Genetic Function]
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035687:Splicing [Genetic Function]
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1523987:Alternative [Conceptual Entity]
   753   C2610186:splicing [Genetic Function]
   719 E C1706701:Obtain [Activity]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.201: Each of the three forms was represented by mouse and rat sequences. 

Phrase: "Each of the three forms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205449:Three [Quantitative Concept]
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C1457900:Each [Quantitative Concept]
   726 E C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "represented by mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   756   C1882932:Represent [Activity]

Phrase: "and"

Phrase: "rat sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.202: The three forms had distinct 5' sequences (exons 1,2, or 3), but shared downstream sequences (exon 4). 

Phrase: "The three forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "had"

Phrase: "distinct 5' sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(exons 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "shared downstream sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.203: Shown in this figure are: MTR1-I, first form of mouse TR1 (accession number AB027565, dbNR cDNA sequence); 

Phrase: "Shown in this figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "MTR1-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "form of mouse TR1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AB027565,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbNR cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.204: MTR1-II, second form of mouse TR1 (accession number AI956288, dbEST sequence); 

Phrase: "MTR1-II,"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "form of mouse TR1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AI956288,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbEST sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.205: MTR1-III, third form of mouse TR1 (this work); 

Phrase: "MTR1-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "form of mouse TR1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.206: RTR1-I, first form of rat TR1 (accession number AF220761, dbNR cDNA sequence); 

Phrase: "RTR1-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "form of rat TR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AF220761,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbNR cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.207: RTR1-II, second form of rat TR1 (accession number AF108213, dbNR cDNA sequence); 

Phrase: "RTR1-II,"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "form of rat TR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AF108213,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbNR cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.208: RTR1-III, third form of rat TR1 (accession number AF189711, dbNR genomic sequence); 

Phrase: "RTR1-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "form of rat TR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AF189711,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbNR genomic sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.209: and RTR1 gene, partial sequence of the rat TR1 gene (accession number AF189711, dbNR genomic sequence). 

Phrase: "and"

Phrase: "RTR1 gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "partial sequence of the rat TR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "(accession number AF189711,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "dbNR genomic sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.210: ATG codons that correspond to the previously predicted initiation site within mammalian TR1 sequences are shown in uppercase. 

Phrase: "ATG codons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "that"

Phrase: "correspond to the previously predicted initiation site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205145:Site [Spatial Concept]
   748   C0589507:Initiation [Mental Process]
   748   C0681842:Predicted [Idea or Concept]
   748   C1158830:Initiation [Genetic Function]
   748   C1515974:Site [Body Location or Region]
   748   C1704686:Initiation [Functional Concept]
   748   C1882327:%{Predicted} [Quantitative Concept]
   748   C2825164:Site [Spatial Concept]

Phrase: "within mammalian TR1 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "shown in uppercase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.211: Intronic sequence is boxed. 

Phrase: "Intronic sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "boxed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]
Processing 00000000.tx.212: The vertical line indicates sites for junction of exons 1,2,or 3to exon 4.

Phrase: "The vertical line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "indicates"

Phrase: "sites for junction of exons 1,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3to exon 4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.213: Numbers on the left correspond to nucleotide numbers for GenBankTM sequences shown in the figure. 

Phrase: "Numbers on the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "correspond to nucleotide numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "for GenBankTM sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown in the figure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.214: This proposition was consistent with the BLAST analysis of rat NR and EST data bases using sequences for three forms of mouse TR1 mRNA. 

Phrase: "This proposition"

Phrase: "was"

Phrase: "consistent with the BLAST analysis of rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "NR"

Phrase: "and"

Phrase: "EST data bases"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   867   C0242356:data base [Intellectual Product]
   867   C0993637:Data Base [Intellectual Product]
   827   C0178499:bases [Chemical Viewed Functionally]
   827   C1511726:Data [Idea or Concept]
   827   C1626935:Bases [Quantitative Concept]
   827   C3245479:data [Medical Device]
   793 E C0002055:base [Inorganic Chemical]
   793 E C1527178:Basis [Functional Concept]
   793 E C1874451:Basis [Pharmacologic Substance]
   793 E C1880279:Base [Biomedical or Dental Material]
   743 E C0205112:Basal [Spatial Concept]
   734 E C0016617:Foundation [Organization]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sequences for three forms of mouse TR1 mRNA."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.215: It revealed three potential forms of rat TR1 mRNA that corresponded to the three mouse mRNA forms (Fig. 5). 

Phrase: "It"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "three potential forms of rat TR1 mRNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "corresponded to the three mouse mRNA forms"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205449:Three [Quantitative Concept]
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.216: Moreover, the availability of the partial sequence for the rat TR1 gene allowed us to predict partial features of an exon-intron structure within this region (Fig. 6). 

Phrase: "Moreover,"

Phrase: "the availability of the partial sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "for the rat TR1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "predict"

Phrase: "partial features of an exon-intron structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "within this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.217: The first exon within the rat genomic sequence corresponded to the 5' end of our mouse TR1 cDNA sequence, whereas the second exon that was separated from the first exon by an ~1.5-kilobase long intron, corresponded to the first common exon within the three forms. 

Phrase: "The first exon within the rat genomic sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponded to the 5' end of our mouse TR1 cDNA sequence,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0025914:Mouse [Mammal]
   738   C0025929:mouse [Mammal]
   738   C0026809:Mouse [Mammal]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0444930:End [Spatial Concept]
   738   C1519249:Sequence [Functional Concept]
   738   C2746065:End [Temporal Concept]

Phrase: "whereas"

Phrase: "the second exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "was"

Phrase: "separated from the first exon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086972:Separated [Finding]
   760   C0205435:First [Quantitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "by an ~1.5-kilobase long intron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponded to the first common exon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205214:Common [Quantitative Concept]
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "within the three forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]
Processing 00000000.tx.218: View larger version (7K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(7K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.219: 6.  

Phrase: "6."
Processing 00000000.tx.220: Predicted structural organization of mouse and rat TR1 genes. 

Phrase: "Predicted structural organization of mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0026559:structural organization [Organism Function]
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "rat TR1 genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.221: Upper portion of the figure shows organization of the TR1 gene in mice and rats. 

Phrase: "Upper portion of the figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "organization of the TR1 gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1517495:Gene Organization [Gene or Genome]
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.222: Three alternative forms of TR1 mRNA are obtained from a single TR1 gene by initiating transcription at exons 1,2,or 3(indicated by numbers above exon boxes), followed by alternative splicing to link a used exon to exon 4.

Phrase: "Three alternative forms of TR1 mRNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "obtained from a single TR1 gene"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0017337:Gene [Gene or Genome]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "by initiating transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "at exons 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "("

Phrase: "indicated by numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]
   790   C1444656:Indicated [Finding]

Phrase: "above exon boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "followed by alternative splicing to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0002345:Alternative Splicing [Genetic Function]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0035687:Splicing [Genetic Function]
   760   C1523987:Alternative [Conceptual Entity]
   760   C2610186:splicing [Genetic Function]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "a used exon to exon 4."
Processing 00000000.tx.223: The downstream organization of the gene is not known (shown as question mark). 

Phrase: "The downstream organization of the gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1517495:Gene Organization [Gene or Genome]
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "("

Phrase: "shown as question mark"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0522501:mark [Qualitative Concept]
   770   C1522634:Question [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.224: ATG codons indicate alternative translation initiation sites. 

Phrase: "ATG codons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "indicate"

Phrase: "alternative translation initiation sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.225: Filled boxes indicate translated sequences. 

Phrase: "Filled boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "indicate"

Phrase: "translated sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.226: Open boxes correspond to untranslated regions. 

Phrase: "Open boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "correspond to untranslated regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600680:Untranslated Regions [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
Processing 00000000.tx.227: Lower portion of the figure shows organization of several ESTs (accession numbers AI526517, AI527732, AI226627, AI787452, AI314145, and AI315024) that were used to determine the order of exons in the TR1 gene. 

Phrase: "Lower portion of the figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "organization of several ESTs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0029237:Organisation [Physiologic Function]
   770   C0029246:Organization [Organization]
   770   C0220885:organization [Qualitative Concept]
   770   C1300196:Organization [Functional Concept]
   770   C1522486:Organization [Professional or Occupational Group]

Phrase: "(accession numbers AI526517,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1510755:Accession Number [Intellectual Product]

Phrase: "AI527732,"

Phrase: "AI226627,"

Phrase: "AI787452,"

Phrase: "AI314145,"

Phrase: "and"

Phrase: "AI315024"

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the order of exons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "in the TR1 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.228: These ESTs contained sequences that were identical with partial sequences of exon 1,exon 2,and the last exon of the TR1 gene. 

Phrase: "These ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "identical with partial sequences of exon 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "exon 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the last exon of the TR1 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.229: In addition, ESTs contained an internal stretch of sequences identical with internal sequences of exon 4of apolipoprotein E gene (shown as ApoE in the upper portion of the figure). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an internal stretch of sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "identical with internal sequences of exon 4of apolipoprotein E gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205280:Identical [Qualitative Concept]

Phrase: "("

Phrase: "shown as ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1547282:Show [Intellectual Product]

Phrase: "in the upper portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of the figure"

Phrase: ")."
Processing 00000000.tx.230: The three TR1 forms, TR1-I, TR1-II, and TRI-III (Fig. 6), were designated according to order of exons within genomic sequences, which was derived from the following observations. 

Phrase: "The three TR1 forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "TR1-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TR1-II,"

Phrase: "and"

Phrase: "TRI-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "designated according to order of exons"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0680240:according [Social Behavior]
   753   C1524084:Designated [Functional Concept]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "within genomic sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "derived from the following observations."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0302523:observations [Research Activity]
   760   C0700325:observations [Health Care Activity]
   760   C1441547:Derived [Qualitative Concept]
   760   C3244290:observations [Functional Concept]
   760   C3245521:derived [Idea or Concept]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.231: The first exon of the TR1-III sequence was present in the rat genomic clone that also contained the downstream sequences common for three TR1 forms, whereas the first exons of the TR1-I and TR1-II sequences were not present in the rat genomic clone sequence. 

Phrase: "The first exon of the TR1-III sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "present in the rat genomic clone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "that also"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the downstream sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "common for three TR1 forms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "whereas"

Phrase: "the first exons of the TR1-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "TR1-II sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the rat genomic clone sequence."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0009013:Clone [Cell]
   748   C0017428:Genomic [Gene or Genome]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0150312:Present [Quantitative Concept]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0449450:Present [Idea or Concept]
   748   C0887950:genomic [Biomedical Occupation or Discipline]
   748   C1519249:Sequence [Functional Concept]
   748   C1522642:Clone [Tissue]
Processing 00000000.tx.232: Thus, 5' exons of TR1-I and TR1-II were upstream of the 5' exon of TR1-III. 

Phrase: "Thus,"

Phrase: "5' exons of TR1-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "TR1-II"

Phrase: "were upstream of the 5' exon of TR1-III."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0439070:III [Intellectual Product]
   742   C0522505:Upstream [Spatial Concept]
   742   C1705160:III [Qualitative Concept]
Processing 00000000.tx.233: We also found several EST sequences (accession numbers AI526517, AI527732, AI226627, AI787452, AI314145, and AI315024) that contained partial sequences for first exons of TR1-I and TR1-II as well as downstream sequences that were common for the three forms (Fig. 6). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "several EST sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(accession numbers AI526517,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1510755:Accession Number [Intellectual Product]

Phrase: "AI527732,"

Phrase: "AI226627,"

Phrase: "AI787452,"

Phrase: "AI314145,"

Phrase: "and"

Phrase: "AI315024"

Phrase: ")"

Phrase: "that contained partial sequences for first exons of TR1-I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0162326:Sequences [Nucleotide Sequence]
   706 E C0004793:Sequence [Nucleotide Sequence]
   706 E C0162327:Sequence [Nucleotide Sequence]
   706 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "TR1-II"

Phrase: "as well as"

Phrase: "downstream sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "common for the three forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.234: Within these ESTs, 5' sequences of TR1-I preceded 5' sequences of TR1-II. 

Phrase: "Within these ESTs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5' sequences of TR1-I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "5' sequences of TR1-II."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.235: Thus, within the genomic sequences, the 5' exon of TR1-I should be first, the 5' exon of TR1-II, second, and the 5' exon of TR1-III, third, followed by a fourth exon that had sequences common for the three TR1 forms. 

Phrase: "Thus,"

Phrase: "within the genomic sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "the 5' exon of TR1-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "should"

Phrase: "be"

Phrase: "first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the 5' exon of TR1-II,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "the 5' exon of TR1-III,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "followed by a fourth exon"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205438:Fourth [Quantitative Concept]
   760   C1706303:Fourth [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "had"

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "common for the three TR1 forms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]
Processing 00000000.tx.236: Interestingly, ESTs that contained 5' sequences for TR1-I and TR-II had an additional internal stretch of 176nucleotides, which was 100% identical to internal sequences of exon 4of a mouse apolipoprotein E (ApoE) gene. 

Phrase: "Interestingly,"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "5' sequences for TR1-I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "TR-II"

Phrase: "had"

Phrase: "an additional internal stretch of 176nucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "was"

Phrase: "100% identical to internal sequences of exon 4of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "a mouse apolipoprotein E (ApoE) gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.237: It should be noted that known TR1 (chromosome 10) and ApoE (chromosome 7) genes in mice are located on different chromosomes. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that known TR1"

Phrase: "(chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "ApoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(chromosome 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008670:Chromosome 7 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "genes in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1417166:MICE gene [Gene or Genome]
   790   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "located on different chromosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008633:Chromosomes [Cell Component]
   770   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.238: If ESTs containing TR1 and ApoE sequences were formed by alternative splicing, then one possible explanation for their formation is that mice may have an additional ApoE gene or a pseudogene located within the TR1 gene. 

Phrase: "If"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "TR1"

Phrase: "and"

Phrase: "ApoE sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "formed by alternative splicing,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002345:Alternative Splicing [Genetic Function]
   770   C0035687:Splicing [Genetic Function]
   770   C0205431:Formed [Functional Concept]
   770   C1523987:Alternative [Conceptual Entity]
   770   C2610186:splicing [Genetic Function]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "then one possible explanation for their formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "have"

Phrase: "an additional ApoE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "or"

Phrase: "a pseudogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033799:Pseudogene [Gene or Genome]

Phrase: "located within the TR1 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.239: Alternatively, ESTs containing a 176-nucleotide stretch could be formed by possible novel genetic mechanisms (such as "reverse splicing"), which would allow insertion of a DNA (or mRNA) sequence within another DNA (or mRNA) sequence. 

Phrase: "Alternatively,"

Phrase: "ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 176-nucleotide stretch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "formed by possible novel genetic mechanisms"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205314:Novel [Temporal Concept]
   753   C0205431:Formed [Functional Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C0332149:Possible [Qualitative Concept]
   753   C0441712:Mechanisms [Functional Concept]
   753   C0679622:novel [Intellectual Product]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "such as ""reverse splicing"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "would"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "insertion of a DNA ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021107:Insertion [Therapeutic or Preventive Procedure]
   770   C0441587:Insertion [Health Care Activity]
   770   C1512796:Insertion [Genetic Function]
   770   C1883719:Insertion [Functional Concept]

Phrase: "or"

Phrase: "mRNA) sequence within another DNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "("

Phrase: "or"

Phrase: "mRNA) sequence."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.240: Alternative Use of First Exons within TR3 Genes-- The observation of alternative mRNA forms of TR1 in rats and mice prompted us to test whether this mechanism is used in genes for other TRs. 

Phrase: "Alternative Use of First Exons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "within TR3 Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "The observation of alternative mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "forms of TR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "used in genes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0017337:Genes [Gene or Genome]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for other TRs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.241: Indeed, computer search analysis of NR and EST data bases revealed three alternative human TR3 transcripts (TR3-I, TR3-II, and TR3-III) that differed in their 5' sequences (Fig. 7) and were formed by alternative first exon splicing (Fig. 8). 

Phrase: "Indeed,"

Phrase: "computer search analysis of NR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1516770:Computer Analysis [Machine Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "EST data bases revealed three alternative human TR3 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(TR3-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TR3-II,"

Phrase: "and"

Phrase: "TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "differed in their 5' sequences"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "formed by alternative first exon splicing"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0002345:Alternative Splicing [Genetic Function]
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035687:Splicing [Genetic Function]
   753   C0205431:Formed [Functional Concept]
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1523987:Alternative [Conceptual Entity]
   753   C2610186:splicing [Genetic Function]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.242: TR3-I (accession numbers AF171054, AF044212, AF106697, and AB019694) was a previously reported nucleus-encoded mitochondrial form of TR3 (5-10). 

Phrase: "TR3-I (accession numbers AF171054,"

Phrase: "AF044212,"

Phrase: "AF106697,"

Phrase: "and"

Phrase: "AB019694"

Phrase: ")"

Phrase: "was"

Phrase: "a previously reported nucleus-encoded mitochondrial form of TR3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "(5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.243: The TR3-II transcript (accession number AF166127) was a previously identified isoform of human TR3 mRNA, SelZf2 (26). 

Phrase: "The TR3-II transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(accession number AF166127"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "a previously identified isoform of human TR3 mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "SelZf2"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.244: This transcript appeared to be inhibitory for TR3 expression since it contained an initiator ATG codon, followed by an in-frame stop signal, in a different frame with established TR3 sequences. 

Phrase: "This transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inhibitory for TR3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3463820:Inhibitory [Activity]

Phrase: "since"

Phrase: "it"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an initiator ATG codon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0242610:Codon, Initiator [Nucleotide Sequence]
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "followed by an in-frame stop signal,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C1705858:Frame [Manufactured Object]
   748   C1710082:Signal [Phenomenon or Process]
   748   C1947925:Stop [Activity]
   748   C2746065:Stop [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "in a different frame"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080089:Frame [Nucleotide Sequence]
   861   C0180979:Frame [Medical Device]
   861   C1705858:Frame [Manufactured Object]

Phrase: "with established TR3 sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.245: The TR3-III transcript (accession number AB019695) encoded a protein that lacked a mitochondrial signal but instead contained a 5-amino acid extension. 

Phrase: "The TR3-III transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(accession number AB019695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "a mitochondrial signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "but"

Phrase: "instead"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a 5-amino acid extension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0231448:Extension [Functional Concept]
   812   C1880641:Extension [Conceptual Entity]
Processing 00000000.tx.246: The lack of signal peptides in TR3-III suggested that the protein could reside in the cytosol. 

Phrase: "The lack of signal peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "reside in the cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1383501:Cytosol [Cell Component]
   770   C2982691:Reside [Activity]
Processing 00000000.tx.247: View larger version (41K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.248: 7.  

Phrase: "7."
Processing 00000000.tx.249: Sequence comparisons of TR3 forms obtained by alternative first exon splicing in mice, rats, and humans. 

Phrase: "Sequence comparisons of TR3 forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "obtained by alternative first exon splicing"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0002345:Alternative Splicing [Genetic Function]
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0035687:Splicing [Genetic Function]
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1523987:Alternative [Conceptual Entity]
   753   C2610186:splicing [Genetic Function]
   719 E C1706701:Obtain [Activity]

Phrase: "in mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.250: A, nucleotide sequence comparisons of three alternative TR3 cDNA forms. 

Phrase: "A,"

Phrase: "nucleotide sequence comparisons of three alternative TR3 cDNA forms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1707455:Comparison [Activity]
Processing 00000000.tx.251: The three forms utilize alternative first exons (exons 1,2,or 3), followed by the common exon (exon 4). 

Phrase: "The three forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "utilize"

Phrase: "alternative first exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exons 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "followed by the common exon"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.252: Exon-intron splicing sites are shown by interruptions in horizontal lines. 

Phrase: "Exon-intron splicing sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "shown by interruptions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0332453:interruption [Functional Concept]
   756   C1512900:Interruption [Temporal Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "in horizontal lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.253: Exonic sequences are shown in uppercase, and intronic sequences, in lowercase. 

Phrase: "Exonic sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "shown in uppercase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "intronic sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "in lowercase."
Processing 00000000.tx.254: Numbers on the left and right indicate nucleotide numbers within GenBankTM genomic sequences that were used to assemble the figure. 

Phrase: "Numbers on the left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "indicate"

Phrase: "nucleotide numbers within GenBankTM genomic sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2348184:Sequence Number [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assemble"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706853:Assemble [Activity]

Phrase: "the figure."
Processing 00000000.tx.255: Numbers within sequences indicate numbers of intronic nucleotides present within sequences shown in the figure. 

Phrase: "Numbers within sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C2348184:Sequence Number [Quantitative Concept]
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "indicate"

Phrase: "numbers of intronic nucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "present within sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0162326:Sequences [Nucleotide Sequence]
   790   C0449450:Present [Idea or Concept]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown in the figure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.256: ATG codons that are predicted to initiate translation of TR3-III mRNAs are shown in bold. 

Phrase: "ATG codons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "that"

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "translation of TR3-III mRNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0597295:mRNA Translation [Molecular Function]
           translation
   760   C0040712:Translation [Intellectual Product]
   760   C1519614:Translation [Genetic Function]

Phrase: "are"

Phrase: "shown in bold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.257: These are characterized by favorable Kozak consensus sequences for phasing mRNA for initiation of translation. 

Phrase: "These"

Phrase: "are"

Phrase: "characterized by favorable Kozak consensus sequences"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0079160:Sequences, Consensus [Nucleotide Sequence]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   753   C1880022:Characterized [Activity]
   753   C3640814:Favorable [Qualitative Concept]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "for phasing mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of translation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]
Processing 00000000.tx.258: The occurrence of exons 2and 3in human sequences is indicated by the analysis of dbNR. 

Phrase: "The occurrence of exons 2and 3in human sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243132:occurrence [Functional Concept]
   744   C1554210:occurrence [Idea or Concept]
   744   C2745955:Occurrence [Temporal Concept]

Phrase: "is"

Phrase: "indicated by the analysis of dbNR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1444656:Indicated [Finding]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.259: The occurrence of exon 3in mouse and rat sequences is predicted in this study based on the analysis of mouse and rat genomic sequences with an exon-searching program. 

Phrase: "The occurrence of exon 3in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243132:occurrence [Functional Concept]
   753   C1554210:occurrence [Idea or Concept]
   753   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "rat sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "predicted in this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0557651:Study [Manufactured Object]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "based on the analysis of mouse"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "rat genomic sequences with an exon-searching program."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.260: Sequences shown are from the following dbNR genomic sequences: HTR3-I, first form of human TR3 (accession number AC000090), MTR3-I, first form of mouse TR3 (accession number AC003066), RTR3-I, first form of rat TR3 (accession number RN5CATOMT), HTR3-II, second form of human TR3 (accession number AC000090), HTR3-III, third form of human TR3 (accession number AC000090); 

Phrase: "Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are from the following dbNR genomic sequences"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0017428:Genomic [Gene or Genome]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0887950:genomic [Biomedical Occupation or Discipline]
   748   C1551058:Are [Quantitative Concept]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714   C0332283:follow [Temporal Concept]
   714 E C1519249:Sequence [Functional Concept]
   714   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "HTR3-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "form of human TR3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086418:Human [Human]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AC000090"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "MTR3-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "form of mouse TR3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AC003066"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "RTR3-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "form of rat TR3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number RN5CATOMT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "HTR3-II,"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "form of human TR3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086418:Human [Human]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AC000090"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "HTR3-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "form of human TR3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086418:Human [Human]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AC000090"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.261: MTR3-III, third form of mouse TR3 (accession number AC003066); 

Phrase: "MTR3-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "form of mouse TR3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number AC003066"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.262: RTR3-III, third form of rat TR3 (accession number RN5CATOMT). 

Phrase: "RTR3-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "form of rat TR3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "(accession number RN5CATOMT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.263: B, amino acid sequence comparisons of TR3-I and TR3-III. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "amino acid sequence comparisons of TR3-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "TR3-III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]
Processing 00000000.tx.264: Same sequences were used here as in Fig. 

Phrase: "Same sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.265: 7A. 

Phrase: "7A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.266: Exon-intron junctions (indicated by interruptions within horizontal lines) were predicted with an exon finding program and by matching cDNA and genomic sequences. 

Phrase: "Exon-intron junctions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205144:Junction [Spatial Concept]
   793   C1706311:Junction [Medical Device]

Phrase: "("

Phrase: "indicated by interruptions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1444656:Indicated [Finding]
   756   C0332453:interruption [Functional Concept]
   756   C1512900:Interruption [Temporal Concept]

Phrase: "within horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "predicted with an exon finding program"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C0681842:Predicted [Idea or Concept]
   753   C1709697:Program [Conceptual Entity]
   753   C1882327:%{Predicted} [Quantitative Concept]
   753   C2728259:Program [Pharmacologic Substance]
   753   C2825141:Finding [Finding]
   753   C3484370:Program [Functional Concept]

Phrase: "and by matching cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150103:MATCHING [Research Activity]
   770   C1515981:And [Idea or Concept]
   770   C1708943:Matching [Qualitative Concept]

Phrase: "and"

Phrase: "genomic sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.267: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.268: 8.  

Phrase: "8."
Processing 00000000.tx.269: Structural organization of human TR3 and COMT genes. 

Phrase: "Structural organization of human TR3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0026559:structural organization [Organism Function]
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "COMT genes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   844   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
Processing 00000000.tx.270: TR3 and COMT genes are located on complementary DNA stands and overlap in their first exons such that transcription within the membrane-bound form (MB-COMT) of the COMT gene is initiated within the coding region of the mitochondrial (TR3-I) form of the TR3 gene. 

Phrase: "TR3"

Phrase: "and"

Phrase: "COMT genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   844   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "are"

Phrase: "located on complementary DNA stands"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0596013:Stands [Finding]
   726 E C1704644:Stand [Medical Device]

Phrase: "and"

Phrase: "overlap in their first exons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185027:overlap [Therapeutic or Preventive Procedure]
   760   C1948020:Overlap [Conceptual Entity]

Phrase: "such"

Phrase: "that transcription within the membrane-bound form"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]

Phrase: "(MB-COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   884   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   804   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "of the COMT gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   861   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "is"

Phrase: "initiated within the coding region of the mitochondrial"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0079941:Coding Region [Gene or Genome]
   744   C0009219:Coding [Occupational Activity]
   744   C0017446:Region [Geographic Area]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0205147:Region [Spatial Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   711 E C0805701:Code [Intellectual Product]
   711   C1548602:Initiate [Idea or Concept]
   711   C1704686:Initiate [Functional Concept]

Phrase: "(TR3-I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "form of the TR3 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.271: However, transcription start sites in the TR3-III gene and a soluble form (S-COMT) of the COMT gene are separated by ~30 kilobases. 

Phrase: "However,"

Phrase: "transcription start sites in the TR3-III gene"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   800   C0949639:Transcription Start Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767   C0040649:Gene Transcription [Genetic Function]
           Transcription
   744   C0205145:Sites [Spatial Concept]
   744   C0439659:Start [Temporal Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a soluble form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "S-"

Phrase: "COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "of the COMT gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   861   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "are"

Phrase: "separated by ~30 kilobases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   737   C0582519:kilobase [Quantitative Concept]
Processing 00000000.tx.272: Alternative first exon splicing is used in the TR3 gene. 

Phrase: "Alternative first exon splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "used in the TR3 gene."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0017337:Gene [Gene or Genome]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.273: TR3-I mRNA is composed of 6exons (exons 1and 4-8); 

Phrase: "TR3-I mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "composed of 6exons"

Phrase: "(exons 1and 4-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.274: TR3-II mRNA, 6exons (exons 2and 4-8); 

Phrase: "TR3-II mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "6exons"

Phrase: "(exons 2and 4-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.275: TR3-III mRNA, 6exons (3-8); 

Phrase: "TR3-III mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "6exons"

Phrase: "(3-8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.276: MB-COMT mRNA, 6exons (exons 1-6); 

Phrase: "MB-COMT mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "6exons"

Phrase: "(exons 1-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.277: and S-COMT mRNA, 4exons (exons 3-6). 

Phrase: "and S-"

Phrase: "COMT mRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   756   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]

Phrase: "4exons"

Phrase: "(exons 3-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.278: Translation start sites within TR3 and COMT genes are indicated by ATG codons. 

Phrase: "Translation start sites within TR3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040712:Translation [Intellectual Product]
   760   C0205145:Sites [Spatial Concept]
   760   C0439659:Start [Temporal Concept]
   760   C0597295:translation [Molecular Function]
   760   C1519614:Translation [Genetic Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "COMT genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   844   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "are"

Phrase: "indicated by ATG codons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0009221:Codon [Nucleotide Sequence]
   770   C1095825:Codon [Plant]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.279: Initiator ATG codon for TR3-I mRNA is located within exon 1,and for TR3-III mRNA, within exon 2.

Phrase: "Initiator ATG codon for TR3-I mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0242610:Codon, Initiator [Nucleotide Sequence]
   748   C0009221:Codon [Nucleotide Sequence]
   748   C1095825:Codon [Plant]

Phrase: "is"

Phrase: "located within exon 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and for TR3-III mRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439070:III [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   760   C1705160:III [Qualitative Concept]

Phrase: "within exon 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.280: Translation start site for TR3-II is located within exon 2,but followed by an in-frame stop signal (not shown). 

Phrase: "Translation start site for TR3-II"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040712:Translation [Intellectual Product]
   753   C0205145:Site [Spatial Concept]
   753   C0439659:Start [Temporal Concept]
   753   C0597295:translation [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C1519614:Translation [Genetic Function]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located within exon 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "followed by an in-frame stop signal"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C1705858:Frame [Manufactured Object]
   748   C1710082:Signal [Phenomenon or Process]
   748   C1947925:Stop [Activity]
   748   C2746065:Stop [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.281: The translation initiation site in the MB-COMT mRNA is the first ATG within exon 3,and in the S-COMT mRNA, the second ATG within exon 3.Filled boxes indicate translated sequences. 

Phrase: "The translation initiation site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C1519613:Translation Initiation [Genetic Function]
   827   C0040712:Translation [Intellectual Product]
   827   C0205145:Site [Spatial Concept]
   827   C0589507:Initiation [Mental Process]
   827   C0597295:translation [Molecular Function]
   827   C1158830:Initiation [Genetic Function]
   827   C1515974:Site [Body Location or Region]
   827   C1519614:Translation [Genetic Function]
   827   C1704686:Initiation [Functional Concept]
   827   C2825164:Site [Spatial Concept]

Phrase: "in the MB-COMT mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "the first ATG within exon 3,"

Phrase: "and in the S-COMT mRNA,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   800   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   744   C0007413:catechol [Organic Chemical]
   744   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0054858:catechol [Organic Chemical,Pharmacologic Substance]
   744   C1515981:And [Idea or Concept]

Phrase: "the second ATG within exon 3.Filled boxes"

Phrase: "indicate"

Phrase: "translated sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.282: Open boxes correspond to untranslated regions. 

Phrase: "Open boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "correspond to untranslated regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600680:Untranslated Regions [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
Processing 00000000.tx.283: The human TR3 gene, located on chromosome 22(accession number AC000090), was previously sequenced by the Human Genome Project as evidenced by the BLAST analysis of dbNR. 

Phrase: "The human TR3 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "located on chromosome 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008665:Chromosome 22 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "(accession number AC000090"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "previously"

Phrase: "sequenced by the Human Genome Project"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020125:Human Genome Project [Research Activity]
   790   C0017429:Genome, Human [Gene or Genome]
   753   C0017428:Genome [Gene or Genome]
   753   C0086418:Human [Human]
   753   C1709701:Project [Conceptual Entity]
   753   C2338314:Genome [Conceptual Entity]
   719   C0004793:Sequence [Nucleotide Sequence]
   719   C0162326:Sequence [Nucleotide Sequence]
   719   C0162327:Sequence [Nucleotide Sequence]
   719   C1519249:Sequence [Functional Concept]

Phrase: "as"

Phrase: "evidenced by the BLAST analysis of dbNR."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0337026:Blast [Natural Phenomenon or Process]
   748   C0368761:blast [Cell]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.284: Organization of the human TR3 gene and its upstream region are shown in Fig. 

Phrase: "Organization of the human TR3 gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1517495:Gene Organization [Gene or Genome]
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "its upstream region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1883644:Upstream Region [Nucleotide Sequence]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0522505:Upstream [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.285: 8. 

Phrase: "8."
Processing 00000000.tx.286: Comparison of cDNA and genomic sequences indicated that alternative TR3-I, TR3-II, and TR3-III transcripts were formed due to alternative use of three 5' exons within the gene. 

Phrase: "Comparison of cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "genomic sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that alternative TR3-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TR3-II,"

Phrase: "and"

Phrase: "TR3-III transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "formed due to alternative use of three 5' exons"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0678226:Due to [Functional Concept]
           due
   764   C1524063:Use of [Functional Concept]
   742   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0042153:use [Functional Concept]
   742   C0205431:Formed [Functional Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0457083:Use [Functional Concept]
   742   C1523987:Alternative [Conceptual Entity]
   742   C1947944:Use [Intellectual Product]
   742   C3146286:Due [Idea or Concept]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1522492:Form [Functional Concept]

Phrase: "within the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.287: We also analyzed partial sequences of the mouse TR3 gene (accession number AC003066, clone tbx1, strain 129X1/SvJ ES, from cell line RW4, located on chromosome 16) that were generated by the Mouse Genome Project and partial rat TR3 genomic sequences that were found in the genomic clone containing an upstream region of the COMT gene. 

Phrase: "We also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "partial sequences of the mouse TR3 gene"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "(accession number AC003066,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "clone tbx1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420603:TBX1 [Gene or Genome]

Phrase: "strain 129X1/SvJ ES,"

Phrase: "from cell line RW4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007600:Cell Line [Cell]

Phrase: "located on chromosome 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008658:Chromosome 16 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "generated by the Mouse Genome Project"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0017428:Genome [Gene or Genome]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1709701:Project [Conceptual Entity]
   753   C2338314:Genome [Conceptual Entity]
   753   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "partial rat TR3 genomic sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "found in the genomic clone"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009013:Clone [Cell]
   760   C0017428:Genomic [Gene or Genome]
   760   C0150312:Found [Quantitative Concept]
   760   C0887950:genomic [Biomedical Occupation or Discipline]
   760   C1522642:Clone [Tissue]
   726 E C0243095:Find [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an upstream region of the COMT gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1883644:Upstream Region [Nucleotide Sequence]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C0522505:Upstream [Spatial Concept]
Processing 00000000.tx.288: Analyses of these sequences with an exon finding program revealed the presence of a predicted conserved exon that could generate TR3-III forms of mouse and rat TR3 (Fig. 7). 

Phrase: "Analyses of these sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "with an exon finding program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of a predicted conserved exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "could"

Phrase: "generate"

Phrase: "TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "forms of mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "rat TR3"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.289: Thus, the use of alternative first exon splicing to form multiple TR3 forms appeared to be conserved in humans, mice, and rats. 

Phrase: "Thus,"

Phrase: "the use of alternative first exon splicing to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "multiple TR3 forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "conserved in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.290: However, no ESTs that corresponded to mouse and rat TR3-III were detected. 

Phrase: "However,"

Phrase: "no ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "corresponded to mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.291: We have previously noted that the human TR3 gene partially overlapped with the gene for COMT (10). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the human TR3 gene partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0314604:Human gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "overlapped with the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "for COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.292: In the present study, we performed detailed computer analysis of human TR3 and COMT genes and analyzed whether this structural organization of these genes is conserved in other animals. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "detailed computer analysis of human TR3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1516770:Computer Analysis [Machine Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "COMT genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   991   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   844   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "whether"

Phrase: "this structural organization of these genes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0026559:structural organization [Organism Function]
   767   C1517495:Gene Organization [Gene or Genome]
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "is"

Phrase: "conserved in other animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003062:Animals [Animal]
Processing 00000000.tx.293: We found that the first exon of the human TR3 gene overlapped with the first exon of the gene for membrane-bound (MB)-COMT (Fig. 8). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the first exon of the human TR3 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "overlapped with the first exon of the gene"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017337:Gene [Gene or Genome]
   744   C0185027:overlapped [Therapeutic or Preventive Procedure]
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   711 E C1948020:Overlap [Conceptual Entity]

Phrase: "for membrane-bound (MB)-COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   884   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   804   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.294: The mTR3 and MB-COMT genes were located on different DNA strands on a chromosome 22q11.2 band. 

Phrase: "The mTR3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425980:MTR3 [Gene or Genome]

Phrase: "and"

Phrase: "MB-COMT genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   892   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
   810   C1334751:Methyltransferase Gene [Gene or Genome]
   799   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "located on different DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1705242:Different [Qualitative Concept]

Phrase: "strands on a chromosome 22q11.2 band."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0935660:chromosome 22q11 [Gene or Genome]
   778   C1521104:22q11.2 [Cell Component]
   774   C0008627:band chromosome [Laboratory Procedure,Molecular Biology Research Technique]
   774   C0008662:Chromosome 2 [Cell Component]
   774   C1521913:Chromosome band [Cell Component]
           band
   748   C0008633:Chromosome [Cell Component]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521101:22q11 [Cell Component]
   748   C1704972:Strand [Spatial Concept]
   748   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.295: Translation of MB-COMT mRNA resulted in the 30-kDa protein containing an N-terminal transmembrane domain (27). 

Phrase: "Translation of MB-COMT mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597295:mRNA Translation [Molecular Function]
           translation
   744   C0040712:Translation [Intellectual Product]
   744   C1519614:Translation [Genetic Function]

Phrase: "resulted in the 30-kDa protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1532717:kDa [Quantitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an N-terminal transmembrane domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1519623:Transmembrane Domain [Amino Acid Sequence]
   812   C1167322:transmembrane [Cell Component]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C2752508:transmembrane [Cell Component]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.296: Interestingly, the COMT gene, like the human TR3 gene, had an additional transcription initiation site. 

Phrase: "Interestingly,"

Phrase: "the COMT gene,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   861   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "like the human TR3 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "had"

Phrase: "an additional transcription initiation site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   812   C0040649:Transcription [Genetic Function]
   812   C0205145:Site [Spatial Concept]
   812   C0589507:Initiation [Mental Process]
   812   C1515974:Site [Body Location or Region]
   812   C1704686:Initiation [Functional Concept]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.297: The use of this site resulted in a transcript that lacked the first two exons and translated into a shorter 26-kDa soluble catechol-O-methyltransferase (S-COMT) (27). 

Phrase: "The use of this site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "resulted in a transcript"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "that"

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the first two exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "translated into a shorter 26-kDa soluble catechol-O-methyltransferase (S-COMT)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   782   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   739   C0007413:catechol [Organic Chemical]
   739   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0040710:translated [Occupational Activity]
   739   C0054858:catechol [Organic Chemical,Pharmacologic Substance]
   739   C1532717:kDa [Quantitative Concept]
   739   C1749467:soluble [Cell Component]
   739   C1948047:Soluble [Qualitative Concept]
   706   C1282927:short [Qualitative Concept]
   706   C1806781:Short [Quantitative Concept]
   706   C2350002:Short [Quantitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.298: Human DNA sequences containing exon 1of the TR3-I gene and exon 1of the MB-COMT gene were well separated from other exons within these genes. 

Phrase: "Human DNA sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "exon 1of"

Phrase: "the TR3-I gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "exon 1of"

Phrase: "the MB-COMT gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
   827   C1334751:Methyltransferase Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "well separated from other exons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086972:Separated [Finding]
   760   C0205170:Well [Qualitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "within these genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.299: For example, transcription start sites for S-COMT and TR3-III were separated by ~30 kilobases (Fig. 8). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "transcription start sites for"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   909   C0949639:Transcription Start Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0040649:Transcription [Genetic Function]
   770   C0205145:Sites [Spatial Concept]
   770   C0439659:Start [Temporal Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "S-"

Phrase: "COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "were"

Phrase: "separated by ~30 kilobases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   737   C0582519:kilobase [Quantitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.300: Further analysis of mouse and rat TR3 genes revealed that exons encoding a mitochondrial signal overlapped with the first exons of mouse and rat MB-COMT genes. 

Phrase: "Further analysis of mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "rat TR3 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a mitochondrial signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "overlapped with the first exons of mouse"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0185027:overlapped [Therapeutic or Preventive Procedure]
   748   C0205435:First [Quantitative Concept]
   748   C1279901:First [Qualitative Concept]
   714 E C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "rat MB-COMT genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   869   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
   801   C1334751:Methyltransferase Gene [Gene or Genome]
   795   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.301: Conservation of structural organization of TR3 and COMT genes in humans, mice, and rats suggested that certain TR3 and COMT forms could potentially exhibit parallel or contrasting regulation of expression. 

Phrase: "Conservation of structural organization of TR3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347858:Conservation [Qualitative Concept]

Phrase: "and"

Phrase: "COMT genes in humans,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   874   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
   773   C1334751:Methyltransferase Gene [Gene or Genome]
   767   C0314604:gene humans [Gene or Genome]
   753   C0017337:Genes [Gene or Genome]

Phrase: "mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that certain TR3"

Phrase: "and"

Phrase: "COMT forms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   756   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]

Phrase: "could"

Phrase: "potentially"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "or"

Phrase: "contrasting regulation of expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.302: Alternative Use of First Exons in the Drosophila TR Gene-- In addition to the finding of alternative first exons within mammalian TR genes, we detected a Drosophila gene for TR that produced two alternative transcripts (Fig. 9). 

Phrase: "Alternative Use of First Exons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "in the Drosophila TR Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "In addition to the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "of alternative first exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "within mammalian TR genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a Drosophila gene for TR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0079429:A Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "that produced two alternative transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.303: Like TR3 forms, these transcripts encoded proteins that differed in their N-terminal regions. 

Phrase: "Like TR3 forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "these transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "differed in their N-terminal regions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]
Processing 00000000.tx.304: The previously reported Drosophila TR sequence (accession number U81995) corresponded to a putative cytosolic form of this enzyme, while the additional form of the protein was evident from the BLAST analysis of dbEST and was represented by several ESTs (e.g. accession numbers AA803764 and AA820592 and 6other ESTs). 

Phrase: "The previously reported Drosophila TR sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "(accession number U81995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "corresponded to a putative cytosolic form of this enzyme,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1383501:Cytosolic [Cell Component]
   742   C1522492:Form [Functional Concept]

Phrase: "while"

Phrase: "the additional form of the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "evident from the BLAST analysis of dbEST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0332120:Evidence of [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "represented by several ESTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1882932:Represent [Activity]

Phrase: "("

Phrase: "e.g. accession numbers AA803764"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1510755:Accession Number [Intellectual Product]

Phrase: "and"

Phrase: "AA820592"

Phrase: "and"

Phrase: "6other ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.305: This second form of the Drosophila TR contained a predicted mitochondrial signal peptide. 

Phrase: "This second form of the Drosophila TR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a predicted mitochondrial signal peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037081:Signal Peptide [Amino Acid Sequence]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.306: Thus, it is likely that a single Drosophila TR gene encodes two proteins, mitochondrial and cytosolic. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "a single Drosophila TR gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "two proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "cytosolic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]
Processing 00000000.tx.307: Interestingly, although the order of predicted mitochondrial and cytosolic exons was different, the location of the splicing site that separated variable and common sequences was conserved between mammalian TR3 and Drosophila TR genes (Fig. 9B). 

Phrase: "Interestingly,"

Phrase: "although"

Phrase: "the order of predicted mitochondrial"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1882348:Order [Qualitative Concept]

Phrase: "and"

Phrase: "cytosolic exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "the location of the splicing site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "that separated variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "common sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "conserved between mammalian TR3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024660:Mammalian [Mammal]

Phrase: "and"

Phrase: "Drosophila TR genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.308: View larger version (43K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.309: 9.  

Phrase: "9."
Processing 00000000.tx.310: Alternative forms of Drosophila TR. 

Phrase: "Alternative forms of Drosophila TR."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.311: A, structural organization of the Drosophila TR gene. 

Phrase: "A,"

Phrase: "structural organization of the Drosophila TR gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0026559:structural organization [Organism Function]
   774   C1517495:Gene Organization [Gene or Genome]
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
   748   C0220885:organization [Qualitative Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1522486:Organization [Professional or Occupational Group]
Processing 00000000.tx.312: Each numbered box represents an exon within the gene. 

Phrase: "Each numbered box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an exon within the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.313: Open boxes show untranslated regions, and filled boxes, coding regions. 

Phrase: "Open boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "untranslated regions,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0600680:Untranslated Regions [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "filled boxes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "coding regions."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.314: There are two alternative forms of Drosophila TR mRNA that are encoded by either exons 1and 3-5 (DTR-I, accession number U81995), or exons 2-5 (DTR-II; accession number AA803764 and AA820592). 

Phrase: "There"

Phrase: "are"

Phrase: "two alternative forms of Drosophila TR mRNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "encoded by either exons 1and 3-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0679058:encoded [Mental Process]
   748   C2700640:Encoded [Activity]

Phrase: "(DTR-I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "accession number U81995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "exons 2-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(DTR-II"

Phrase: "; accession number AA803764"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "and"

Phrase: "AA820592"

Phrase: ")."
Processing 00000000.tx.315: B, amino acid sequences of N-terminal regions of two alternative Drosophila TR sequences. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "amino acid sequences of N-terminal regions"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   835   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   814   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   721   C1515860:Acidic Region [Amino Acid Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "of two alternative Drosophila TR sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.316: Human TR3-I and TR3-III, which deviate from each other at the same site within the intron-exon structure, are shown for comparison. 

Phrase: "Human TR3-I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "TR3-III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "which"

Phrase: "deviate from each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012727:deviate [Spatial Concept]

Phrase: "at the same site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "within the intron-exon structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "are"

Phrase: "shown for comparison."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Comparison [Activity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.317: Boxed residues represent predicted mitochondrial signal peptides. 

Phrase: "Boxed residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "predicted mitochondrial signal peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037081:Signal Peptides [Amino Acid Sequence]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   812   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.318: The vertical line represents exon-intron junctions. 

Phrase: "The vertical line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "exon-intron junctions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205144:Junction [Spatial Concept]
   793   C1706311:Junction [Medical Device]
Processing 00000000.tx.319: Identical residues within four sequences are highlighted. 

Phrase: "Identical residues within four sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "highlighted."
Processing 00000000.tx.320: The horizontal line over the sequences shows the location of the disulfide active center.  

Phrase: "The horizontal line over the sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205132:Line [Spatial Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the location of the disulfide active center."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]
Processing 00000000.tx.321: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES We report in the present study that extensive heterogeneity exists among animal TRs and that splicing of first exons of TR genes occurs as a general genetic mechanism for producing multiple mRNA isoforms. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "report in the present study"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1317750:Study report [Intellectual Product]
   797   C1831145:Study report [Clinical Attribute]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C2603343:Study [Research Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "that extensive heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "exists among animal TRs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0003062:Animal [Animal]
   760   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C2987476:Exist [Conceptual Entity]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "that splicing of first exons of TR genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0017365:gene splicing [Gene or Genome]
   750   C0017387:Gene Splicing [Molecular Biology Research Technique]
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]

Phrase: "occurs as a general genetic mechanism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205246:General [Spatial Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1553889:General [Idea or Concept]
   753   C1706376:Mechanism [Manufactured Object]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "for producing multiple mRNA isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3178793:mRNA Isoforms [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.322: The data suggest that this evolutionary conserved genetic mechanism contributes to heterogeneity that is observed among animal TRs. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this evolutionary conserved genetic mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "contributes to heterogeneity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0019409:Heterogeneity [Qualitative Concept]
   790   C1880177:Contribute [Activity]
   706 E C1512426:Heterogenous [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "observed among animal TRs."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0003062:Animal [Animal]
   760   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441672:Observed [Functional Concept]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.323: The fact that human TR1 isolated from HeLa cells occurs in at least two distinct forms has been established previously (16-18). 

Phrase: "The fact"

Phrase: "that human TR1"

Phrase: "isolated from HeLa cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "occurs in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1709305:Occur [Activity]
   833   C2745955:OCCUR [Temporal Concept]

Phrase: "at least two distinct forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "previously"

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.324: The two forms could be separated by affinity chromatography on a heparin column. 

Phrase: "The two forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "separated by affinity chromatography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0008551:Chromatography, Affinity [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "on a heparin column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.325: The first form was not retained on a heparin column, exhibited full catalytic activity and selenium content and showed reactivity with anti-rat liver TR1 antibodies. 

Phrase: "The first form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "retained on a heparin column,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0333118:Retained [Functional Concept]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "full catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "selenium content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reactivity with anti-rat liver TR1 antibodies."
Processing 00000000.tx.326: This form could be converted into the high-affinity TR1 form upon reduction. 

Phrase: "This form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "converted into the high-affinity TR1 form"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205250:High [Qualitative Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1299351:High [Qualitative Concept]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   748   C1522492:Form [Functional Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "upon reduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.327: An additional TR1 form was also isolated that could bind the heparin column without prior reduction. 

Phrase: "An additional TR1 form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "that"

Phrase: "could"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the heparin column without prior reduction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
Processing 00000000.tx.328: This form contained ~0.5 selenium per subunit and had reduced catalytic activities and reactivity with anti-rat liver TR1 antibodies. 

Phrase: "This form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "~0.5 selenium per subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C2348282:Selenium [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "had"

Phrase: "reduced catalytic activities"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   896   C0086439:Reduced Activity [Sign or Symptom]
   884   C0243102:catalytic activity [Molecular Function]
   884   C1264638:Catalytic activity [Functional Concept]
   884   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "reactivity with anti-rat liver TR1 antibodies."
Processing 00000000.tx.329: Our present study indicates that the number of TR1 forms is much larger than previously thought and that these forms differ in electrophoretic mobility on SDS-PAGE and isoelectrofocusing gels. 

Phrase: "Our present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "that"

Phrase: "the number of TR1 forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "much larger than previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "and"

Phrase: "that"

Phrase: "these forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "differ in electrophoretic mobility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0425245:Mobility [Finding]
   770   C0449580:Mobility [Qualitative Concept]

Phrase: "on SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "isoelectrofocusing gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]
Processing 00000000.tx.330: In particular, minor 67-kDa isoforms of TR1 were detected in our study that migrated significantly slower on SDS-PAGE gels than would be predicted from previously reported gene sequences. 

Phrase: "In particular, minor 67-kDa isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "of TR1"

Phrase: "were"

Phrase: "detected in our"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "significantly slower on SDS-PAGE gels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439834:Slow [Qualitative Concept]

Phrase: "than"

Phrase: "would"

Phrase: "be"

Phrase: "predicted from previously reported gene sequences."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0017337:Gene [Gene or Genome]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0681842:Predicted [Idea or Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1882327:%{Predicted} [Quantitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.331: To characterize various mouse TR1 forms, we used affinity chromatography on ADP-Sepharose. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "various mouse TR1 forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "affinity chromatography on ADP-Sepharose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0008551:Chromatography, Affinity [Laboratory Procedure]
   797   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.332: Interestingly, this simple technique was sufficient to enrich TR1 to an extent that it could be directly analyzed on two-dimensional gels and visualized by protein staining. 

Phrase: "Interestingly,"

Phrase: "this simple technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205410:Sufficient [Qualitative Concept]

Phrase: "enrich"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:Enrich [Food]

Phrase: "TR1 to an extent"

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "analyzed on two-dimensional gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1705052:2-Dimensional [Spatial Concept]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0205448:Two [Quantitative Concept]
   760   C0936012:Analyzed [Research Activity]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by protein staining."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.333: Since multiple forms of TR1 were visualized after only a single isolation step, this procedure may provide a basis for future high-throughput protein microchemistry analyses of TRs isolated from multiple sources or under various conditions. 

Phrase: "Since"

Phrase: "multiple forms of TR1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "visualized after only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C0234621:Visualized [Functional Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "a single isolation step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "this procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a basis for future high-throughput protein microchemistry analyses of TRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1527178:Basis [Functional Concept]
   736   C1874451:Basis [Pharmacologic Substance]

Phrase: "isolated from multiple sources"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205409:Isolated [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0449416:sources [Finding]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1705919:Source [Idea or Concept]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or under various conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.334: To define the basis for heterogeneity within human and mouse enzyme preparations, we initially used protein microchemistry techniques and established that detected tryptic peptides did not differ between various enzyme isoforms that had different electrophoretic mobility on polyacrylamide gels or were isolated from normal or malignant cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the basis for heterogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1527178:Basis [Functional Concept]
   770   C1874451:Basis [Pharmacologic Substance]

Phrase: "within human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse enzyme preparations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0360722:ENZYME PREPARATIONS [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "we initially used protein microchemistry techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0025664:techniques [Intellectual Product]
   804   C0449851:Techniques [Functional Concept]

Phrase: "and"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that detected tryptic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between various enzyme isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "had"

Phrase: "different electrophoretic mobility on polyacrylamide gels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   768   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   756   C2348289:Difference Gel Electrophoresis [Laboratory Procedure]
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]
   731   C0596607:Gel Electrophoresis [Laboratory Procedure]
   731   C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "were"

Phrase: "isolated from normal"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0205307:Normal [Qualitative Concept]
   790   C0205409:Isolated [Functional Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C2347086:% Normal [Quantitative Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "malignant cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0334227:Malignant cells [Cell]
  1000   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.335: It remains to be determined what post-translational modifications, if any, are involved in the formation of 55-57-kDa TR1 forms in humans and mice. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "what post-translational modifications,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1704687:Post [Manufactured Object]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "if"

Phrase: "any,"

Phrase: "are"

Phrase: "involved in the formation of 55-57-kDa TR1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0450382:55 [Intellectual Product]
   742   C1314939:Involved [Functional Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1532717:kDa [Quantitative Concept]

Phrase: "forms in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086418:Humans [Human]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.336: To further characterize a mechanism responsible for the formation of multiple TR1 forms and, in particular, for the occurrence of 67-kDa TR1 species, we turned our attention to possible genetic mechanisms. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the formation of multiple TR1 forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: ","

Phrase: "in particular,"

Phrase: "for the occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243132:occurrence [Functional Concept]
  1000   C1554210:occurrence [Idea or Concept]
  1000   C2745955:Occurrence [Temporal Concept]

Phrase: "of 67-kDa TR1 species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "we"

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "our attention to possible genetic mechanisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004268:Attention [Mental Process]
Processing 00000000.tx.337: Since no mouse TR1 sequences were available in sequence data bases, we initially determined the mouse TR1 cDNA sequence. 

Phrase: "Since"

Phrase: "no mouse TR1 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "available in sequence data bases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "determined"

Phrase: "the mouse TR1 cDNA sequence."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.338: Interestingly, this cDNA encoded a protein of 67kDa that was formed from a coding region starting with an ATG codon (in a favorable Kozak consensus sequence for phasing the message for translation) upstream of the previously predicted translation start site. 

Phrase: "Interestingly,"

Phrase: "this cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "a protein of 67kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "was"

Phrase: "formed from a coding region starting"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0079941:Coding Region [Gene or Genome]
   753   C0009219:Coding [Occupational Activity]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0205431:Formed [Functional Concept]
   750   C2985772:Form Code [Intellectual Product]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719   C0439659:Start [Temporal Concept]
   719 E C0805701:Code [Intellectual Product]
   719 E C1522492:Form [Functional Concept]

Phrase: "with an ATG codon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "("

Phrase: "in a favorable Kozak consensus sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0079160:Consensus Sequence [Nucleotide Sequence]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0376298:Consensus [Social Behavior]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "for phasing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205390:Phase [Temporal Concept]

Phrase: "the message for translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470166:Message [Intellectual Product]

Phrase: ")"

Phrase: "upstream of the previously predicted translation start site."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0040712:Translation [Intellectual Product]
   804   C0205145:Site [Spatial Concept]
   804   C0439659:Start [Temporal Concept]
   804   C0597295:translation [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C1519614:Translation [Genetic Function]
   804   C2825164:Site [Spatial Concept]
Processing 00000000.tx.339: The predicted extended N-terminal domain had no homology to known protein sequences, and at present its function is not known. 

Phrase: "The predicted extended N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "had"

Phrase: "no homology to known protein sequences,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0162777:Sequence Homology, Protein [Quantitative Concept]
   767   C0162775:Sequence Homology [Quantitative Concept]
   754 E C0162776:Protein Sequence Homologs [Amino Acid Sequence]
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]
   733   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   717 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "and at present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.340: Recently, several new mammalian TR1 cDNA sequences, including one for mouse TR1 (28), were deposited into GenBankTM. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "several new mammalian TR1 cDNA sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0162326:Sequences [Nucleotide Sequence]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]
   716 E C1548958:Sequential [Idea or Concept]
   716 E C1705294:Sequential [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "one for mouse TR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "deposited into GenBankTM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:deposited [Functional Concept]
Processing 00000000.tx.341: Examination of NR and EST sequences and their comparison to the mouse TR1 cDNA sequence that was determined in the present study, revealed three forms of mouse and rat TR1 cDNAs that had unrelated 5' sequences, but common downstream sequences. 

Phrase: "Examination of NR"

Phrase: "and"

Phrase: "EST sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "their comparison to the mouse TR1 cDNA sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707455:Comparison [Activity]

Phrase: "that"

Phrase: "was"

Phrase: "determined in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "three forms of mouse"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "rat TR1 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "had"

Phrase: "unrelated 5' sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "but"

Phrase: "common downstream sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.342: We also observed three human TR1 forms (BE618239, AU077310, and previously known TR1 sequences) obtained by alternative exon splicing. 

Phrase: "We also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "three human TR1 forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "(BE618239,"

Phrase: "AU077310,"

Phrase: "and"

Phrase: "previously known TR1 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: "obtained by alternative exon splicing."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0002345:Alternative Splicing [Genetic Function]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035687:Splicing [Genetic Function]
   760   C1301820:Obtained [Functional Concept]
   760   C1523987:Alternative [Conceptual Entity]
   760   C2610186:splicing [Genetic Function]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.343: The location of an alternative splicing site was conserved among mouse, rat, and human TR1 genes. 

Phrase: "The location of an alternative splicing site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450429:Location [Spatial Concept]
   748   C1515974:Location [Body Location or Region]

Phrase: "was"

Phrase: "conserved among mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "human TR1 genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0314604:Human gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.344: Alternative first exon splicing that was found to be used to synthesize alternative mRNA forms of mouse and rat TR1 mRNA is a previously recognized genetic phenomenon (29). 

Phrase: "Alternative first exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "that"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "synthesize"

Phrase: "alternative mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "forms of mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "rat TR1 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "a previously"

Phrase: "recognized"

Phrase: "genetic phenomenon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2350469:Genetic Phenomenon [Natural Phenomenon or Process]
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.345: It is used to accommodate requirements for elevated expression of a protein in a tissue-specific manner and to synthesize protein species that differ in their intracellular location (e.g. alternative forms may contain or lack an organelle-targeting signal peptide or a trans-membrane domain). 

Phrase: "It"

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accommodate"

Phrase: "requirements for elevated expression of a protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0556043:protein requirements [Finding]
   714   C1514873:Requirement [Functional Concept]

Phrase: "in a tissue-specific manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1955394:Tissue specific [Body Substance]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "synthesize"

Phrase: "protein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "differ in their intracellular location"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "("

Phrase: "e.g. alternative forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "or"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "an organelle-targeting signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037081:Signal Peptide [Amino Acid Sequence]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "a trans-membrane domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.346: In addition, alternative first exon splicing may be used as an on/off switch, which functions by alternative expression of protein-expressing and protein-suppressing mRNA forms. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "alternative first exon splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "used as an on/"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "off switch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:Switch [Manufactured Object]

Phrase: "which"

Phrase: "functions by alternative expression of protein-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1171362:expression protein [Genetic Function]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1523987:Alternative [Conceptual Entity]
   753   C1705273:Function [Intellectual Product]

Phrase: "expressing"

Phrase: "and"

Phrase: "protein-suppressing mRNA forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]
Processing 00000000.tx.347: In this case, the "off" form would contain additional upstream initiation sites followed by stop signals that would suppress protein expression, whereas the "on" form would produce a functional protein. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the ""off"" form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "would"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "additional upstream initiation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0205145:Sites [Spatial Concept]
   812   C0589507:Initiation [Mental Process]
   812   C1158830:Initiation [Genetic Function]
   812   C1704686:Initiation [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "followed by stop"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1947925:Stop [Activity]
   790   C2746065:Stop [Temporal Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "would"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "protein expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "the ""on"" form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "would"

Phrase: "produce"

Phrase: "a functional protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.348: Well characterized examples of alternative first exon splicing include genes of enzymes that are involved in "liver-associated" xenobiotic metabolism and detoxification. 

Phrase: "Well characterized examples of alternative first exon splicing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1707959:Example [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "genes of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1333402:Enzyme Gene [Gene or Genome]
   790   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in ""liver-associated"" xenobiotic metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1373178:liver metabolism [Organ or Tissue Function]
   840   C1154744:Xenobiotic Metabolism [Molecular Function]
   804   C0025519:Metabolism [Organism Function]
   804   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "detoxification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025516:Detoxification [Organism Function]
  1000   C0150543:Detoxification [Therapeutic or Preventive Procedure]
Processing 00000000.tx.349: The human microsomal glutathione S-transferase utilizes four alternative first exons, two of which appear to be functional and result in mRNA sequences differing in the 5'-untranslated region, and two nonfunctional forms as they contain additional upstream out of frame initiation signals (30). 

Phrase: "The human microsomal glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   804   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "utilizes"

Phrase: "four alternative first exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "two of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "result in mRNA sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "differing in the 5'-untranslated region,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "two nonfunctional forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "as"

Phrase: "they"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "additional upstream out of frame initiation signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522505:Upstream [Spatial Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.350: These four mRNA forms were predicted to be generated from a common promoter. 

Phrase: "These four mRNA forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "generated from a common promoter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3146294:Generated [Activity]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.351: The rat -glutamyltransferase gene also has four alternative first exons but utilizes four alternative promoters to form mRNA species differing in the 5'-untranslated region but encoding identical proteins (31). 

Phrase: "The rat -glutamyltransferase gene also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "four alternative first exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "utilizes"

Phrase: "four alternative promoters to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mRNA species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "differing in the 5'-untranslated region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "but"

Phrase: "encoding identical proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.352: Additional examples of alternative first exon splicing include family 19of the cytochrome P450 gene superfamily (32) and the UDP-glucoronosyltransferase gene (33), which contain numerous first exons but a common splice junction located upstream of the translation start site. 

Phrase: "Additional examples of alternative first exon splicing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707959:Example [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "family 19of"

Phrase: "the cytochrome P450 gene superfamily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1883220:Superfamily [Conceptual Entity]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "the UDP-glucoronosyltransferase gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "numerous first exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "a common splice junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205144:Junction [Spatial Concept]
   827   C1706311:Junction [Medical Device]

Phrase: "located upstream of the translation start site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C2945843:Site of [Qualitative Concept]
   748   C0040712:Translation [Intellectual Product]
   748   C0205145:Site [Spatial Concept]
   748   C0439659:Start [Temporal Concept]
   748   C0522505:Upstream [Spatial Concept]
   748   C0597295:translation [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C1519614:Translation [Genetic Function]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.353: One interesting observation made in the present study is that several mouse ESTs contained apolipoprotein E sequences within the TR1 sequences. 

Phrase: "One interesting observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0302523:Observation [Research Activity]
   827   C0700325:observation [Health Care Activity]
   827   C1964257:Observation [Diagnostic Procedure]
   755 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "made in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726   C1881534:Make [Functional Concept]

Phrase: "is"

Phrase: "that several mouse ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sequences within the TR1 sequences."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.354: Since all these ESTs originate from the same cDNA library (Sugano mouse kidney mkia), additional sequences from other sources may be required to confirm the observed puzzling location of the ApoE sequences. 

Phrase: "Since"

Phrase: "all these ESTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600510:ESTs [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "originate from the same cDNA library"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0023621:Library [Manufactured Object,Organization]
   753   C0445247:Same [Qualitative Concept]
   753   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Sugano mouse kidney mkia"

Phrase: ")"

Phrase: ","

Phrase: "additional sequences from other sources"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the observed puzzling location of the ApoE sequences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0450429:Location [Spatial Concept]
   742   C1515974:Location [Body Location or Region]
Processing 00000000.tx.355: If confirmed, the finding that an ApoE gene is located within the mouse TR1 gene may have important biomedical implications. 

Phrase: "If"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "an ApoE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "located within the mouse TR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]

Phrase: "may"

Phrase: "have"

Phrase: "important biomedical implications."
Processing 00000000.tx.356: Previous molecular genetic studies identified three genes (presenilin 1,presenilin 2,and -amyloid precursor protein) associated with early onset of Alzheimer's disease (AD), and one gene (ApoE) associated with late onset of AD (34). 

Phrase: "Previous molecular genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   844   C2827447:Genetic Study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(presenilin 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilin 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and -"

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "associated with early onset of Alzheimer's disease"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   870   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1833334:Early-onset [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "one gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(ApoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "associated with late onset of AD (34"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205087:Late [Temporal Concept]
   748   C0332162:Onset [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.357: An additional AD susceptibility locus has been mapped to a broad region of chromosome 12,but the gene responsible for a defect has not been identified. 

Phrase: "An additional AD susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to a broad region of chromosome 12,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C1953345:Region of chromosome [Cell]
           Chromosome region
   770   C0008654:Chromosome 12 [Cell Component]
   750   C0814036:chromosome map [Intellectual Product]
   744   C0008633:Chromosome [Cell Component]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0332464:Broad [Spatial Concept]
   711   C0024779:Map [Manufactured Object]
   711   C1706473:Map [Conceptual Entity]

Phrase: "but"

Phrase: "the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "responsible for a defect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.358: Whereas the human ApoE gene resides on chromosome 19,the TR1 gene is located on human chromosome 12.If a mouse TR1 gene indeed contains an additional ApoE gene and this gene organization is conserved in humans, then a new ApoE gene may provide an additional susceptibility marker for AD. 

Phrase: "Whereas"

Phrase: "the human ApoE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   902   C0314604:Human gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "resides on chromosome 19,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0008661:Chromosome 19 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   770   C2982691:Reside [Activity]

Phrase: "the TR1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "located on human chromosome 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0008643:Human Chromosome [Cell Component]
   806   C0008654:Chromosome 12 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0086418:Human [Human]

Phrase: "If"

Phrase: "a mouse TR1 gene indeed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an additional ApoE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "this gene organization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1517495:Gene Organization [Gene or Genome]
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "is"

Phrase: "conserved in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a new ApoE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an additional susceptibility marker for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.359: Alternatively, the ApoE sequences located within the mouse TR1 gene may be a part of an ApoE pseudogene, or the internal ApoE sequences could have been incorporated into TR1 sequences by an unknown genetic mechanism. 

Phrase: "Alternatively,"

Phrase: "the ApoE sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "located within the mouse TR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "a part of an ApoE pseudogene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "or"

Phrase: "the internal ApoE sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "could"

Phrase: "have"

Phrase: "been"

Phrase: "incorporated into TR1"

Phrase: "sequences by an unknown genetic mechanism."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0332240:unknown origin [Functional Concept]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0314603:Genetic [Functional Concept]
   753   C0439673:Unknown [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.360: To confirm the predicted organization of mouse and rat TR1 genes and to determine the actual mechanism involved in linking TR1 and ApoE sequences, we have to wait until actual sequences of TR1 genes are available. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the predicted organization of mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "rat TR1 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the actual mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "involved in linking TR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "ApoE sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "wait until actual sequences of TR1 genes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0017337:Genes [Gene or Genome]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0237400:Actual [Qualitative Concept]
   748   C1610166:wait [Functional Concept]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.361: Having determined the use of alternative first exon splicing in regulation of expression of mouse and rat TR1 mRNAs, we tested whether this mechanism is used to express multiple forms of other TRs. 

Phrase: "Having"

Phrase: "determined"

Phrase: "the use of alternative first exon splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat TR1 mRNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "multiple forms of other TRs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.362: Indeed, two unrelated 5'-end sequences, followed by common downstream sequences were evident from the analysis of two human TR2 cDNA sequences (EST sequence, accession number AA460989, and a cDNA sequence, accession number AF133519). 

Phrase: "Indeed,"

Phrase: "two unrelated 5'-end sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "followed by common downstream sequences"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0205214:Common [Quantitative Concept]
   760   C0522506:Downstream [Spatial Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "were"

Phrase: "evident from the analysis of two human TR2 cDNA sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   722   C0332120:Evidence of [Functional Concept]

Phrase: "(EST sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "accession number AA460989,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: "and"

Phrase: "a cDNA sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "accession number AF133519"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.363: However, the lack of full-size cDNAs and genomic sequences for mammalian TR2 did not allow us to evaluate the significance of this finding. 

Phrase: "However,"

Phrase: "the lack of full-size cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "genomic sequences for mammalian TR2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the significance of this finding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.364: The analysis of mammalian TR3 genes was more fruitful and revealed a remarkable genetic complexity within genomic segments that contained TR3 genes. 

Phrase: "The analysis of mammalian TR3 genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "more fruitful"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0016767:Fruit [Food]
   789   C1509510:fruit [Food]
   789   C3255628:FRUIT [Pharmacologic Substance]

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a remarkable genetic complexity within genomic"

Phrase: "segments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]

Phrase: "that contained TR3 genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.365: Like mouse and rat TR1 genes, the human TR3 gene contained three alternative first exons. 

Phrase: "Like mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat TR1 genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "the human TR3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0314604:Human gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "three alternative first exons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.366: However, the previously defined translation initiation site was located upstream of the first common exon and thus the use of alternative first exons resulted in different N-terminal sequences of the protein. 

Phrase: "However,"

Phrase: "the previously defined translation initiation site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C1519613:Translation Initiation [Genetic Function]
   804   C0040712:Translation [Intellectual Product]
   804   C0205145:Site [Spatial Concept]
   804   C0589507:Initiation [Mental Process]
   804   C0597295:translation [Molecular Function]
   804   C1158830:Initiation [Genetic Function]
   804   C1515974:Site [Body Location or Region]
   804   C1519614:Translation [Genetic Function]
   804   C1704686:Initiation [Functional Concept]
   804   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "located upstream of the first common exon"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205214:Common [Quantitative Concept]
   748   C0205435:First [Quantitative Concept]
   748   C0522505:Upstream [Spatial Concept]
   748   C1279901:First [Qualitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "thus"

Phrase: "the use of alternative first exons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "resulted in different N-terminal sequences of the protein."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C0002518:protein sequences [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0162326:Sequences [Nucleotide Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708   C1274040:Result [Functional Concept]
   708 E C1519249:Sequence [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]
Processing 00000000.tx.367: The use of exon 1resulted in the formation of a mitochondrial form of the enzyme, TR1-I (exon 1encoded a mitochondrial signal peptide). 

Phrase: "The use of exon 1resulted"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "in the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of a mitochondrial form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "TR1-I (exon 1encoded"

Phrase: "a mitochondrial signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.368: The use of exon 2instead of exon 1generated an mRNA form (TR3-II) that contained an upstream out of frame initiation site followed by a termination signal. 

Phrase: "The use of exon 2instead of exon 1generated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "an mRNA form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(TR3-II"

Phrase: ")"

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an upstream out of frame initiation site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522505:Upstream [Spatial Concept]

Phrase: "followed by a termination signal."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1549081:Termination [Intellectual Product]
   760   C1692758:termination [Idea or Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.369: This form could potentially be used as an off switch. 

Phrase: "This form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "could"

Phrase: "potentially"

Phrase: "be"

Phrase: "used as an off switch."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C1273517:used [Finding]
   760   C1707719:Switch [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.370: If exon 3was used in place of either exon 1or exon 2,the N-terminal sequence of TR3 was extended by only 5residues. 

Phrase: "If"

Phrase: "exon 3was"

Phrase: "used in place of either exon 1or exon 2,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   745   C1524063:Use of [Functional Concept]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0442504:Place [Spatial Concept]
   742   C1273517:used [Finding]
   742   C1704765:Place [Functional Concept]
   742   C1882509:Place [Activity]
   742   C3496241:place [Disease or Syndrome]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "the N-terminal sequence of TR3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "extended by only 5residues."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.371: The lack of signal sequences within TR3-III suggested that this protein could be located in the cytosol. 

Phrase: "The lack of signal sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "within TR3-III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "located in the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.372: Such a complex organization of TR3 genes was even more complicated by the fact that exon 1of human, mouse, and rat TR3 genes overlapped with exon 1of the MB-COMT gene located on a complementary DNA strand. 

Phrase: "Such"

Phrase: "a complex organization of TR3 genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1517495:Gene Organization [Gene or Genome]
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]

Phrase: "was"

Phrase: "even more"

Phrase: "complicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231242:Complicated [Functional Concept]

Phrase: "that exon 1of human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086418:Human [Human]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat TR3 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "overlapped with exon 1of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "the MB-COMT gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
   827   C1334751:Methyltransferase Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: "located on a complementary DNA strand."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.373: It has previously been established that the COMT gene gives rise to two alternative protein forms, a membrane-bound and a soluble form (27). 

Phrase: "It"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the COMT gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1135159:Catechol-O-Methyltransferase Gene [Gene or Genome]
           CATECHOL-O-METHYLTRANSFERASE
   861   C1334751:Methyltransferase Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to two alternative protein forms,"

Phrase: "a membrane-bound"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0025255:Membrane [Tissue]
   861   C0332297:bound [Spatial Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1145667:Bound [Activity]
   861   C1167622:Bound [Molecular Function]
   861   C1689898:% bound [Quantitative Concept]
   861   C1706182:Membrane [Manufactured Object]
   861   C2349209:Bound [Conceptual Entity]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "a soluble form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.374: Only the MB-COMT mRNA had common sequences with TR3 mRNA, and only TR3-I mRNA (mitochondrial form) overlapped with MB-COMT mRNA. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the MB-COMT mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "common sequences with TR3 mRNA,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "only TR3-I mRNA (mitochondrial form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0348078:Form [Qualitative Concept]
   799   C0376315:Form [Manufactured Object]
   799   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "overlapped with MB-COMT mRNA."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   800   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   800   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   744   C0007413:catechol [Organic Chemical]
   744   C0025255:Membrane [Tissue]
   744   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0054858:catechol [Organic Chemical,Pharmacologic Substance]
   744   C0185027:overlapped [Therapeutic or Preventive Procedure]
   744   C0332297:bound [Spatial Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C2349209:Bound [Conceptual Entity]
   711 E C1948020:Overlap [Conceptual Entity]
Processing 00000000.tx.375: Interestingly, the COMT knockout mice have been previously generated and found to exhibit sexually dimorphic changes in catecholamine levels and behavior (35). 

Phrase: "Interestingly,"

Phrase: "the COMT knockout mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "sexually dimorphic changes in catecholamine levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.376: No sufficient experimental details were reported (35) to evaluate whether knockouts could have affected expression of some of the TR3 forms. 

Phrase: "No sufficient experimental details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1522508:Details [Qualitative Concept]
   793 E C1561567:detail [Functional Concept]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(35"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "whether"

Phrase: "knockouts"

Phrase: "could"

Phrase: "have"

Phrase: "affected expression of some of the TR3 forms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   725   C1554102:Formal Expression [Idea or Concept]
Processing 00000000.tx.377: It is also not known whether TR3 could be involved in psychiatric disorders and symptoms, including the psychopathology associated with the 22q11 microdeletion, the area of the human chromosome 22,where the COMT and TR3 genes are located. 

Phrase: "It"

Phrase: "is"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "TR3"

Phrase: "could"

Phrase: "be"

Phrase: "involved in psychiatric disorders"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004936:Psychiatric disorders [Mental or Behavioral Dysfunction]
   770   C0012634:Disorders [Disease or Syndrome]
   770   C0205487:Psychiatric [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "symptoms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the psychopathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033927:Psychopathology [Biomedical Occupation or Discipline]

Phrase: "associated with the 22q11 microdeletion,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1521101:22q11 [Cell Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the area of the human chromosome 22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]

Phrase: "where"

Phrase: "the COMT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "TR3 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "located."
Processing 00000000.tx.378: Availability of the completely sequenced Drosophila genome and a large number of EST sequences allowed us to test if alternative first exon splicing is also used in Drosophila. 

Phrase: "Availability of the completely sequenced Drosophila genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "and"

Phrase: "a large number of EST sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2348184:Sequence Number [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "alternative first exon splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0002345:Alternative Splicing [Genetic Function]
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "also"

Phrase: "used in Drosophila."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0013138:Drosophila [Eukaryote]
   790   C1028876:Drosophila [Fungus]
   790   C1273517:used [Finding]
   790   C1504613:Drosophila [Eukaryote]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.379: We identified two alternative exons within the Drosophila TR gene that generated predicted mitochondrial and cytosolic enzymes. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two alternative exons within the Drosophila TR gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that generated predicted mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "cytosolic enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.380: Interestingly, the site for junction of alternative first exons and a common downstream exon was conserved between mammalian TR3 and Drosophila TR genes, suggesting a close evolutionary relation between these genes. 

Phrase: "Interestingly,"

Phrase: "the site for junction of alternative first exons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2945843:Site of [Qualitative Concept]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a common downstream exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "conserved between mammalian TR3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024660:Mammalian [Mammal]

Phrase: "and"

Phrase: "Drosophila TR genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a close evolutionary relation between these genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]
Processing 00000000.tx.381: In addition, homology and phylogenetic analyses (data not shown) indicated slightly higher evolutionary linkage between Drosophila TR and mammalian TR3 genes than between mammalian TR1 and TR3 genes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334043:Homology [Gene or Genome]
  1000   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "phylogenetic analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C1519068:Phylogenetic Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   768   C0031797:Phylogenies [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "slightly higher evolutionary linkage between Drosophila TR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "mammalian TR3 genes than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "between mammalian TR1"

Phrase: "and"

Phrase: "TR3 genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.382: In conclusion, we identified alternative exon splicing as a general mechanism to express multiple mRNA forms of animal TRs. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "alternative exon splicing as a general mechanism to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0002345:Alternative Splicing [Genetic Function]
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]

Phrase: "express"

Phrase: "multiple mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "forms of animal TRs."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   773   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0003062:Animal [Animal]
   760   C0030016:Reductases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1522492:Form [Functional Concept]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.383: Such mRNA forms encoded proteins that have common or different N-terminal sequences and that were responsible, at least in part, for observed heterogeneity within animal TR preparations. 

Phrase: "Such mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "encoded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "have"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "or"

Phrase: "different N-terminal sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "were"

Phrase: "responsible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1273518:Responsible [Finding]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "for observed heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "within animal TR preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.384: The use of alternative first exon splicing has not been described previously for any known selenoprotein. 

Phrase: "The use of alternative first exon splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for any known selenoprotein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0074302:Selenoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.385: Further studies are required to determine the functional role of alternative first exon splicing in regulation of expression and function of animal thioredoxin reductases.  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the functional role of alternative first exon splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1705810:Functional Role [Conceptual Entity]
           Role
   744   C0035820:Role [Social Behavior]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function of animal thioredoxin reductases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.386: Addendum A recent paper by Rundlof et al. 

Phrase: "Addendum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510776:Addendum [Intellectual Product]

Phrase: "A recent paper by Rundlof et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0030351:Paper [Manufactured Object]
   748   C1547566:Paper [Idea or Concept]
Processing 00000000.tx.387: (36) also reported identification of three variants of rodent TR1 mRNA.  

Phrase: "(36"

Phrase: ")"

Phrase: "also reported identification of three variants of rodent TR1 mRNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0020792:Identification [Mental Process]
   739   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.388: FOOTNOTES * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.389: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.390: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.391: The nucleotide mouse TR1 cDNA sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number AF333036. 

Phrase: "The nucleotide mouse TR1 cDNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   897   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM/EBI Data Bank"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0242356:Data Bank [Intellectual Product]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C1420599:EBI [Gene or Genome]
   748   C1511726:Data [Idea or Concept]
   748   C1515023:Submitted [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "with accession number AF333036."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]
Processing 00000000.tx.392: ** To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.393: Fax: 402-472-7842; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "402-472-7842"

Phrase: ";"
Processing 00000000.tx.394: E-mail: vgladyshev1@unl.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "vgladyshev1@unl.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.395: Published, JBC Papers in Press, November 1,2000,DOI 10.1074/jbc.M004750200  ABBREVIATIONS The abbreviations used are: TR, thioredoxin reductase; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "November 1,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M004750200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "TR,"

Phrase: "thioredoxin reductase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.396: TGF, transforming growth factor ; PAGE, polyacrylamide gel electrophoresis; 

Phrase: "TGF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]
   717   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transforming growth factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "; PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.397: HPLC, high performance liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.398: MALDI, matrix-assisted laser desorption ionization; 

Phrase: "MALDI,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C0596801:Ionization [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1269765:Assisted [Finding]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706315:Laser [Medical Device]
   804   C1706515:Matrix [Body Substance]
   771 E C0018896:assist [Social Behavior]
   771 E C0557034:assist [Health Care Activity]

Phrase: "matrix-assisted laser desorption ionization"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C0596801:Ionization [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1269765:Assisted [Finding]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706315:Laser [Medical Device]
   804   C1706515:Matrix [Body Substance]
   771 E C0018896:assist [Social Behavior]
   771 E C0557034:assist [Health Care Activity]

Phrase: ";"
Processing 00000000.tx.399: GPx, glutathione peroxidase; 

Phrase: "GPx,"

Phrase: "glutathione peroxidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.400: Sec, selenocysteine; 

Phrase: "Sec,"

Phrase: "selenocysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074289:Selenocysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.401: NR, nonredundant; 

Phrase: "NR, nonredundant"

Phrase: ";"
Processing 00000000.tx.402: COMT, catechol-O-methyltransferase; 

Phrase: "COMT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "catechol-O-methyltransferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.403: MB-COMT, membrane-bound catechol-O-methyltransferase; 

Phrase: "MB-COMT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   884   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   804   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "membrane-bound catechol-O-methyltransferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   884   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   804   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.404: S-COMT, soluble catechol-O-methyltransferase; 

Phrase: "S-"

Phrase: "COMT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
  1000   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   827   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "soluble catechol-O-methyltransferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0007407:Catechol O-Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
           Catechol Methyltransferase
   923   C1135159:CATECHOL-O-METHYLTRANSFERASE [Gene or Genome]
   812   C0025831:Methyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.405: AD, Alzheimer's disease.  

Phrase: "AD,"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.406: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.407: Sies, H. 

Phrase: "Sies,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.408: (1999) Free Radic. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.409: Biol. 

Phrase: "Biol."
Processing 00000000.tx.410: Med. 

Phrase: "Med."
Processing 00000000.tx.411: 27, 916-921[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "27,"

Phrase: "916-921"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.412: Holmgren, A. 

Phrase: "Holmgren,"

Phrase: "A."
Processing 00000000.tx.413: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.414: Biol. 

Phrase: "Biol."
Processing 00000000.tx.415: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.416: 264, 13963-13966[Free FullText] 3. 

Phrase: "264,"

Phrase: "13963-13966"

Phrase: "[Free FullText"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.417: Halliwell, B. 

Phrase: "Halliwell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.418: (1999) Free Radic. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.419: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.420: 31, 261-272[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "261-272"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.421: Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., and Taketo, M. 

Phrase: "Matsui,"

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takaku,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Maruyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yodoi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Taketo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.422: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.423: (1986) Dev. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.424: Biol. 

Phrase: "Biol."
Processing 00000000.tx.425: 178, 179-185[CrossRef] 5. 

Phrase: "178,"

Phrase: "179-185"

Phrase: "[CrossRef"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.426: Gasdaska, P. 

Phrase: "Gasdaska,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.427: Y., Berggren, M. 

Phrase: "Y.,"

Phrase: "Berggren,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.428: M., Berry, M. 

Phrase: "M."

Phrase: ","

Phrase: "Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005135:Berry [Food]
  1000   C0982158:BERRY [Food]
  1000   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: J., and Powis, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Powis,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.430: (1999) FEBS Lett. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.431: 442, 105-111[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "442,"

Phrase: "105-111"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.432: Lee, S. 

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: R., Kim, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.434: R., Kwon, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kwon,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.435: S., Yoon, H. 

Phrase: "S."

Phrase: ","

Phrase: "Yoon,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.436: W., Levine, R. 

Phrase: "W., Levine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.437: L., Ginsburg, A., and Rhee, S. 

Phrase: "L., Ginsburg,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.438: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.439: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.440: Biol. 

Phrase: "Biol."
Processing 00000000.tx.441: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.442: 274, 4722-4734[Abstract/Free FullText] 7. 

Phrase: "274,"

Phrase: "4722-4734"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.443: Miranda-Vizuete, A., Damdimopoulos, A. 

Phrase: "Miranda-Vizuete,"

Phrase: "A.,"

Phrase: "Damdimopoulos,"

Phrase: "A."
Processing 00000000.tx.444: E., Pedrajas, J. 

Phrase: "E.,"

Phrase: "Pedrajas,"

Phrase: "J."
Processing 00000000.tx.445: R., Gustafsson, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gustafsson,"

Phrase: "J."
Processing 00000000.tx.446: A., and Spyrou, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Spyrou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.447: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.448: J.

Phrase: "J."
Processing 00000000.tx.449: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.450: 261, 405-412[Abstract/Free FullText] 8. 

Phrase: "261,"

Phrase: "405-412"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.451: Watabe, S., Makino, Y., Ogawa, K., Hiroi, T., Yamamoto, Y., and Takahashi, S. 

Phrase: "Watabe,"

Phrase: "S."

Phrase: ","

Phrase: "Makino,"

Phrase: "Y.,"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hiroi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.452: Y. 

Phrase: "Y."
Processing 00000000.tx.453: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.454: J.

Phrase: "J."
Processing 00000000.tx.455: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.456: 264, 74-84[Abstract/Free FullText] 9. 

Phrase: "264,"

Phrase: "74-84"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.457: Miranda-Vizuete, A., Damdimopoulos, A. 

Phrase: "Miranda-Vizuete,"

Phrase: "A.,"

Phrase: "Damdimopoulos,"

Phrase: "A."
Processing 00000000.tx.458: E., and Spyrou, G. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Spyrou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.459: (1999) Biochim. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.460: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.461: Acta 1447, 113-118[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "Acta 1447,"

Phrase: "113-118"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.462: Sun, Q.-A., Wu, Y., Zappacosta, F., Jeang, K.-T., Lee, B. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Q.-A.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Y.,"

Phrase: "Zappacosta,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jeang,"

Phrase: "K.-T.,"

Phrase: "Lee,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.463: J., Hatfield, D. 

Phrase: "J.,"

Phrase: "Hatfield,"

Phrase: "D."
Processing 00000000.tx.464: L., and Gladyshev, V. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gladyshev,"

Phrase: "V."
Processing 00000000.tx.465: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.466: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.469: 274, 24522-24530[Abstract/Free FullText] 11. 

Phrase: "274,"

Phrase: "24522-24530"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.470: Tamura, T., and Stadtman, T. 

Phrase: "Tamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.471: C. 

Phrase: "C."
Processing 00000000.tx.472: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.473: Natl. 

Phrase: "Natl."
Processing 00000000.tx.474: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.475: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.476: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.477: 93, 1006-1011[Abstract/Free FullText] 12. 

Phrase: "93,"

Phrase: "1006-1011"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450317:1011 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.478: Gladyshev, V. 

Phrase: "Gladyshev,"

Phrase: "V."
Processing 00000000.tx.479: N., Jeang, K.-T., and Stadtman, T. 

Phrase: "N., Jeang,"

Phrase: "K.-T.,"

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.480: C. 

Phrase: "C."
Processing 00000000.tx.481: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.482: Natl. 

Phrase: "Natl."
Processing 00000000.tx.483: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.484: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.485: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.486: 93, 6146-6151[Abstract/Free FullText] 13. 

Phrase: "93,"

Phrase: "6146-6151"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.487: Fujiwara, N., Fujii, T., Fujii, J., and Taniguchi, N. 

Phrase: "Fujiwara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fujii,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujii,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.488: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.489: J. 

Phrase: "J."
Processing 00000000.tx.490: 340, 439-444[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "340,"

Phrase: "439-444"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.491: Lee, S. 

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.492: R., Bar-Noy, S., Kwon, J., Levine, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bar-Noy,"

Phrase: "S."

Phrase: ","

Phrase: "Kwon,"

Phrase: "J.,"

Phrase: "Levine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: L., Stadtman, T. 

Phrase: "L., Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: C., and Rhee, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.495: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.496: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.497: Natl. 

Phrase: "Natl."
Processing 00000000.tx.498: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.499: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.500: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.501: 97, 2521-2526[Abstract/Free FullText] 15. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "2521-2526"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.502: Gasdaska, J. 

Phrase: "Gasdaska,"

Phrase: "J."
Processing 00000000.tx.503: R., Harney, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Harney,"

Phrase: "J."
Processing 00000000.tx.504: W., Gasdaska, P. 

Phrase: "W., Gasdaska,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.505: Y., Powis, G., and Berry, M. 

Phrase: "Y.,"

Phrase: "Powis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005135:Berry [Food]
  1000   C0982158:BERRY [Food]
  1000   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 274, 25379-25385[Abstract/Free FullText] 16. 

Phrase: "274,"

Phrase: "25379-25385"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.511: Liu, S. 

Phrase: "Liu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.512: Y., and Stadtman, T. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.513: C. 

Phrase: "C."
Processing 00000000.tx.514: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.515: Natl. 

Phrase: "Natl."
Processing 00000000.tx.516: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.517: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.518: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.519: 94, 6138-6141[Abstract/Free FullText] 17. 

Phrase: "94,"

Phrase: "6138-6141"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.520: Gorlatov, S. 

Phrase: "Gorlatov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.521: N., and Stadtman, T. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: C. 

Phrase: "C."
Processing 00000000.tx.523: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.524: Natl. 

Phrase: "Natl."
Processing 00000000.tx.525: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.526: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.527: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.528: 95, 8520-8525[Abstract/Free FullText] 18. 

Phrase: "95,"

Phrase: "8520-8525"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.529: Gorlatov, S. 

Phrase: "Gorlatov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.530: N., and Stadtman, T. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.531: C. 

Phrase: "C."
Processing 00000000.tx.532: (1999) Arch. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.533: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.534: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.535: 369, 133-142[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "369,"

Phrase: "133-142"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.536: Gladyshev, V. 

Phrase: "Gladyshev,"

Phrase: "V."
Processing 00000000.tx.537: N., Factor, V. 

Phrase: "N., Factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "V."
Processing 00000000.tx.538: M., Housseau, F., and Hatfield, D. 

Phrase: "M."

Phrase: ","

Phrase: "Housseau,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hatfield,"

Phrase: "D."
Processing 00000000.tx.539: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.540: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.541: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.542: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.543: Commun. 

Phrase: "Commun."
Processing 00000000.tx.544: 251, 488-493[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "251,"

Phrase: "488-493"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.545: Appella, E., Arnott, D., Sakaguchi, K., and Wirth, P. 

Phrase: "Appella,"

Phrase: "E.,"

Phrase: "Arnott,"

Phrase: "D."

Phrase: ","

Phrase: "Sakaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Wirth,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.546: J. 

Phrase: "J."
Processing 00000000.tx.547: (2000) EXS (Exper. Suppl.) 

Phrase: "(2000"

Phrase: ")"

Phrase: "EXS"

Phrase: "(Exper. Suppl."

Phrase: ")"
Processing 00000000.tx.548: 88, 1-27 21. 

Phrase: "88,"

Phrase: "1-27 21."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.549: Sutton, C. 

Phrase: "Sutton,"

Phrase: "C."
Processing 00000000.tx.550: W., Pemberton, K. 

Phrase: "W., Pemberton,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.551: S., Cottrell, J. 

Phrase: "S."

Phrase: ","

Phrase: "Cottrell,"

Phrase: "J."
Processing 00000000.tx.552: S., Corbett, J. 

Phrase: "S."

Phrase: ","

Phrase: "Corbett,"

Phrase: "J."
Processing 00000000.tx.553: M., Wheeler, C. 

Phrase: "M."

Phrase: ","

Phrase: "Wheeler,"

Phrase: "C."
Processing 00000000.tx.554: H., Dunn, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dunn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: J., and Pappin, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Pappin,"

Phrase: "D."
Processing 00000000.tx.556: J. 

Phrase: "J."
Processing 00000000.tx.557: (1995) Electrophoresis 16, 308-316[Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Electrophoresis 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "308-316"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.558: Zappacosta, F., Borrego, F., Brooks, A. 

Phrase: "Zappacosta,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Borrego,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Brooks,"

Phrase: "A."
Processing 00000000.tx.559: G., Parker, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Parker,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.560: C., and Coligan, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Coligan,"

Phrase: "J."
Processing 00000000.tx.561: E. 

Phrase: "E."
Processing 00000000.tx.562: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.563: Natl. 

Phrase: "Natl."
Processing 00000000.tx.564: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.565: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.566: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.567: 94, 6313-6318[Abstract/Free FullText] 23. 

Phrase: "94,"

Phrase: "6313-6318"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.568: Altschul, S. 

Phrase: "Altschul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.569: F., Madden, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Madden"

Phrase: ","

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.570: L., Schffer, A. 

Phrase: "L., Schffer,"

Phrase: "A."
Processing 00000000.tx.571: A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. 

Phrase: "A.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "W.,"

Phrase: "and"

Phrase: "Lipman,"

Phrase: "D."
Processing 00000000.tx.572: J. 

Phrase: "J."
Processing 00000000.tx.573: (1997) Nucleic Acids Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.574: 25, 3389-3402[Abstract/Free FullText] 24. 

Phrase: "25,"

Phrase: "3389-3402"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.575: Gasdaska, P. 

Phrase: "Gasdaska,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.576: Y., Gasdaska, J. 

Phrase: "Y.,"

Phrase: "Gasdaska,"

Phrase: "J."
Processing 00000000.tx.577: R., Cochran, S., and Powis, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cochran,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Powis,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.578: (1995) FEBS Lett. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.579: 373, 5-9[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "373,"

Phrase: "5-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.580: Zhong, L., Arner, E. 

Phrase: "Zhong,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Arner,"

Phrase: "E."
Processing 00000000.tx.581: S., Ljung, J., Aslund, F., and Holmgren, A. 

Phrase: "S."

Phrase: ","

Phrase: "Ljung,"

Phrase: "J.,"

Phrase: "Aslund,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Holmgren,"

Phrase: "A."
Processing 00000000.tx.582: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.583: Biol. 

Phrase: "Biol."
Processing 00000000.tx.584: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.585: 273, 8581-8591[Abstract/Free FullText] 26. 

Phrase: "273,"

Phrase: "8581-8591"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.586: Lescure, A., Gautheret, D., Carbon, P., and Krol, A. 

Phrase: "Lescure,"

Phrase: "A.,"

Phrase: "Gautheret,"

Phrase: "D."

Phrase: ","

Phrase: "Carbon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Krol,"

Phrase: "A."
Processing 00000000.tx.587: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.588: Biol. 

Phrase: "Biol."
Processing 00000000.tx.589: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.590: 274, 38147-38154[Abstract/Free FullText] 27. 

Phrase: "274,"

Phrase: "38147-38154"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.591: Tenhunen, J., Salminen, M., Lundstrom, K., Kiviluoto, T., Savolainen, R., and Ulmanen, I. 

Phrase: "Tenhunen,"

Phrase: "J.,"

Phrase: "Salminen,"

Phrase: "M."

Phrase: ","

Phrase: "Lundstrom,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kiviluoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Savolainen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ulmanen,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.592: (1994) Eur. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.593: J.

Phrase: "J."
Processing 00000000.tx.594: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.595: 223, 1049-1059[Abstract] 28. 

Phrase: "223,"

Phrase: "1049-1059"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 28."
Processing 00000000.tx.596: Kawai, H., Ota, T., Suzuki, F., and Tatsuka, M. 

Phrase: "Kawai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069299:OTA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tatsuka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: (2000) Gene 242, 321-330[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Gene 242,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "321-330"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.598: Breitbart, R. 

Phrase: "Breitbart,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: E., Andreadis, A., and Nadal-Ginard, B. 

Phrase: "E.,"

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Nadal-Ginard,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.600: (1987) Annu. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.601: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.602: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.603: 56, 467-495[CrossRef][Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "56,"

Phrase: "467-495"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.604: Kelner, M. 

Phrase: "Kelner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.605: J., Bagnell, R. 

Phrase: "J.,"

Phrase: "Bagnell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.606: D., Montoya, M. 

Phrase: "D."

Phrase: ","

Phrase: "Montoya,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.607: A., Estes, L. 

Phrase: "A.,"

Phrase: "Estes,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.608: A., Forsberg, L., and Morgenstern, R. 

Phrase: "A.,"

Phrase: "Forsberg,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Morgenstern,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.609: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.610: Biol. 

Phrase: "Biol."
Processing 00000000.tx.611: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.612: 275, 13000-13006[Abstract/Free FullText] 31. 

Phrase: "275,"

Phrase: "13000-13006"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.613: Okamoto, T., Darbouy, M., Brouillet, A., Lahuna, O., Chobert, M. 

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Darbouy,"

Phrase: "M."

Phrase: ","

Phrase: "Brouillet,"

Phrase: "A.,"

Phrase: "Lahuna,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Chobert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: N., and Laperche, Y. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Laperche,"

Phrase: "Y."
Processing 00000000.tx.615: (1994) Biochemistry 33, 11536-11543[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "11536-11543"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.616: Simpson, E. 

Phrase: "Simpson,"

Phrase: "E."
Processing 00000000.tx.617: R., Michael, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Michael,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.618: D., Agarwal, V. 

Phrase: "D."

Phrase: ","

Phrase: "Agarwal,"

Phrase: "V."
Processing 00000000.tx.619: R., Hinshelwood, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hinshelwood,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.620: M., Bulun, S. 

Phrase: "M."

Phrase: ","

Phrase: "Bulun,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.621: E., and Zhao, Y. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zhao,"

Phrase: "Y."
Processing 00000000.tx.622: (1997) FASEB J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.623: 11, 29-36[Abstract/Free FullText] 33. 

Phrase: "11,"

Phrase: "29-36"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.624: Strassburg, C. 

Phrase: "Strassburg,"

Phrase: "C."
Processing 00000000.tx.625: P., Oldhafer, K., Manns, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oldhafer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Manns,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.626: P., and Tukey, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tukey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.627: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.628: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.629: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.630: 52, 212-220[Abstract/Free FullText] 34. 

Phrase: "52,"

Phrase: "212-220"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.631: St. 

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.632: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.633: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.634: (1999) Semin. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Semin."
Processing 00000000.tx.635: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.636: 19, 371-383[Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "19,"

Phrase: "371-383"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.637: Gogos, J. 

Phrase: "Gogos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1939700:Gogo [Fish]

Phrase: "J."
Processing 00000000.tx.638: A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., and Karayiorgou, M. 

Phrase: "A.,"

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Luine,"

Phrase: "V.,"

Phrase: "Santha,"

Phrase: "M."

Phrase: ","

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "S."

Phrase: ","

Phrase: "Pfaff,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Karayiorgou,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.639: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.640: Natl. 

Phrase: "Natl."
Processing 00000000.tx.641: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.642: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.643: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.644: 95, 9991-9996[Abstract/Free FullText] 36. 

Phrase: "95,"

Phrase: "9991-9996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.645: Rundlof, A. 

Phrase: "Rundlof,"

Phrase: "A."
Processing 00000000.tx.646: K., Carlsten, M., Giacobini, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Carlsten,"

Phrase: "M."

Phrase: ","

Phrase: "Giacobini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.647: M., and Arner, E. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Arner,"

Phrase: "E."
Processing 00000000.tx.648: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.649: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.650: J. 

Phrase: "J."
Processing 00000000.tx.651: 347, 661-668[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "347,"

Phrase: "661-668"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

